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 The development of atom-, redox-, and step-, and pot-economonical strategies 
for the streamlined synthesis of biologically active small molecules stands at the 
forefront of modern-day organic synthesis and early-stage drug discovery. In 
particular, those approaches that employ methods which allow for the reliable, 
predictable, and high-yielding coupling of a variety of both simple and elaborate 
chemical fragments to common core structural motifs represent some of the most 
efficient and versatile strategies to accomplish this goal. Since its first report in 2005, 
the use of phosphate triesters as temporary tethers has proven to be a powerful 
method for the facile formation of complex 1,3-skipped polyol-containing small 
molecules and biologically active natural products. The ability of phosphate tethers to 
impart differential olefin reactivity (exocyclic versus endocyclic), serve as temporary 
protecting groups, as well as latent leaving groups, and mediate several reactions in 
one-pot, sequential reactions continues to provide unique reactivity pathways to 
stereochemically rich intermediates, while minimizing chemical waste and the need 
for time-consuming purification. To date, phosphate-tether methods have served as 
the cornerstone in the total syntheses of dolabelide C, tetrahydrolipstatin, 
strictifolione, and Sch-725674, the formal synthesis of salicylihalimide A, and 
synthetic efforts toward lyngbouilloside and spirastrellolide B. Current efforts in the 
 iv 
group are focused on the expansion and diversification of phosphate tether-mediated 
RCM strategies for the two-directional synthesis of biologically active small 
molecules. 
This thesis is dedicated to describing synthetic studies that augment previous 
work reported by our group involving P-stereogenic bicyclic phosphorus heterocycles 
and temporary tether strategies for the synthesis of complex polyols. Chapter 2 
outlines a detailed study on the effects of stereochemical complexity, ring size, and 
olefin substitution on phosphate tether-mediated RCM. Studies focus on the 
formation of bicyclo[4.3.1]-, bicyclo[5.3.1]-, bicyclo[7.3.1]-, and 
bicyclo[8.3.1]phosphates, with a special emphasis on the factors that affect the 
success and stereochemical outcome of the P-tether mediated RCM event to form 10- 
and 11-membered bicyclic phosphates. Chapter 3 focuses on the synthesis of P-
stereogenic bicyclo[4.3.1]phosphite-borane systems for the two-directional synthesis 
of complex polyols. These studies highlight the P-tether systems’ ability to facilitate 
chemoselective olefin functionalization, divergent oxidation strategies that allow 
access to the corresponding phosphate or thiophosphate, and a stereocontrolled, 
iterative SN2’-cuprate displacement protocol that marries the chemistry of phosphite 
borane tethers with that of their all oxygen-containing counterparts to generate polyol 
stereotetrads that were previously inaccessible via phosphate tether strategies alone. 
Chapter 4 presents the application of phosphate tether-mediated, one-pot sequential 
processes toward the total synthesis of 2S-sanctolide A and outlines plans for the 
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 The development of step-, atom-, and redox-economical methods that allow for 
the facile formation of complex intermediates from simple starting materials is central to 
the design and execution of streamlined syntheses of biologically active small molecules, 
natural products, and natural product analogs.1 In particular, temporary tether strategies, 
which can provide enhanced control of substrate reactivity and transformation selectivity 
through innate intramolecularity,2 have served as powerful synthetic tools to accomplish 
this goal. While temporary silicon tethers are by far the most studied and well represented 
in the literature,3 other tether systems, including ketal4 and carboxylate tethers,5 have 
been developed for intermediate coupling via ring-closing metathesis (RCM) olefination. 
Though every useful tether system will meet certain necessary requirements (i.e. high-
yielding installation, stability to reaction conditions, easily removable),2b the benefit of 
additional synthetic utility, arising from the inherent chemical properties of the tether 
itself, magnifies the significance of the tool by allowing it to serve as a manipulatable 
functional handle for further diversification of substrates. In this regard, the ability of 
phosphate triesters to serve as tripodal tethers with the ability to act as both a protecting 
group and a latent leaving group capable of activating multiple carbinol centers to 
nucleophilic attack makes them intriguing targets for tether development. Moreover, in 
addition to their well-established reactivity profiles (Figure 1.1),6 phosphates also possess 
a rich biological history—as phosphates are ubiquitous in nature7 and are present in 
biologically active natural products,8 as well as FDA-approved drugs and pro-drugs 
(Figure 1.2).9 Thus, those intermediates that contain phosphate tether systems, obtained 
3 
en route to the total synthesis of a natural product or biologically active small molecule, 
may also possess interesting biological activity in their own right. For these reasons, the 
development of phosphate-based tripodal tether systems would be an attractive 
alternative to the more classically utilized divalent silicon systems.  
Figure 1.1 Chemistry of phosphates. 
 
 
Figure 1.2 Phosphate-containing biologically active small molecules. 
 
 In 2005, our group published the synthesis and reactivity of the first reported 
phosphate triester temporary tether strategy for the synthesis of 1,3-anti-diol-containing 
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Phosphates as Leaving Groups






































































































enantiomer] with phosphorus(V) oxychloride (POCl3), in the presence of triethylamine 
(Et3N) and catalytic 4-dimethylaminopyridine (DMAP), provides the corresponding 
monocyclic, mono-chlorophosphate (not shown). Treatment of this unstable intermediate 
with the lithium alkoxide of allyl alcohol smoothly generates pseudo-C2-symmetric 
phosphate triene (S,S)-1.1.2, which exists as two conformers (1.1.2a and 1.1.2b, 
respectively). Subsequent ring-closing metathesis of triene 1.1.2, facilitated by catalytic 
Grubbs second-generation catalyst [G-II, (ImesH2)(PCy3)(Cl)2Ru=CHPh],12 then provides 
a single diastereomer of bicyclo[4.3.1]phosphate,13 (SP,S,S)-1.1.3, through reactive 
conformer (S,S)-1.1.2a.  
 
























































































































 The authors next sought to identify a basic reactivity profile for bicyclic 
phosphate 1.1.3, which was found to be remarkably acid stable (up to 6 N HCl), as well 
as benchtop stable (>3 years). Reductive tether removal, by LiAlH4, afforded triol 1.1.4 
in good yield. Selective functionalization of the exocyclic olefin through cross metathesis 
(CM) with acrolein or hydrogenation via diimide reduction14 generated functionalized 
systems 1.1.5 and 1.1.6 in 78% and 82% yields, respectively (Scheme 1.1). 
Stereoselective SN2’-cuprate displacement of the phosphate tether in 1.1.6 provided 6-
membered monocyclic phosphoric acid 1.1.7 in excellent yield and selectivity through 
C5-addition. Complementarily, SN2’-cuprate displacement of the phosphate tether in 
1.1.3 afforded 7-membered monocyclic phosphoric acid 1.1.8 in excellent yield and good 
selectivity (rs ~8:1) via C10-addition to the exocyclic olefin. In addition to establishing 
method viability, this original publication highlighted the synthetic utility of the 
phosphate triester tether and represented a solid platform upon which to expand the 
potential of the phosphate to serve as both a temporary tether and latent functional handle 
for subsequent substrate diversification.  
 Over the past 10 years, on-going efforts in our group have sought to exploit the 
inherent properties of phosphate triesters to develop tripodal P-tether systems for the 
generation of complex polyol-containing natural products.15 This chapter will review 
recent advances in this methodology and its application in the synthesis of biologically 
active small molecules and natural product analogs (Figure 1.3). In particular, the ability 
of phosphate tethers to mediate several transformations in one-pot sequential processes 
will be highlighted. All in all, this chapter will seek to provide the reader with the 
6 
sufficient context necessary to fully understand how the work presented hereafter 
(Chapters 2-4 of this thesis) contributes to the on-going narrative within the field 
regarding P-stereogenic, bicyclic phosphorus heterocycles and temporary tether strategies 
for the synthesis of complex polyol-containing natural products. 
Figure 1.3 Phosphate tether-mediated synthetic strategies toward the total synthesis of 
natural products.  
 
 Because the earliest syntheses completed in our laboratory have been previously 
reviewed,16 these works—the syntheses of dolabelide C, salicylihalimide A, and  
(–)-tetrahdrolipstatin—will be briefly reviewed with particular focus on those fragments 










































































1.2 Total Synthesis of Dolabelide C 
  Dolabelide C (1.4A), a 24-membered, cytotoxic macrolide, was isolated and fully 
characterized in 1997 from the sea hare Dolabella auricularia by Yamada and coworkers 
(Figure 1.4).17 Inspired by its stereochemical complexity and potent biological activity, 
our group targeted the total synthesis of dolabelide C, which culminated in three separate 
publications—the western portion (C1–C14)18 and the eastern portion (C15–C30)19 in 
2008, followed by the total synthesis in 2011.20 The retrosynthetic analysis involved a 
late-stage, macrocyclic ring-closing metathesis, preceded by a Yamaguchi esterification21 
to couple the two main fragments 1.4B and 1.4C, which would be generated via two 
separate synthetic strategies starting from both enantiomeric bicyclic phosphates 1.1.3. 
For the western fragment (C1–C14), stereochemistry would be introduced using a cross-
metathesis/hydrogenation pathway to provide 1.4D, followed by a regioselective Pd-
mediated allylic transposition of the bicyclic phosphate. For the eastern fragment (C15–
C30), another cross-metathesis/hydrogenation protocol would install the long-chain 
alkenyl group (C15–C19), and a regio- and diastereoselective SN2’-cuprate addition to 
























































































intermediate 1.4E would generate the methyl group at C22 and a terminal olefin for 
further functionalization. 
 The synthesis of 1.4B commenced with the coupling of (RP,R,R)-1.1.3 with 
olefin-containing stereotriad 1.2.1 (4 steps from Roche ester),18 in the presence of 
Hoveyda-Grubbs second-generation catalyst22 (HG-II, 6 mol %) (Scheme 1.2). 
Subsequent chemoselective hydrogenation of the exocyclic olefin, via diimide 
reduction,14 in the corresponding cross-metathesis product provided 1.4D in good overall 
yield. Allylic transposition of the bicyclic phosphate, followed by methylation of the 
resultant phosphoric acid, then afforded terminal olefin-containing monocyclic phosphate 
1.2.2, which was treated with LiAlH4 to provide the corresponding diol in 75% yield. 
Acetal protection of the diol 1.2.3 with 2,2-dimethoxypropane and pyridinium p-toluene 
sulfonate generated 1.2.4 in 96%. Intermediate 1.2.4 was then converted into 1.4B via a 
5-step sequence involving ozonolysis of the terminal olefin, non-selective Grignard 
addition to the resultant aldehyde, and an oxidation-acetal deprotection-stereoselective  
 









































































reduction protocol to install the appropriate stereochemistry of the C11-alcohol.18  
 Likewise, the synthesis of fragment 1.4C commenced with a second cross-
metathesis/hydrogenation sequence (Scheme 1.3). In a similar manner as previously 
described, (SP,S,S)-1.1.3 and PMB-protected 4-penten-1-ol were treated with HG-II (6 
mol %), followed by chemoselective hydrogenation of the resultant exocyclic olefin, to 
afford bicyclic phosphate 1.3.1 in good overall yield. Treatment of 1.3.1 with in-situ-
generated dimethyl cuprate successfully installed the C22-methyl substituent with the 
appropriate stereochemical configuration via a regio- and diastereoselective SN2’-cuprate 
displacement of the phosphate, and subsequent reductive tether removal generated the 
corresponding diol (1.3.2) in excellent yield. Acetal protection of diol 1.3.2 (96% yield), 
followed by Johnson-Lemieux oxidation of the terminal olefin and reduction of the 
resultant aldehyde with sodium borohydride, afforded primary alcohol 1.3.3 in 81% 
yield. Alcohol 1.3.3 was then TBS-protected and the distal hydroxyl group was PMB-
deprotected with H2, catalytic Pd/C, and sodium bicarbonate, in EtOAc, to provide 
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alcohol 1.3.4. Alcohol 1.3.4 was converted to the primary alkyl iodide with 
triphenylphosphine (PPh3) and I2 and eliminated under basic conditions [potassium tert-
butoxide (tBuOK)] to afford the corresponding terminal olefin (not shown). Subsequent 
TBS-deprotection of the resultant olefinic intermediate with TBAF furnished alcohol 
1.3.5, which was converted into intermediate 1.4C over four steps.20  
Finally, intermediate 1.4C was coupled with acid 1.4.1, which was obtained in 3 
steps from intermediate 1.4B, under conditions developed by Yamaguchi and coworkers, 
to provide 1.4.2 (Scheme 1.4).21 Functional group interconversion over 4 steps generated 
diene 1.4.3, which was subjected to a variety of ring-closing metathesis conditions to 
generate the title natural product. Ultimately, it was found that treatment of 1.4.3 with  
G-II (20 mol %), in refluxing methylene chloride (0.5 mM) provided dolabelide C (1.4A)  
in an optimized yield of 57%, albeit as a 1:1 mixture of E- and Z-isomers. Unfortunately, 
 















































































this diastereomeric ratio was not improved through the use of alternative reaction 
conditions, though the advent of stereoselective metathesis catalysts23 may provide a 
much-needed solution to the selectivity problem of this final macrocyclization step. 
1.3 Formal Synthesis of (–)-Salicylihalimide A 
 In 2011, Hanson and coworkers published the formal synthesis24 of (–)-
salicylihalimide A (1.5A), a cytotoxic macrolide isolated from marine sponge Halicona 
sp. in 1997 (Figure 1.5).25 Retrosynthetic analysis revealed that 1.5A, and its relative 
salicyclihalimide B,25 could be obtained from distal functionalization of benzofused 
macrolactone 1.5B. In turn, the stereochemically complex subunit in 1.5B, simplified diol 
1.5C, could be derived from bicyclic phosphate (RP,R,R)-1.1.3 via a hydroboration-
oxidation functionalization of the exocyclic olefin, followed by a regio- and 
diastereoselective SN2’-cuprate addition to install the necessary branched methyl group 
and reveal a terminal olefin for further functionalization. 
Figure 1.5 Retrosynthetic analysis of (–)-salicylihalimide A 
 
 Following this strategy, (RP,R,R)-1.1.3 was hydroborated with  
9-borabicyclo[3.3.1]nonane (9-BBN), followed by oxidation of the intermediate aliphatic 
borane, to provide the corresponding alcohol; p-methoxy-benzyl protection of the 
resultant alcohol afforded bicyclic phosphate 1.5.4 in 92% yield (Scheme 1.5). Treatment 























P = PMB (RP,R,R)-1.1.3
12 
phosphoric acid, provided monocyclic 1.5.5 in 75% yield, as a 1:1 mixture of 
diastereomers at phosphorus. Subsequent cross-metathesis of 1.5.5 with cis-1,4-
diacetoxy-2-butene generated allyl-acetate-functionalized intermediate 1.5.6. Pd-
mediated allylic transposition of the allyl acetate moiety in 1.5.6, followed by reductive 
removal of the monocyclic phosphate, generated the corresponding diol (1.5C) in 
excellent yield. Base-promoted transesterification of intermediate 1.5.7, obtained in 3 
steps from commercially available 2,6-dihydroxy-benzoic acid,26 with the alkoxide of 
1.5C provided the desired ester 1.5.8 in 72% yield. MOM-protection of both the phenolic 
and aliphatic alcohols furnished intermediate 1.5.9, which was treated with Grubbs first 
generation catalyst (G-I, 10 mol %) in refluxing methylene chloride to generate 
macrolactone core 1.5B in 82% yield as a 9:1 mixture of E- and Z-isomers. 
 
Scheme 1.5 Formal synthesis of (–)-salicylihalimide A. 
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1.4 Total Synthesis of (–)-Tetrahydrolipstatin: One-pot, Sequential 
RCM/CM/Hydrogenation 
 In 2010, Hanson and coworkers reported the total synthesis of the anti-obesity 
drug (–)-tetrahydrolipstatin (1.6.1)27 in a route consisting of 11-longest linear pots, 
including the first reported phosphate tether-mediated, one-pot sequential process—ring-
closing metathesis/cross-metathesis/hydrogenation (Scheme 1.6).28 Treatment of triene 
(S,S)-1.1.2 with G-II (3 mol %), followed by addition of HG-II catalyst and olefinic 
cross-partner (1-undecene), then chemoselective diimide reduction (hydrogenation) of the 
exocyclic olefin, provided functionalized bicyclic phosphate 1.6.2 in 40% yield over 3 
reactions in one pot (75% average per reaction). This one-pot, sequential process was 
optimized and the substrate scope expanded in a follow-up method development paper 
that was reported in 2012,29  and it has served to streamline almost every synthetic effort 
towards other natural products and their analogs developed by our laboratory since its 
publication.  
 Bicyclic phosphate 1.6.2 was then treated with in-situ-generated dihexyl cuprate, 
followed by methylation of the resultant phosphoric acid, to provide monocyclic 
phosphate 1.6.3, again as a 1:1 mixture of diastereomers at phosphorus (Scheme 1.6). 
Reductive tether removal, followed by TIPS-protection of the most sterically accessible 
secondary alcohol, afforded 1.6.4 in 85% and 80% yields, respectively. Subsequent 
ozonolysis and Pinnick oxidation30 of the resultant aldehyde provided carboxylic acid 
1.6.5 in excellent overall yield. β-Lactone formation was achieved by treating acid 1.6.5 
with coupling reagent bis(2-oxo-3-oxazolidinyl)phosphinic chloride (BOP-Cl) to 
14 
generate, after TIPS-deprotection with HF•pyridine, β-lactone 1.6.6. Finally, coupling of 
1.6.6 and N-formyl leucine, carried out under Mitsunobu conditions developed by 
Schneider,31 afforded (–)-tetrahydrolipstatin (1.6.1) in 11-longest linear pots. 
 
Scheme 1.6 Total synthesis of (–)-tetrahydrolipstatin. 
1.5 Total Synthesis of (+)-Strictifolione and (6R)-6[(E,4R,6R)-4,6-dihydroxy-10-
phenyl-1-decenyl]-5,6-dihydro-2H-2-pyrone 
 The repertoire of phosphate tether-mediated, one-pot, sequential processes was 
expanded in application toward the streamlined and modular total synthesis of anti-fungal 
natural product (+)-strictifolione (1.7.1)32 which was reported by our laboratory in 2014 
(Scheme 1.7).33 This synthetic strategy employed two one-pot, sequential processes to 
generate the title natural product in 6 longest-linear pots. Starting from triene (R,R)-1.1.2, 
one-pot RCM/cross metathesis (with cis-stilbene)/chemoselective hydrogenation 
(RCM/CM/hydrogenation) provided bicyclic phosphate 1.7.2 in 52% yield over 3 
reactions (81% average per reaction). Pd-mediated, allylic transposition of the bicyclic 
phosphate in 1.7.2, followed by methylation of the resultant phosphoric acid and 
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CH2Cl2, reflux, 2 h
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reductive tether removal with lithium aluminum hydride, afforded diol 1.7.3 in 65% over 
3 reactions in one pot (87% average per reaction). Finally, diol 1.7.3 was coupled with 
α,β-unsaturated lactone 1.7.4 (5 steps from commercially available starting materials),34 
in the presence of HG-II (5 mol %) in refluxing methylene chloride, to provide (+)-
strictifolione (1.7.1) in 77% yield, 26% overall yield from starting triene (R,R)-1.1.2. 
 
Scheme 1.7 Total synthesis of (+)-strictifolione. 
 In addition, a similar synthetic strategy was applied to the total synthesis of 
strictifolione relative (6R)-6[(E,4R,6R)-4,6-dihydroxy-10-phenyl-1-decenyl]-5,6-dihydro-
2H-2-pyrone (1.8.1) (Scheme 1.8).32c,d A one-pot RCM/CM/hydrogenation protocol 
involving the coupling of the bicyclic phosphate resulting from RCM of triene (S,S)-1.1.2 
with but-3-en-1-ylbenzene provided functionalized bicyclic phosphate 1.8.2 in 54% yield 
over 3 reactions (82% average per reaction). Finally, intermediate 1.8.2 was converted to 
the natural product 1.8.1 via a two-pot procedure—a one-pot, sequential Pd-mediated 
allylic transposition/methylation/tether removal protocol, followed by cross-metathesis of 
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the intermediate olefinic alcohol with α,β-unsaturated lactone 1.7.4.34 Thus, the 
successful two-pot procedure provided (6R)-6[(E,4R,6R)-4,6-dihydroxy-10-phenyl-1-
decenyl]-5,6-dihydro-2H-2-pyrone (1.8.1) from 1.8.2 in 28% yield over 2 steps and 4 
reactions (73% yield average per reaction). 
 
Scheme 1.8 Total synthesis of (6R)-6[(E,4R,6R)-4,6-dihydroxy-10-phenyl-1-decenyl]-
5,6-dihydro-2H-2-pyrone. 
1.6 Synthesis of the Macrolactone Core of (–)-Lyngbouilloside 
 In 2015, Hanson and Chegondi reported synthetic efforts35 toward (–)-
lyngbouilloside (1.6A), a cytotoxic macrolactone isolated from marine cyanobacteria 
Lyngbya bouillonii in 2002 (Figure 1.6).36 The authors proposed that the natural product 
could be obtained through an intermediate lactone core (1.6B), which was the primary 
target of the synthetic publication. In turn, macrolactone 1.6B could be generated from a 
Boeckman acylketene cyclization37 of β-ketoester 1.6C, derived from the Roskamp 
homologation of the one-pot, sequential RCM/CM/hydrogenation product resulting from 
triene (R,R)-1.1.2 and olefin 1.6D.  Finally, olefin 1.6D could be synthesized from 
geraniol (1.6E), and (R,R)-1.1.2 could be formed from the corresponding (R,R)-dienediol 
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Figure 1.6 Retrosynthetic analysis to the macrolactone core of (–)-lyngbouilloside. 
 
 Thus, geraniol (1.6E) was exposed to allylic alcohol-directed Sharpless 
asymmetric epoxidation conditions38 to provide the corresponding tri-substituted epoxide 
(not shown); subsequent regioselective, reductive epoxide opening with Red-Al, followed 
by PMP-acetal formation, provided intermediate 1.9.1 (Scheme 1.9). Ozonolysis of the 
trisubstituted olefin in 1.9.1, followed by reduction of the resultant aldehyde, afforded 
primary alcohol 1.9.2 in 87% yield. TBS-protection of alcohol 1.9.2 and regioselective 
mono-deprotection of the PMP-acetal generated intermediate alcohol 1.9.3. Parikh-
Doering oxidation39 of alcohol 1.9.3, followed by Brown asymmetric crotylation40 of the 
resultant aldehyde, furnished 1.9.4 in 72% yield over 2 steps. Finally, TBS-protection of 

























































Scheme 1.9 Synthesis of C8–C16 fragment 1.6D. 
 Intermediate 1.6D was then coupled with (R,R)-1.1.2 in a one-pot, sequential 
RCM/CM/hydrogenation protocol (as previously described) to generate bicyclic 
phosphate 1.10.1 (Scheme 1.10). Regioselective, Pd-mediated allylic transposition of 
bicyclic phosphate 1.10.1, followed by methylation of the resultant phosphoric acid and 
reductive tether removal of the corresponding monocyclic phosphate, afforded diol 1.10.2 
in 82% and 76% yields, respectively (transposition-methylation and tether removal). The 
free alcohols were silyl-protected with TESOTf and 2,6-lutidine to generate intermediate 
1.10.3 in excellent yield, and oxidative cleavage of the terminal olefin via a modified 
Johnson-Lemieux protocol41 provided the corresponding aldehyde which was 
immediately subjected to a two-carbon Roskamp homologation,42 with ethyl diazoacetate 
in the presence of SnCl4•5H2O, to furnish β-keto ester 1.10.4 in good overall yield.  
Finally, PMB-deprotection of the tertiary alcohol in 1.10.4 generated Boeckman 
cyclization precursor 1.6C, which was cyclized in refluxing toluene to afford the target 
macrolactone in good overall yield. 
O O
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Scheme 1.10 Synthesis of lyngbouilloside macrolactone 1.6B. 
1.7 Total Synthesis of Sch-725674 
 In 2016, Hanson and coworkers published a modular and pot-economical 
synthesis43 of antifungal macrolide Sch-725674 (1.7A) that was isolated and 
characterized by Yang and coworkers in 2005.44 Retrosynthetic analysis of 1.7A showed 
that the natural product could be derived from the macrocyclic RCM of acyclic precursor 
1.7B, which could be generated from 1.7C via two, one-pot, sequential processes: a one-
pot tosylation of the primary alcohol and acryloylation of the secondary alcohol, followed 
by a one-pot Finkelstein substitution of the resultant primary tosylate, Boord olefination45 
of the intermediate alkyl iodide, and acetonide deprotection of the 1,3-anti-diol moiety. 
Correspondingly, epoxide 1.7C could be formed from bicyclic phosphate 1.7D via 
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reductive tether removal and Sharpless asymmetric epoxidation,38 and 1.7D would result 
from a one-pot sequential RCM/CM/hydrogenation protocol involving the appropriate 
olefinic alcohol and phosphate triene (S,S)-1.1.2. 
Figure 1.7 Retrosynthetic analysis to Sch-725674. 
 
 Following this approach, the authors first set out to synthesize 1.7B (Scheme 
1.11). Thus, phosphate triene (S,S)-1.1.2 was coupled with olefinic alcohol 1.11.1 in a 
one-pot sequential RCM/CM/hydrogenation protocol similar to those previously 
described to provide functionalized bicyclic phosphate 1.7D in 59% yield over 3 
reactions in one pot (84% average per reaction). Reductive tether removal with LiAlH4, 
followed by acetal protection of the 1,3-anti-diol moiety, afforded intermediate 1.11.2 in 
excellent yield over two steps. Alcohol-directed, asymmetric Sharpless epoxidation of 
allylic alcohol 1.11.2 provided the corresponding epoxide 1.7C in good yield and 
diastereoselectivity. Subsequent one-pot tosylation of the most sterically accessible 
primary alcohol and acryloylation of the remaining secondary alcohol generated 1.11.3 in 
86% yield over 2 reactions in one pot (93% average per reaction). Primary tosylate 1.11.3 
was then treated with sodium iodide, in refluxing acetone (Finkelstein reaction), followed 
by Boord olefination45 and acetal deprotection, to generate RCM-precursor 1.7B in 


























































Scheme 1.11 Synthesis of intermediate 1.7B. 
 Finally, though RCM of 1.7B could provide the target of interest (1.7A, as 
previously reported),46 it was found that global MOM-protection of triol 1.7B 
significantly improved the efficiency of the final, macrocyclic RCM event. Thus, 
treatment of 1.7B with MOM-Cl, in the presence of diisopropyl(ethyl)amine, provided 
1.12.1 in excellent yield (97%), and subsequent one-pot sequential RCM/MOM-
deprotection [G-II, then trifluoroacetic acid (TFA)] generated the natural product, Sch-
725674, in 84% yield over two reactions in one pot (92% average per reaction) (Scheme 
1.12). Overall, this strategy provided 1.7A in 8 longest linear pots and 14.6% overall 
yield from triene (S,S)-1.1.2. In particular, this approach highlights the phosphate tether’s 
ability to mediate a variety of transformations in one-pot sequential processes that allow 
for high-yielding, streamlined syntheses of natural products and natural product analogs. 
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Scheme 1.12 End-game to Sch-725674 (1.7A). 
1.8 Pot-Economical Syntheses of 1,3-Skipped Polyols and α ,β-Unsaturated 
Macrolactones 
 In addition to the synthesis of natural products, efforts in our laboratory have 
aimed at the development and expansion of known one-pot sequential pathways to 
generate natural-product-like libraries of small molecules. In 2014, Hanson and 
coworkers published a modular and divergent approach to the synthesis of 1,3-skipped 
polyols via a variety of one-pot sequential processes.47 As shown in Scheme 1.13, 
coupling of mono-chlorophosphate (S,S)-1.13.1 with either chiral, non-racemic olefinic 
alcohol 1.13.2 or 1.13.3 provided phosphate trienes 1.13.4 and 1.13.5, respectively 
(Scheme 1.13). These substrates were then diversified utilizing three different pot-
economical processes. The two-pot RCM/CM/hydrogenation-reductive tether removal 
strategy allowed for the coupling of triene 1.13.4 with olefinic alcohol 1.13.3 to afford 
tetraol 1.13.6 in 26% yield over 2 pots and 4 reactions (71% average per reaction). 
Similarly, triene 1.13.5 was coupled with olefinic alcohol 1.13.2 in a one-pot sequential 
RCM/CM/hydrogenation sequence, followed by reductive tether removal, to generate 
polyol 1.13.7 in 24% yield over 2 pots and 4 reactions (70% average per reaction). 
Conversely, triene 1.13.5 was again coupled with alcohol 1.13.3 in a one-pot, sequential 
MOMCl, DIPEA 
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RCM/CM/tether removal protocol to provide polyol 1.13.8 in 35% yield over three 
reactions in one pot (70% average per reaction), and triene 1.13.5 was exposed to similar 
conditions—with addition of alcohol 1.13.2—to afford polyol 1.13.9 in similar yield. 
Finally, two convergent, two-pot protocols involving a one-pot RCM/CM/tether removal, 
followed by global olefin reduction with o-NBSH and Et3N, furnished tetraol 1.13.10 
from either triene 1.13.4 or 1.13.5 (via the addition of the appropriate olefinic alcohol 
cross-partner). Taken collectively, these transformations highlighted the potential utility 
of one-pot sequential processes to provide diversified small molecule libraries from 
simple starting materials. In addition, this study served as an important basis set that 
legitimized further exploration and development of other phosphate tether-mediated, one-
pot sequential processes for the facile formation of natural products. 
 
Scheme 1.13 One-pot sequential strategies to 1,3-skipped polyols. 
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 Following the report of the total synthesis of macrolactone Sch-725674, in 2016, 
Hanson and coworkers published the synthesis of a small library of α,β-unsaturated 
macrolactones and macrolactone analogs via a series of one-pot sequential processes 
(Figure 1.8).48 In a sequence reminiscent of those used in the previously reported 
synthesis of Sch-725674, a one-pot sequential RCM/CM/hydrogenation protocol coupled 
triene (R,R)-1.1.2 with TBS-protected olefinic alcohol 1.8A to provide intermediate 1.8B, 
which was exposed to a one-pot sequential allylic transposition/methylation/tether 
removal (see the total synthesis of strictifolione, vide supra) to generate intermediate 
1.8C. This intermediate was then diversified via one of two pathways involving 2–3 one-
pot sequential protocols to synthesize a library of 6, 14-membered macrocycles— 
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including lactones, lactams, sultones, sultams, phosphonates, and phosphonamides 
(1.8D–I, Figure 1.8). Thus, following Path A, 1.8C was exposed to a one-pot sequential 
diol-protection with MOM-chloride and facilitating diisopropyl(ethyl)amine, de-
silylation with TBAF, and O-functionalization (with acryloyl chloride, 2-
chloroethanesulfonyl chloride, or ethyl(vinyl)phosphonochloridate49) to afford the 
corresponding dienes in 72–75% yield over 3 reactions in one-pot (60% yield for 3 
reactions in 2 pots for 1.8F diene). The dienes were then treated with G-II (10 mol %), 
and—in some cases—MOM-deprotection with HCl, to furnish final macrocycles 1.8D–F 
in excellent overall yield. Similarly, following Path B, 1.8C was transformed to 
macrolactam 1.8G, macrosultam 1.8H, and macrophostam 1.8I via 3, one-pot sequential 
processes—including a one-pot Mitsunobu reaction with diphenylphosphorylazide, azide 
reduction with LiAlH4, and amine functionalization (with acryloyl chloride, 2-
chloroethanesulfonyl chloride, or ethyl(vinyl)phosphonochloridate). These investigations 
further illustrated the power of one-pot, sequential processes—including phosphate 
tether-mediated transformations—to generate structurally diverse libraries of natural 
product analogs in a modular fashion with minimal intermediate isolation/purification. 
1.8 Efforts Toward the Total Synthesis of Spirastrellolide B: Phosphate Tether 
Strategies to the C9–C25 Fragment 
 In 2016, Hanson and coworkers reported efforts toward the synthesis of 
spirastrellolide B (1.9A),50 a marine macrolide isolated from Caribbean marine sponge 
Spirastrella coccinea by Andersen and coworkers in 2007.51 The authors proposed that 
the stereochemically rich C9–C25 fragment (1.9B) could be formed via an Achmatowicz 
26 
spiroketalization52 of furan polyol 1.9C, which, in turn, could arise from the Suzuki-
Miyaura coupling of bromo-furan 1.9D and vinyl-borane 1.9E (Figure 1.9). 1,3-Anti-diol-
containing intermediate 1.9E could be synthesized from bicyclic phosphate (RP,R,R)-
1.1.3 via a regioselective hydroboration-oxidation of the exocyclic olefin and a 
diastereoselective SN2’-addition of dimethyl cuprate to install the C14-methyl group. 
Figure 1.9 Retrosynthetic analysis to spirastrellolide B. 
 
 Synthesis commenced with the generation of intermediate 1.9D. PMB-protection 
of the primary alcohol in (S)-Roche ester 1.14.1, followed by Weinreb amide53 formation 
with N,O-dimethylhydroxylamine•hydrochloride and iPr-MgCl, provided intermediate 
1.14.2 in excellent overall yield (Scheme 1.14). Vinylation of 1.14.2, carried out with 1-
propenylmagnesium bromide, and subsequent Corey-Bakshi-Shibata reduction54 of the 
resultant α,β-unsaturated ketone afforded chiral, non-racemic allylic alcohol 1.14.3 in 
77% yield (dr = 8:1). Ruthenium-catalyzed cross-metathesis of 1.14.3 with 2-bromo-5-





















































































1.14.5 in 75% yield. Subsequent TBS-protection of the allylic alcohol with TBSOTf and 
2,6-lutidine, followed by Sharpless asymmetric dihydroxylation55 of the internal olefin 
with AD-mix-α, osmium tetroxide, and hydroquinine 1,4-phthalazinediyl diether 
(DHQ)2PHAL, in tert-butanol:water (1:1) at 0 oC, generated intermediate 1.9D in 69% 
yield and 7 longest-linear pots (8 total pot count). 
 
Scheme 1.14 Synthesis of intermediate 1.9D. 
 With 1.9D in hand, the authors turned their sights to the generation of the second 
Suzuki-Miyaura coupling partner, intermediate 1.9E (Figure 1.9). RCM of phosphate 
triene (R,R)-1.1.2 with G-II (3 mol %), followed by chemoselective hydroboration of the 
resultant bicyclic phosphate with BH3•DMS and oxidation with sodium perborate, 
afforded functionalized bicyclic phosphate 1.15.1 in 31% yield over 2 reactions in one 
pot (56% average per reaction, unoptimized). It should be noted that these individual 
steps were optimized and reported, as well (86% for the RCM, 84% for the 
hydroboration-oxidation sequence), though the one-pot process—even unoptimized—





CH2Cl2, PPTS, rt, 16 h
80%
2. (OMe)NH(Me)•HCl




































HG-II (6 mol %)



















0 ºC, 2 d
 69%
1.9D 
7 LLP, 8 TPC
88%
28 
framework, which is why it is included here. Subsequent benzyl protection of the primary 
alcohol with BnBr and Ag2O afforded 1.15.2, which was treated with in-situ-generated 
dimethyl cuprate, followed by reductive removal of the resultant phosphoric acid, to 
provide diol 1.15.3 and install the C14-methyl group with the appropriate stereochemical 
configuration. Diol 1.15.3 was acetal protected to generate 1.15.4 in 87% yield, and 
subsequent cross metathesis of 1.15.4 with commercially available pinacol vinylboronate 
successfully furnished intermediate 1.9E in near quantitative yield (98%). 
 
Scheme 1.15 Synthesis of intermediate 1.9E. 
 Finally, Suzuki-Miyaura coupling of vinylboronate 1.9E with bromo-furan 1.9D, 
with Pd(PPh3) and tripotassium phosphate base, provided the desired coupling partner 
(not shown) in the best—though still modest—yield (50%). Diimide reduction of the 
resultant olefin, with excess o-NBSH and Et3N, generated Achmatowicz-cyclization 
precursor 1.9C in 84% yield. Subsequent acetal deprotection with catalytic 
camphorsulfonic acid (CSA, 10 mol %), followed by cascade Achmatowicz-
spiroketalization (m-CPBA, then CSA), afforded the desired spiroketal-containing diol 
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global TBS-protection of 1.16.1 with TBSOTf and 2,6-lutidine, C=C double bond 
reduction with H2 and Lindlar catalyst, and diastereoselective reduction (ds = 88%) of the 
resultant ketone provided the C9–C25 fragment of spirastrellolide B (1.9B) in good 
overall yield.   
 
Scheme 1.16 Synthesis of C9–C25 fragment of spirastrellolide B. 
1.9 Conclusions 
 Since its first report in 2005, the use of phosphate triesters as temporary tethers 
has proven to be a powerful method for the facile formation of complex 1,3-skipped 
polyol-containing small molecules and biologically active natural products. The ability of 
phosphate tethers to impart differential olefin reactivity (exocyclic versus endocyclic) and 
serve as temporary protecting groups, as well as latent leaving groups, bolsters the 
synthetic utility of this tripodal tether system by allowing for the simple, modular 
diversification of common core intermediates to rapidly build molecular complexity. In 
addition, the ability of phosphate triester tethers to mediate several reactions in one-pot, 
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rich intermediates while minimizing chemical waste and the need for time-consuming 
purification. To date, phosphate-tether methods have served as the cornerstone in the total 
syntheses of dolabelide C, tetrahydrolipstatin, strictifolione, and Sch-725674, the formal 
synthesis of salicylihalimide A, and synthetic efforts toward lyngbouilloside and 
spirastrellolide B (vide supra), and current efforts in the group are focused on the 
expansion and diversification of phosphate tether-mediated, one-pot sequential processes 
for use in the streamlined synthesis of biologically active small molecules.  
The remainder of this thesis is dedicated to describing synthetic studies that 
augment previous work outlined in this introductory chapter. These investigations 
include: (i) a detailed study on the effects of stereochemical complexity, ring size, and 
olefin substitution on phosphate tether-mediated RCM; (ii) the development of 
complementary phosphite-borane tether systems that can be used separately or in tandem 
with phosphate tethers to generate 1,3-skipped polyol stereotetrads that were previously 
inaccessible via phosphate tether methods alone; and (iii) the application of phosphate 
tether-mediated one-pot sequential processes toward the total synthesis of 2S-sanctolide 
A (Figure 1.10). 
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Phosphate Tether-Mediated Ring-Closing Metathesis Studies to 
Bicyclo[n.3.1]phosphates: Extended Investigations on the Effect of Ring 





 The development of methods that allow for the mild, high-yielding, and 
predictable coupling of simple chemical fragments to provide complex intermediates 
from core motifs common to a variety of natural products stands at the forefront of 
modern-day organic synthesis. In particular, methods that employ temporary tether 
strategies have emerged as intriguing tools to control substrate reactivity, site specificity 
and stereochemical outcome of tether-mediated transformations.1 While the use and study 
of temporary silicon-based tether systems in RCM is well represented in the literature,2 
on-going efforts in our group have sought to exploit the inherent properties of phosphate 
triesters to develop tripodal P-tether systems3 for the generation of complex polyol-
containing intermediates en route to the total synthesis of natural products (see Chapter 1 
of this thesis). This work has led to the completion of a number of total and formal 
syntheses, including dolabelide C,4 salicylihalimide A (formal synthesis),5 (–)-
tetrahydrolipstatin,6 (+)-strictifolione,7 and lyngbouilloside (core macrolactone).8 In an 
effort to expand the scope of the method, in 2013, we completed a detailed study on the 
effects of ring size and stereochemical complexity on the successful formation of 
bicyclo[4.3.1]-,9 bicyclo[5.3.1]-,10 and bicyclo[7.3.1]phosphates11,12 via diastereoselective 
RCM.13  In 2015, we published a continuation of these efforts to provide a number of 
stereochemically complex bicyclo[6.3.1]phosphates,14 along with a few simple examples 
of bicyclo[7.3.1]- and bicyclo[8.3.1]phosphates.15,16  However, the complexity of large 
ring dynamics—combined with the small sample size of bicyclo[7.3.1]- and 
bicyclo[8.3.1]phosphates in both studies—can complicate the generalization of those 
	
 45 
findings. Since the preliminary studies represented some of the first reports of RCM to 
afford phosphates of this ring size, much still remains to be discovered in this particular 
area of macrocyclic phosphate synthesis. Thus, in 2016, we reported an investigation that 
expands upon previous efforts by focusing on the formation of bicyclo[7.3.1]- and 
bicyclo[8.3.1]phosphates (10- and 11-membered RCM), with a special emphasis on the 
effect of olefin- and C3-substition, as well as proximity of the forming olefin to the 
bridgehead carbon of the resultant bicyclic phosphate, on the success and stereochemical 
outcome of the macrocyclic, ring-closing metathesis event.17 This chapter presents our 
recent work in P-tether-mediated RCM studies to provide a variety of P-stereogenic 
bicyclo[4.3.1]-, bicyclo[5.3.1]-, bicyclo[7.3.1]-, and bicyclo[8.3.1]phosphates,  with a 
detailed analysis of the factors affecting 10- and 11-membered ring formation (Figure 
2.1).  
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2.1.1 Temporary Silicon Tethered Ring-Closing Metathesis in the Formation of Medium 
to Large Rings 
 Though the vast majority of temporary silicon tether-mediated ring-closing 
metatheses (TST-RCM) result in the formation 7- or 8-membered rings,2 investigations 
involving the generation of medium- to large-ring-containing silicon heterocycles via 
RCM have been reported—albeit in limited scope. In 1999, Hoye and Promo reported a 
study focused on TST-RCM reactions for self- and cross-coupling of alkenyl alcohols.18 
Investigations included the formation of 7-, 9-, and 11-membered silicon heterocycles, 
and a few examples are shown in Scheme 2.1. Dienes 2.1.1 and 2.1.2, derived from the 
coupling of diphenylchlorosilane with the appropriate olefinic alcohol, were treated with 
Grubbs first generation catalyst19 (G-I, 10 mol %, added slowly over 10 hours) to provide 
the corresponding 9- and 11-membered monocyclic silicon heterocycles in good yield 
and high Z-selectivity (Scheme 2.1). The authors noted, that although the formation of Z-
configured olefins was overwhelmingly preferred, small amounts of stereoisomer 
(assigned as the E-diastereomer) were observed by GC and GC-MS for nearly every 
example, and unsurprisingly, selectivity tended to decrease with increasing ring-size. 
 
Scheme 2.1 Temporary silicon-tether mediated RCM to 9- and 11-membered silicycles. 
 In 2006, the same group reported the use of temporary silicon tether-mediated 
RCM en route to the total synthesis of cytotoxic, anti-tumor agent (+)-gigantecin (2.2.1) 
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could be derived from triene 2.2.3 and lactone 2.2.4 via a one-pot, three-component 
RCM-CM or CM-RCM metathesis strategy involving the formation of an intermediate 7-
membered ring-containing silicon heterocycle.  However, treatment of triene 2.2.3 with 
Hoveyda-Grubbs second-generation catalyst21 (HG-II, 15 mol %), in refluxing toluene, 
provided 11-membered ring-containing 2.2.5, instead of the expected 7-membered ring. 
The authors hypothesize that the formation of 2.2.5 is the direct result of preferential 
catalyst-initiation at the more active, Type I-like C8-olefin. Cross-metathesis of 2.2.5 
with 2.2.4, in the presence of Grubbs second-generation catalyst22 (G-II, 
[(ImesH2)(PCy3)(Cl)2Ru=CHPh], 20 mol %), followed by diimide reduction and global 
silicon-deprotection, then afforded 14-deoxy-9-oxy-gigantecin, 2.2.2, in 48% yield.  
 
Scheme 2.2 Temporary silicon-tether mediated RCM to 9- and 11-membered silicycles 
en route to the total synthesis of gigantecin. 
 In 2007, Kozmin and Marjanovic published the stereoselective synthesis of anti-
















Gigantecin, 2.2.1: R1 = OH, R2 = H






















































selective silicon-tethered RCM reaction (Scheme 2.3).23 Retrosynthetic analysis of 
spirofungin A (2.3.1) revealed that the natural product could be formed via silicon-
containing spiroketal-core 2.3.2, which results from a silicon-tether-mediated ketalizaiton 
of diol-containing, macrocyclic ketone 2.3.3. In turn, 2.3.3 could be provided via a Si-
tether-mediated 15-membered RCM of 2.3.4, followed by a 
hydrogenation/deprotection/ketalization protocol. As predicted, treatment of 2.3.4 with 
G-II (20 mol %), in refluxing benzene, generated the corresponding E-configured, 15-
membered, monocyclic silicon heterocycle 2.3.5 in 85% yield. The authors highlight that 
this RCM proceeded chemoselectively between the two terminal olefins of 2.3.4, and 
none of the truncated 12-membered RCM product was observed. 
 
Scheme 2.3 Temporary silicon-tether mediated RCM to 15-membered silicycle 2.3.5 en 

















































































 In 2007, Pickett and coworkers reported the use of diastereoselective silicon-
tethered RCM en route to the synthesis of (2S,7S)-dibutyroxynonane (2.4.4), a sex 
pheromone of the orange wheat blossom midge Sitodiplosis mosellana used to optimize 
pesticide treatment of wheat (Scheme 2.4).24 Chiral, non-racemic olefinic alcohol 2.4.1 
was coupled with pro-chiral 1,4-pentadien-3-ol, in the presence of di-tert-
butylsilyltriflate, pyridine, and facilitating 4-dimethylaminopyridine, to provide silylketal 
2.4.2, which was filtered through a neutral aluminum plug and concentrated. Subsequent 
RCM with G-I (5 mol %), in refluxing methylene chloride, generated 9-membered silicon 
heterocycle 2.4.3 in 70% yield over 2 steps, 95% diastereomeric excess, and high Z-
selectivity. Silyl-deprotection with TBAF, global hydrogenation with H2/PtO2, and 
acylation with butyric anhydride then provided (2S,7S)-dibutyroxynonane (2.4.4) in good 
overall yield. 
 
Scheme 2.4 Silicon-tether mediated RCM to 9-membered silicycle en route to the 
synthesis of (2S,7S)-dibutyroxynonane. 
 In 2008, van Otterlo and coworkers published an RCM strategy for the synthesis 
of novel 9- and 10-membered silicon-containing benzo-fuzed heterocycles derived from 
catechol starting materials—a select few are shown in Scheme 2.5.25 Catechol (2.5.1) was 






































silylation via treatment with excess allylchlorosilane] to provide phenoxysilanes 2.5.2 
and 2.5.3 in good overall yield. Subsequent treatment of 2.5.2 with G-II (5 mol %) in 
refluxing methylene chloride provided Z-configured, 9-membered silicon heterocycle 
2.5.4, albeit in low unoptimized yield. Similarly, RCM of phenoxysilane 2.5.3 under 
similar reaction conditions afforded Z-configured, 10-membered silicon heterocycle 2.5.5 
in 96% yield. An analogous 9-membered benzofused silicon heterocycle, 2.5.6, was 
generated in 82% yield from the corresponding diene 2.5.7—proving that high-yielding 
9-membered ring formation of benzo-fused silicon heterocycles of this type is also 
achievable via RCM. 
 
Scheme 2.5 Silicon-tether mediated RCM to 9- and 10-membered silicycles. 
 Recently, in 2015, Basabe and coworkers reported the synthesis of anti-
proliferative natural products luffarin L (2.6.1) and 16-epi-luffarin L (2.6.2) via a 
temporary silicon tether-mediated RCM protocol and the formation of intermediate 10-
membered-ring containing monocyclic silaketals (Scheme 2.6). In this regard, 






































































presence of diisopropylchlorosilane and imidazole, to provide diastereomeric silaketals 
2.6.5 and 2.6.6 in 49% and 60% yields, respectively. Subsequent RCM with G-II (20 mol 
%), carried out in toluene at 80 oC, furnished Z-configured, 10-membered silicon 
heterocycles 2.6.7 and 2.6.8 in moderate to good yield, and olefin configuration was 
confirmed by NOE 1H NMR analysis. Finally, silyl-deprotection with HF•pyridine 
afforded luffarin L (2.6.1) and 16-epi-luffarin L (2.6.2) in 57% and 81% yields, 
respectively. 
 
Scheme 2.6 Temporary silicon tether-mediated RCM to 10-membered silicon 















































































2.1.2 Phosphate Tether-Mediated Ring-Closing Metathesis for the Synthesis of P-
Stereogenic Bicyclo[4.3.1]phosphates: Conformational Analysis and Rationalization of 
Diastereoselectivity 
 In 2005, our group reported the desymmetrization of C2-symmetric, 1,3-anti-diol-
containing dienes through a phosphate tether-mediated diastereoselective ring-closing 
olefin metathesis reaction (Figure 2.2).3 As previously described (see Chapter 1 of this 
thesis), dienediol (S,S)-1.1.126—or the corresponding enantiomer—could be coupled with 
POCl3, in the presence of triethylamine and catalytic 4-dimethylaminopyridine (DMAP), 
to provide a relatively unstable intermediate monochlorophosphate (2.2A) in excellent 
yields. This intermediate was then immediately coupled with the lithium alkoxide of allyl 
alcohol to afford phosphate triene (S,S)-1.1.2. As shown in Figure 2.2, this pseudo-C2-
symmetric triene, which possesses a chirotopic, non-stereogenic phosphorus atom, can 
exist in either of two possible conformations—the four conformations shown reduce to 
two autonomous conformations by nature of a central C2-axis of symmetry that bisects 
the molecule. Treatment of triene (S,S)-1.1.2 with Grubbs second generation catalyst 
[(ImesH2)(PCy3)(Cl)2Ru=CHPh]27 or Hoveyda-Grubbs second generation catalyst28 
results in a symmetry-breaking ring-closing metathesis (RCM) reaction and furnishes a 
single diastereomer of bicyclic phosphate—in this case, (SP,S,S)-1.1.3. The reactivity 
profile of this bicyclic phosphate, and its corresponding enantiomer, were detailed in a 
number of investigations—most of which focused on the functionalization of the 
exocyclic olefin and SN2’-cuprate additions to the endocyclic olefin.3,29 However, few 
studies had been undertaken to detail the effects of stereochemical complexity, ring-size, 
	
 53 
and olefin substitution on the success and stereochemical outcome of the P-tether 
mediated, diastereoselective ring-closing metathesis event. Thus, efforts were focused on 
the generation of a variety of diverse model systems to provide a better understanding of 
these factors in an effort to expand the scope of the method and its applicability in the 
coupling of both simple and complex chemical fragments en route to the total synthesis 
of natural products and biologically active small molecules. 
Figure 2.2 Synthesis of simple bicyclo[4.3.1]phosphates and conformational rationale 
for diastereoselectivity. 
 
2.2 Results and Discussion 
2.2.1 Syntheiss of Bicyclo[4.3.1]-, Bicyclo[5.3.1]-, and Bicyclo[6.3.1]phosphates 
 We first investigated the effect of C3-substitution on the formation of 














































































racemic allylic alcohol 2.7.130 was coupled with enantiomeric monochlorophosphates 
(S,S)-2.2A and (R,R)-2.2A to generate diastereomeric trienes 2.7.2 and 2.7.3, respectively 
(Scheme 2.7).31 Trienes 2.7.2 and 2.7.3 were exposed to G-II (6 mol % and 3 mol %, 
respectively) to provide the corresponding bicyclo[4.3.1]phosphates trans-2.7.4 and cis-
2.7.532 in 54% and 76% yields, respectively (similar yields based on recovered starting 
material). X-ray crystallographic analysis revealed the caged conformation of trans-2.7.4 
where the C3-substitutent (-CH2OBn) points toward the concave face of the bicyclic 
phosphate;33 it was proposed that the orientation of this C3-substituent results in steric 
strain which manifests in the requirement of higher catalyst loadings and extended 
reaction times to provide trans-2.7.4 versus cis-2.7.5. 
 
Scheme 2.7 Synthesis of 3-substituted bicyclo[4.3.1]phosphates. 
 In addition to bicyclo[4.3.1]phosphate formation, the effect of C3-substitution on 
the generation of bicyclo[5.3.1]phosphates via 8-membered ring-forming RCM was 
studied.12 Thus, chiral, non-racemic homoallylic alcohol 2.8.134 was coupled with 









































































diastereomeric trienes 2.8.2 and 2.8.3, which were treated with G-II catalyst to afford the 
corresponding bicyclo[5.3.1]phosphates trans-2.8.4 and cis-2.8.5 in 71% and 58% yields, 
respectively (Scheme 2.8). Notably, the generation of bicyclo[5.3.1]phosphates cis-2.8.5 
and trans-2.8.4 proceeded under similar reaction conditions (catalyst loading and reaction 
times), unlike the analogous bicyclo[4.3.1]phosphate examples. 
 
Scheme 2.8 Synthesis of 3-substituted bicyclo[5.3.1]phosphates. 
 Following similar protocols, a variety of stereochemically rich bicyclo[5.3.1]- and 
bicyclo[6.3.1]phosphates, with and without olefin substitution, were synthesized via 
phosphate tether-mediated RCM (Figure 2.3).12,16,35 In the case of the bicyclo[5.3.1]- and 
bicyclo[6.3.1]phosphate formation, a mechanistic rationale for the observed reactivity 
based upon proposed Ru-metallocyclobutane intermediate structures was developed, 
highlighting the similarities and differences for observed reactivity of 
bicyclo[6.3.1]phosphates to their smaller bicyclo[5.3.1]phosphate counterparts.  As the 
formation of these stereochemically rich, 8- and 9-membered ring-containing bicyclic 
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examples which resulted in successful formation of the bicyclic phosphate are shown in 
Figure 2.3, and a detailed review of this portion of the study will not be described here. 
Figure 2.3 Other stereochemically rich bicyclo[5.3.1]- and bicyclo[6.3.1]phosphates 
generated via phosphate tether-mediated RCM. 
 
2.2.2 Synthesis of Bicyclo[7.3.1]phosphates 
 In addition to the synthesis of a number of bicyclo[4.3.1]- and 
bicyclo[5.3.1]phosphates, the formation of stereochemically rich bicyclo[7.3.1]-
phosphates was also explored, in pursuit of the total synthesis of dictyostatin (2.9.1) 
(Scheme 2.9).12,35,36 Retrosynthetic analysis of the natural product revealed that it could 
be formed via 10-membered ring-containing bicyclic phosphate 2.9.2, which could be 
accessed via a Z-selective ring-closing metathesis of the corresponding triene (2.9.3). To 
test the viability of this strategy, we coupled dictyostatin-like cross-partners 2.9.4 and 
2.9.537 with monochlorophosphates (S,S)-2.2A and (R,R)-2.2A to generate diastereomeric 
phosphate trienes 2.9.6 and 2.9.7. Subsequent RCM with G-II, in refluxing 1,2-














































































E-selectivity (dr > 20:1). Because studies of monocyclic silicon-tether systems have 
shown that stereochemical complexity of tether fragments can influence the 
stereoselectivity of temporary silicon tether-mediated RCM,2d we proposed that the 
stereochemistry in the side-chain of phosphates 2.9.8 and 2.9.9 could have a similar 
impact on the stereoselectivity of the P-tether-mediated RCM event. 
 
Scheme 2.9 Synthetic efforts toward dictyostatin and the synthesis of stereochemically 
rich bicyclo[7.3.1]phosphates. 
 Thus, a series of simplified phosphate triester trienes were designed to assess the 
impact of stereochemical complexity on the stereoselectivity of phosphate tether-
mediated RCM in bicyclo[7.3.1]phosphate formation.  Coupling of (R,R)-
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phosphate triene (R,R)-2.10.1, which was treated with Grubbs first generation catalyst 
(G-I)38 to furnish bicyclo[7.3.1]phosphate 2.10.2 in 42% yield (74% yield based on 
recovered starting material) and, again, high E-selectivity (Scheme 2.10). This implied 
that ring size—and not stereochemical complexity—may be the most influential factor in 
the stereoselectivity of RCM to form bicyclo[7.3.1]phosphates, as it may contribute to 
flexibility in large-ring dynamics that allows the more stable trans-configured olefin to be 
energetically feasible (and thermodynamically favorable).   
 
Scheme 2.10 The synthesis of simplified bicyclo[7.3.1]phosphates and the effect of C3-
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 The effect of C3-substitution on P-tether mediated RCM was next explored, and 
trienes (S,S,S)-2.10.3 and (R,R,S)-2.10.4 were generated via the coupling of olefinic 
alcohol (S)-2.10.539 with monochlorophosphates (S,S)-2.2A and (R,R)-2.2A (Scheme 
2.10). Triene (S,S,S)-2.10.3 was exposed to G-I catalyst (3 mol %, slow addition), in 
refluxing methylene chloride, to provide cis-2.10.6 in 72% yield and high E-selectivity. 
However, attempts at the RCM of triene (R,R,S)-2.10.4 to form trans-2.10.7 were 
unsuccessful, even under forcing conditions. This result was surprising, as the 
stereochemical complexity of trienes 2.9.6 and 2.9.7 did not inhibit the formation of the 
corresponding bicyclo[7.3.1]phosphates (see above, Scheme 2.9).  
 Due to the complexity of large ring dynamics—which was further complicated by 
the possibility of forming either E- or Z-configured olefins within large rings, it is 
difficult to develop a mechanistic rationale derived from proposed structures for 
intermediate Ru-metallocyclobutanes. However, X-ray crystallographic analysis of cis-
2.10.640 showed a 1,5-steric interaction between the C–H bond of the endocyclic olefin 
(C7) and the C–H bond of the C3-position (Figure 2.4). Thus, based solely on the 
conformations of the product, a pronounced 1,5-steric interaction between the 
substituents on the endocyclic olefin and the C3-position of the olefin tether-partner 
could be responsible for the observed reactivity.  When the β-C3-substituent of the 
olefinic tether-partner is hydrogen, the reaction proceeds—presumably because this 1,5-
interaction is minimized when both interacting groups are hydrogen; however, when the 
β-substituent is larger than hydrogen—as would be the case with bicyclic phosphate 
	
 60 
trans-2.10.7, this unfavorable 1,5-interaction is large enough to prevent the reaction from 
proceeding. 
Figure 2.4 X-ray crystallographic analysis of cis-2.10.6. 
 
 This E-selectivity of the P-tether mediated RCM to afford 
bicyclo[7.3.1]phosphates via the formation of a C7–C8 double bond within the bicyclic 
framework was somewhat surprising, as the RCM of analogous monocyclic Si-tethered 
systems proceeds with predominantly Z-configured olefin formation—even within larger 
rings (vide supra).41 Therefore, in addition to providing a viable means for the generation 
of bicyclic phosphate 2.9.2 en route to dictyostatin (Scheme 2.9), there was some interest 
in attempting to perturb the stereoselectivity of the phosphate tether-mediated RCM to 
provide 10- and 11-membered rings to broaden the scope of the molecules accessible by 
this method. Thus, trienes 2.11.1 and 2.11.2 were chosen as model substrates to assess the 
effect of olefin substitution on the phosphate tether-mediated RCM to generate 
bicyclo[7.3.1]phosphates (Scheme 2.11). 17,42  
 Enantiomeric monochlorophosphates (R,R)-2.2A and (S,S)-2.2A3 were added to 
the lithium alkoxides of 5-hexyn-1-ol and 5-methyl-5-hexen-1-ol, respectively, to afford 
alkynyl diene 2.11.3 and triene 2.11.2 in 65% and 68% yield, respectively (Scheme 2.11). 






























provided vinyl silyloxy-containing triene 2.11.1 in moderate yield. Unfortunately, though 
a variety of catalysts and reaction conditions were attempted, the formation of 
bicyclo[7.3.1]phosphates 2.11.4 and 2.11.5 could not be achieved by RCM. With these 
results in hand, combined with those obtained in previous studies,12,16 we hypothesized 
that the proximity of the forming olefin (C7–C8) to the bridgehead carbon (C9) of the 
resultant bicyclo[7.3.1]phosphate, in combination with C3-substitution, was a significant 
contributor to the success and stereoselectivity of the phosphate tether-mediated RCM. 
Moreover, it was conjectured that homologation of the C2-symmetric dienediol used to 
generate the corresponding phosphate trienes could have important stereochemical and 
conformational effects on the synthesis of bicyclo[7.3.1]phosphates by virtue of 
increasing the distance between the forming olefin (now, C6–C7) and the bridgehead 
carbon (C9).  
 
Scheme 2.11 Ring-closing metathesis to bicyclo[7.3.1]phosphates via formation of C7–
C8-trisubstituted olefins. 
 To assess this hypothesis, diastereomeric phosphate trienes 2.12.1 and 2.12.2 


































































corresponding chiral, non-racemic olefinic alcohols (S)-2.12.444 and (R)-2.12.4,45 
respectively (Scheme 2.12). Treatment of triene 2.12.1 with Grubbs first generation 
catalyst (G-I), added in 1 mol % portions over 7 hours (6 mol %, total), provided the 
corresponding bicyclo[7.3.1]phosphates trans-2.12.546 in 61% combined yield of a 
separable 2:1 mixture of Z/E-stereoisomers (with Z-trans-2.12.5 as the major 
stereoisomer).47 Notably, the formation of the analogous equivalent of this trans-
bicyclo[7.3.1]phosphate via C7–C8 olefin formation was unsuccessful under a variety of 
RCM conditions,16 suggesting that the extension of the forming olefin from C7–C8 to 
C6–7 could provide for conformational flexibility that allows for the reaction of the latter 
to proceed (albeit with lower stereoselectivity). Conversely, RCM of triene 2.12.2 with 
G-I (3 mol %) provided Z-olefin-containing cis-2.12.6 in 88% as a single stereoisomer 
(dr > 20:1). 
 












































































 Olefin stereochemistry (Z- versus E-configuration) was determined by detailed 
NMR analysis of both coupling constants of olefinic protons (which often overlapped and 
complicated coupling constant assignment), proton shift, and NOESY correlation of 
olefinic protons and/or vinylic methylene (CH2) signals. Unambiguous definition of each 
proton signal was necessary to arrive at meaningful conclusions, and as such, it is 
included in the experimental section corresponding to this chapter (see Chapter 5). The 
alkyl region of a sample spectra is shown in Figure 2.5 (for cis-2.12.6), where clear 
NOESY correlation (blue) between allylic C–H signals confirms Z-olefin configuration—  





as only groups in cis-orientation will show through-space correlations. In addition, due to 
the complexity of the 1H NMR spectra for each of these large ring-containing bicyclic 
phosphates, it was often helpful to superimpose the 2-dimensional COSY spectra (shown 
in red in Figure 2.5) onto the NOESY spectra (shown in blue in Figure 2.5) of a single 
molecule, to quickly differentiate through-space correlation from vicinal/geminal 
correlation. 
 In addition to C3-substitution, olefin substitution was introduced to assess the 
effect—if any—on the success and stereochemical outcome of RCM to generate 
bicyclo[7.3.1]phosphates. To separate the effect of olefin substitution from C3-
substitution, we first synthesized simple triene 2.13.1 via the coupling of 
monochlorophosphate (R,R)-2.13.212,16 with 4-penten-1-ol (Scheme 2.13). Exposure of 
2.13.1 to Grubbs second-generation catalyst (G-II) provided the corresponding bicyclic 
phosphate 2.13.3 as the Z-isomer in 87% yield. Olefin configuration was confirmed by 
X-ray crystallographic analysis, as shown in Scheme 2.13.48 Interestingly,  
C3-substitution had little effect on the outcome of RCM for this set of 
bicyclo[7.3.1]phosphates, as the treatment of diastereomeric trienes 2.13.4 and 2.13.5 
with G-II catalyst provided the expected bicyclic phosphates cis-2.13.6 and trans-2.13.7 
in 81% and 87% yields, respectively, with excellent Z:E-diastereomeric ratios in each 
case. However, this substitution had a significant effect on the 1H and 13C NMR of trans-
2.13.7, as high temperatures (95°C, DMSO-d6) and extended experiment times were 
required to partially resolve proton signals and properly identify short, broad carbon 




Scheme 2.13 Synthesis of bicyclo[7.3.1]phosphates via formation of C6–C7-
trisubstituted olefins. 
 Finally, monochlorophosphate (S,S)-2.12.3 was coupled with 4-methyl-4-penten-
1-ol to provide triene 2.14.1, armed with olefin substitution on the alcohol cross-partner, 
in 90% yield (Scheme 4). Triene 2.14.1 was treated with o-tolyl-Grubbs second-
generation catalyst-variant Ru-2.14.2,49 in toluene at 35°C, to generate bicyclic phosphate 
2.14.3 in 26% yield as the Z-isomer—in addition with a significant amount of 
oligomerization by-product. It should be noted that a number of reaction conditions were 
attempted to decrease the amount of oligomerization of 2.14.1 that occurs upon treatment 
with metathesis catalyst. However, extended reaction times and portion-wise addition of 
































































































due to the Type I nature of the mono-substituted olefins in pseudo-C2-symmetric triene 
2.14.1 and the resultant exocyclic olefin in bicyclic phosphate 2.14.3.50 
 
Scheme 2.14 Synthesis of bicyclo[7.3.1]phosphates via formation of C6–C7-
trisubstituted olefins. 
2.2.3 Synthesis of Bicyclo[8.3.1]phosphates 
 The method was extended to include the synthesis of bicyclo[8.3.1]phosphates via 
the formation of a C7–C8 olefin in order to determine the effects of C3-stereochemistry, 
olefin substitution, and proximity of the forming olefin to the bridgehead carbon (C10) on 
the success and stereochemical outcome of the RCM event. Studies commenced with the 
synthesis of diastereomeric trienes 2.15.1 and 2.15.2 from monochlorophosphate 2.12.3 
and the corresponding chiral, non-racemic olefin-containing alcohols (S)-2.15.339 and 
(R)-2.15.351 (Scheme 2.15). Triene 2.15.1 was treated with G-I catalyst, in refluxing 
methylene chloride, to provide trans-2.15.4 in 63% as the Z-isomer (dr > 20:1). 
Conversely, the exposure of triene 2.15.2 to RCM conditions afforded bicyclic 
phosphates cis-2.15.5 as an inseparable mixture of Z/E-isomers (dr = 2:1 Z:E).52 These 
results were somewhat surprising, as the stereoselectivity of RCM to afford these C3-






































analogous bicyclo[7.3.1]phosphate systems (trans-2.12.5 and cis-2.12.6, Scheme 2, vide 
supra). 
 
Scheme 2.15 Synthesis of bicyclo[8.3.1]phosphates via formation of C7–C8-disubstituted 
olefins. 
 The effect of olefin substitution on the success and stereochemical outcome of 
RCM to bicyclo[8.3.1]phosphates was next examined. In this regard, simple triene 2.16.1 
was synthesized, in excellent yield, from the coupling of (R,R)-2.13.2 and 5-hexen-1-ol 
(Scheme 2.16). Exposure of 2.16.1 to G-II catalyst (7 mol % over 9 hours) provided the 
corresponding bicyclo[7.3.1]phosphate 2.16.2 with exclusive Z-selectivity (dr > 20:1, as 
observed by NMR). To examine the effect of C3-substitution in these systems, we next 
synthesized diastereomeric phosphate trienes 2.16.3 and 2.16.4 from the coupling of 
monochlorophosphate 2.13.2 with chiral, non-racemic alcohols (S)-2.15.3 and (R)-2.15.3, 
respectively. Treatment of phosphate trienes 2.16.3 and 2.16.4 with G-II catalyst 


































































Scheme 2.16 Synthesis of bicyclo[8.3.1]phosphates via formation of C7–C8-disubstituted 
olefins. 
 X-ray crystallographic analysis of trans-2.16.6 confirmed the stereochemical 
result determined by NMR analysis (Figure 2.6). Interestingly, while the X-ray structures 
of every bicyclic phosphate obtained to date reveal an expected chair-conformation of the 
6-membered ring of the bicyclic phosphate, the X-ray crystallographic analysis of trans-
2.16.6 show a distorted boat geometry of the 6-membered ring, compensated for by a 
distorted tetrahedral geometry of the phosphate itself. In addition, the C3-substituent is 
directed away from the concave interior of the bicyclic phosphate. Taken collectively, 
this X-ray, in combination with experimental observation (gathered for both 10- and 11-



















































































significant effect on large ring dynamics that influences the stereoselectivity of the RCM 
event. 
Figure 2.6 X-ray confirmation of olefin stereochemistry and revelation of distorted boat 
geometry in trans-2.16.6. 
 
2.3 Conclusion 
 In summary, phosphate tether-mediated RCM to provide a variety of P-
stereogenic bicyclo[4.3.1]-, bicyclo[5.3.1]-, bicyclo[7.3.1]- and bicyclo[8.3.1]phosphates 
is reported. Taken collectively, these results suggest that C3-substitution, olefin 
substitution, the proximity of the forming olefin to the bridgehead carbon of resultant the 
bicyclic phosphate are all important factors in the success and stereochemical outcome of 
the RCM event. In addition, the bicyclic phosphates generated in this report represent an 
interesting class of macrocyclic phosphates with potential synthetic and biological utility 
as small molecule probes. Future efforts are aimed at understanding how ring-size and 
stereochemical complexity of bicyclo[n.3.1]phosphates affects the reactivity profile of 
each bicyclic phosphate, particularly as it relates to the addition of nitrogen-, oxygen-, 
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P-Stereogenic Bicyclo[4.3.1]Phosphite Boranes: Tunable P-Tether Systems 





 The facile formation of complex intermediates from simple core fragments 
common to a variety of natural products is central to the development of effective 
strategies for the synthesis of biologically active small molecules. In particular, those 
methods which couple a variety of simple and complex chemical fragments in a mild, 
manipulatable fashion and allow for the facile generation of molecular complexity 
represent some of the most efficient strategies to accomplish this goal. Over the past 
decade, our group has focused on the development of phosphate triester tether-mediated 
methods for the two-directional synthesis of complex polyols from C2-symmetric 
dienediol substrates.1 These methods have served as key transformations in a number of 
total and formal syntheses [see Chapter 1 of this thesis],2 and on-going efforts continue to 
exploit the inherent chemistry of bicyclic phosphate triesters—particulary their ability to 
mediate multiple transformations in one-pot sequential processes—in the two-directional 
synthesis of complex polyols.3 Additionally, current efforts in our group have aimed at 
exploring alternative tripodal tether systems in order to identify unique reactivity profiles 
which may be utilized in the synthesis of chemical scaffolds that would be difficult, 
expensive, or laborious to access via previously reported methods. In this regard, this 
chapter presents the use of bicyclic P(III)-phosphite borane tethers for the 
desymmetrization of C2-symmetric, 1,3-anti-diols to provide 1,3-skipped polyol 
stereotetrads. These studies highlight the P-tether systems’ ability to facilitate 
chemoselective cross-metathesis reactions with Type I and Type II olefins,4 divergent 
oxidation strategies that allow for the transformation of the P–B bond to P=O or P=S 
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bonds, and a stereocontrolled iterative SN2’-cuprate displacement protocol that marries 
the chemistry of phosphite borane tethers with that of their all oxygen-containing 
counterparts to generate stereotetrads that were previously inaccessible via phosphate 
tether strategies alone (Figure 3.1). In addition to providing unique P-containing 
scaffolds with interesting potential as biological probes, this method may serve as a 
useful alternative to aldol-like coupling strategies5 or other asymmetric crotylation6 
protocols to provide functionalized 1,3-skipped polyol intermediates for the synthesis of 
complex natural products. 
Figure 3.1 Bicyclic phosphite borane triesters as temporary tethers for the synthesis of 
complex polyols. 
 
3.1.1 Introduction to Borane-Complexed Phosphite Triesters 
 Historically, the complexation of P(III)-compounds (phosphines, phosphites, 
phosphinites, phosponites, etc.) with boranes to generate oxidatively stable intermediates 
has been used as a means to generate and store large numbers of phosphite ligands for 
eventual application in transition-metal catalysis.7 The first bicyclic, phosphite borane 
triesters were reported by Heitsche and Verkade in 1962,8 where caged bicyclic 
phosphites were prepared and complexed with a variety of Lewis acidic boranes—































enough to be isolated from the reaction mixture (Figure 3.2). The authors later published 
a detailed study of the 1H, 31P, and 11B NMR characteristics of several of these 
compounds in 1964,9 noting that no P–B coupling was observed for the weaker Lewis 
acid-Lewis base complexes (phosphites with BMe3 or BF3) due to proposed rapid ligand 
exchange. 
Figure 3.2 Borane complexes of polycyclic phosphites and corresponding NMR 
properties. 
 
 In addition to protection strategies for the synthesis of phosphite ligands, borane 
complexes with phosphites or phosphonites have been used as intermediates en route to 
synthetically useful H-phosphonates [(RO)2PHO], H-phosphinates [(RO)RPHO], and 
biologically relevant boranophosphates [(RO)2(BH3)P=O]. In 1998, Jin and Just reported 
the use of phosphite borane adducts en route to the synthesis of P-diastereomeric 
mixtures of dithymidine boranophosphates—valuable intermediates for the formation of 
boranophosphate DNA or RNA with promising applications in the treatment of 
cancer.10,11 Tetrazole-facilitated coupling of commercially available 5’-(4,4’-
dimethoxytrityl)-thymidine phosphoroamidite 3.1.1 with 3’-protected thymidine (R = 
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deprotection, afforded the corresponding phosphite boranes 3.1.2a (R = TBDPS) and 
3.1.2b (R = TBS) as inseparable mixtures of diastereomers at phosphorus (Scheme 3.1). 
DMTr-protection of the primary alcohol allowed for chromatographic separation of P-
diastereomers, and subsequent silyl-deprotection with TBAF provided SP-3.1.3 and RP-
3.1.3 in 65–70% yield. Finally, high yielding DMTr-deprotection with acetic acid and 
exposure of the resultant phosphite borane triesters to concentrated ammonium hydroxide 
generated the corresponding boranophosphates SP-3.1.4 and RP-3.1.4 in excellent overall 
yield.  
 
Scheme 3.1 Phosphite borane complexes as intermediates en route to boranophosphate 
dithymidines. 
 Similarly, in 2006, Wada and coworkers published the use of phosphite borane 
triesters as intermediates en route to diastereopure RP- and SP-dithymidine 
boranophosphates via a method more amenable to solid phase synthesis than 
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butyldiphenylsilyl)thymidine 3’-O-oxazaphospholidine SP-3.2.113 was coupled with 3’-O-
TBDPS-thymidine, in the presence of an ammonium triflate activator, to provide RP-
3.2.2, resulting in inversion of stereochemistry at phosphorus (Scheme 3.2). Treatment of 
phosphite 3.2.2 with BH3•THF afforded the intermediate phosphite borane triester that 
was smoothly converted to boranophosphate SP-3.2.3 (DBU, then Et3N•HF) in 66% yield 
over 4 steps (dr = 98:2). This in-solution protocol was successfully adapted to solid-phase 
synthesis of SP-3.2.3 in the same publication. 
 
Scheme 3.2 Stereoselective synthesis of phosphite borane complexes as intermediates en 
route to diastereopure boranophosphate oligonucleosides. 
 In 2008, Montchamp and coworkers reported the synthesis of O-silyl-H-phosphite 
borane complexes [(R1O)(R2O)P(BH3)H] and their use as synthetic intermediates to 
generate alkylated phosphinite-boranes, H-phosphonates, and boranophosphates (Scheme 
3.3).14 O-Silyl-H-phosphite borane complexes were prepared in one step from the 
corresponding H-phosphonates. In this manner, in situ-generated ethyl phosphinate15 
(3.3.1) was exposed to TIPSCl, in the presence of triethylamine, followed by borane 
protection with BH3•DMS, to provide 3.3.2 in quantitative isolated yield. 
Correspondingly, commercially available anilinium hypophosphite (AHP, 3.3.3) was 
exposed to similar conditions to afford O,O’-disilyl-H-phosphite borane 3.3.4 in 87% 


















































generation of a number of phosphinite-borane intermediates, which can be further 
transformed into either H-phosphinates or boranophosphates. In this regard, 3.3.2 was 
treated with LiHMDS, followed by addition of octyliodide, to provide phosphinite-borane 
3.3.5 in quantitative yield. Subsequent oxidation of 3.3.5 with tetrafluoroboric acid 
etherate then afforded the corresponding H-phosphinate in 80% isolated yield. Similarly, 
treatment of 3.3.4 with LiHMDS, followed by octyl-bromide, provided phosphinite-
borane 3.3.7—which, when exposed to TBAF, generated the free boranophosphate in 
good overall yield. 
 
Scheme 3.3 H-Phosphinite-borane complexes as synthetically useful H-phosphinate 
equivalents. 
 In 2008, Wada and coworkers reported the use of glycosyl-dimethyl-phosphite 
borane triesters as intermediates for the synthesis of glycosyl boranophosphates, 
chemically stable H-phosphonate precursors for the formation of glycosyl phosphate 
analogues.16 Boronation-desilylation of dimethyl trimethylsilyl phosphite 3.4.1,17 using 















































































to rt, 2 h, 82%
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(Scheme 3.4).18 Bop-Cl-mediated coupling of reducing sugar 3.4.3 with 3.4.2, in the 
presence of catalytic 3-nitro-1,2,4-triazole (NT) and diisopropyl(ethyl)amine, afforded 
glycosyl phosphite borane 3.4.4 for further functionalization. Dimethyl phosphite borane 
3.4.4 was demethylated with DABCO, and subsequent treatment with in-situ-generated 
trityl cation provided H-phosphonate 3.4.6 in excellent overall yield. The H-phosphonate 
intermediate (3.4.6) could be further elaborated to the phosphoramidate or 
phosphorothioate in 80% and 54% yield, respectively, as shown in Scheme 3.4. In 
addition, condensation of S-β-citronellol with dimethyl phosphite borane 3.2.4, in the 
presence of BOP-Cl and catalytic NT, generated phosphite borane triester 3.4.8 in 96 
yield; then, acetyl-deprotection, followed by phosphite borane exposure to ammonium  
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hydroxide, yielded the corresponding boranophosphate 3.4.9 in 97% and 93% yields, 
respectively, highlighting the synthetic utility of both the intermediate phosphite borane 
triesters and their boranophosphate counterparts. 
3.1.2 Introduction to Metathesis Reactions with Borane-Complexed P(III)-Substrates 
 Though ring-closing metathesis of borane-complexed phosphite triesters is 
somewhat limited, RCM reactions of olefin-containing P(III)-borane complexes have 
garnered some attention over the past few decades. In 2000, Gouverneur and coworkers 
reported the first examples of ruthenium-catalyzed ring-closing metathesis on 
bis(alkenyl)phosphine-borane complexes.19 Later, in 2003, the same group reported the 
use of both ruthenium- and molybdenum-based methathesis catalysts for similar 
substrates.20 Results of these studies are summarized in Figure 3.3. 
Bis(alkenyl)phosphine-borane complexes were treated with four different metathesis 
catalysts (A–D), in refluxing CH2Cl2 or heated toluene for times ranging from 6–86 
hours, to provide a variety of 5-, 6- (not shown), and 7-membered ring-containing, P-
heterocyclic phosphine-borane compounds. Modification of ring size was fairly well-
tolerated, particularly by catalysts C and D, though olefin functionalization led to marked 
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decrease in yields even under extended stir times with higher catalyst loadings. 
 In 2001, van Boom and coworkers reported the synthesis of mono- and bicyclic, 
borane-complexed P(III)-heterocycles via enyne-RCM and tandem enyne-RCM-RCM.21 
Nucleophilic addition of sodium acetylide to bis(diisopropylamino)chlorophosphine 
(3.5.1) generated (alkynyl)phosphine 3.5.2 in 80% yield (Scheme 3.5). Condensation of 
3.5.2 with allyl alcohol (or an appropriate olefinic alcohol), in the presence of 1H-
tetrazole, followed by boronation with BH3•DMS, provided phosphonite-borane 3.5.3 in 
88% yield. Subsequent ring-closing metathesis, catalyzed by Grubbs second-generation 
catalyst [G-II, (ImesH2)(PCy3)(Cl)2Ru=CHPh],22 quantitatively transformed 3.5.3 into 
monocyclic phosphonite-borane 3.5.4. Similarly, a number of mono- and bicyclic 
phosphonite-boranes were generated from the corresponding trienes in good yields.  
 
Scheme 3.5 Enyne-RCM of phosphinite-borane and phosphoroamidite-borane 
complexes. 
 Recently, in 2013, O’Brien and coworkers published the first enantioselective 
synthesis of P-stereogenic vinylic phospholene boranes via a stereoselective 
deprotonation-alkylation-methenylation-RCM protocol.23 Chiral, base-mediated 





















































presence of (–)-sparteine (via a method developed by Evans and coworkers in 1995),24 
and subsequent allylation of the corresponding carbanion generated P-stereogenic 
phosphine-boranes 3.6.2 in moderate yield. A second deprotonation of the α-CH3 with 
sec-BuLi, followed by trapping with paraformaldehyde, tosylation of the resultant 
alcohol, and elimination of the intermediate tosylate, then afforded dienes 3.6.3 in 56–
73% yield. Finally, treatment of dienes 3.6.3 with catalytic Hoveyda-Grubbs second-
generation catalyst (HG-II) in refluxing toluene provided monocyclic phospholene-
boranes SP-3.6.2 in moderate to excellent yields (based on starting substrate). 
 
Scheme 3.6 Asymmetric synthesis of P-stereogenic, monocyclic phospholene boranes via 
ring-closing metathesis. 
3.2 Results and Discussion 
 Over the past decade, our group has focused on the use of phosphate triester tether 
methods for the synthesis of 1,3-skipped polyol-containing natural products and natural 
product analogs,2 and much like the synthetic community at large, we seek intriguing 
targets containing interesting chemical fragments to help catalyze method development 
and expansion. One such family of targets, the ulapualide polyketide natural products 
(Figure 3.4),25 was found to contain a 1,3-skipped polyol stereotetrad comprised of a 1,3-
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SP-3.6.2b, R1 = Ph, R2 = Me, 46%
SP-3.6.2c, R1 = Ph, R2 = H, 71%
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type could be synthesized utilizing a P-tether-mediated iterative alkylation strategy, 
similar to that outlined in Figure 3.5, where a regio- and diastereoselective SN2’-cuprate 
displacement of an exocyclic leaving group, followed by a second regio- and 
diastereoselective SN2’-cuprate displacement of the tether itself, would allow for the 
formation of functionalized versions of the desired intermediate. 
Figure 3.4 Ulapualide family of natural products containing 1,3-skipped stereotetrads. 
 
Figure 3.5 Proposed strategy to 1,3-skipped stereotetrads using P-tether mediated 
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 Previous work in our laboratory examined the behavior of bicylic phosphate-
containing molecules in the presence of in-situ-generated dialkyl cuprates. As shown in 
Scheme 3.7, the bicyclic phosphate activates multiple carbons for nucleophilic attack—
highlighted are those carbons associated with allylic displacement of the phosphate. In 
2007, Hanson and Whitehead reported that the SN2’-cuprate addition of in-situ-generated 
dimethylcuprate to cross-metathesis product 3.7.1, which contained both an endocyclic 
and exocyclic olefin, preferentially formed 7-membered, monocyclic phosphate 3.7.2, in 
70% yield and excellent selectivity via cuprate addition to C12 of the exocyclic olefin.26 
Correspondingly, when the exocyclic olefin is chemoselectively hydrogenated and the 
endocyclic olefin remains—as in bicyclic phosphate 3.7.3, SN2’-cuprate addition 
proceeds through addition to C5 of the olefin27 to provide—after phosphoric acid 
methylation and tether removal—terminal olefin-containing diol 3.7.4.  
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 Though these examples served as useful references for the general behavior of 
bicyclic phosphate in the presence of dialkyl cuprate, none of the previous reports 
examined substrates which contained an allylic, exocyclic leaving group in addition to 
the unsaturated bicyclic phosphate—and as such, would provide the necessary 
components to study a “competitive” cuprate addition similar to the one proposed in 
Figure 3.5. With this goal in mind, we synthesized di-phosphate 3.8.1 via cross 
metathesis of bicyclic phosphate (SP,S,S)-3.8.21a with chiral, non-racemic allylic alcohol 
R-3.8.3,28 followed by phosphitylation-oxidation of the resultant alcohol, in moderate, 
unoptimized yield (Scheme 3.8). 3.8.1 was treated with in-situ-generated dimethyl 
cuprate (3 equiv) in THF at -40 oC, followed by methylation of the resultant phosphoric 
acid, to provide the product corresponding to phosphate-tether displacement (3.8.4), in 
moderate yield as an inseparable mixture of diastereomers at the cyclic phosphorus.  
 With this result in hand, we proposed that the desired protocol presented in Figure 
3.5 could be made viable by one of two possible scenarios: (i) a non-trivial optimization 
of conditions required to out-compete phosphate-tether displacement via judicious choice 
of generated cuprate, reaction conditions, and appropriate leaving group; or (ii) a 
modification of the tether, such that competitive SN2’-cuprate addition favors the 
displacement of an external leaving group and subsequent modification of tether 
electronics could then favor a second selective cuprate displacement of the tether itself. 
We then proposed that a phosphite borane tether might provide the necessary electronic 
requirements for competitive cuprate displacement—since nucleophilic additions to 
carbinol carbons of other phosphite borane triesters are slow.29 In addition, a phosphite 
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borane tether system would possess the appropriate electronic tunability that would allow 
for the formation of bicyclic phosphate from P-BH3 precursors, since deprotection-
oxidation strategies to provide P=O bonds from P–BH3 bonds are known;30 thus, a 
second diastereoselective cuprate displacement of the intermediate bicyclic phosphate 
obtained from the oxidation of the P-BH3 precursor, followed by tether removal, would 
generate desired 1,3-skipped polyol-containing stereotetrads en route to the synthesis of 
more complex natural products.  
 
Scheme 3.8 Competitive SN2’-cuprate displacement of bicyclic phosphate in presence of 
exocyclic allylic phosphate leaving group and proposed strategy revisited. 
 With this goal in mind, we first examined the ability of phosphite borane triesters 
to desymmetrize 1,3-anti-dienediols through a diastereoselective ring-closing metathesis 
analogous to that developed for the phosphate tether method.1a Enantiomeric dienediols 
(R,R)-3.9.1 and (S,S)-3.9.1 were coupled with commercially available allyl 
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intermediate phosphite, which was subsequently protected by the addition of excess 
BH3•THF to afford the corresponding trienes (R,R)-3.9.1 and (S,S)-3.9.1 in 73% and 
72%, respectively (Scheme 3.9). It should be noted that these trienes were stable for 
storage under argon atmosphere at lower temperatures (<5 oC) for greater than 1 year; 
however, extended times for chromatographic separation resulted in partial triene 
decomposition, even when eluent was doped with triethylamine (5–10%). Thus, 
purification of crude triene reaction mixture via filter column chromatography (silica, 
15% EtOAc in hexanes) is required to separate triene from amine by-product that inhibits 
the following ring-closing metathesis reaction. RCM of trienes (S,S)-3.9.2 and (R,R)-
3.9.3, in the presence of G-II, afforded the corresponding bicyclic phosphite boranes 
(SP,S,S)-3.9.4 and (RP,R,R)-3.9.5 as off-white solids. These bicyclic phosphite boranes 
were stable when stored at low temperature for extended periods of time (>2 years) and 
were also stable to chromatographic separation without observable decomposition. X-ray 
crystallographic analysis31 of (RP,R,R)-3.9.5 and (SP,S,S)-3.9.4 showed that each possess 
concave, caged structures similar to their all-O-containing phosphate counterparts, 
suggesting that the three-dimensional orientation of these substrates may allow for 




Scheme 3.9 Synthesis of enantiomeric bicyclo[4.3.1]phosphite borane tether systems and 
corresponding X-ray crystal structures. 
 In addition to column chromatography, the bicyclic phosphite borane (SP,S,S)-
3.9.4 was found to be stable to acidic conditions common to a variety of work-up 
procedures (1 N HCl in MeOH, 1 M NaHSO4 (aq) in THF, vigorous stirring with equal 
portions of EtOAc and saturated NH4Cl (aq)), though the complex readily decomposed 
upon treatment with hydroxide base (Scheme 3.10). Reductive tether removal using Red-
Al provided the corresponding triol 3.10.1 in excellent yield, though bicyclic (SP,S,S)-
3.9.4 was stable to a variety of other reductants/hydride sources (including LiBH4, 
NaBH4, and DIBAL-H). Chemoselective hydrogenation of the exocyclic olefin under 
diimide reaction conditions showed that, much like with the bicyclic phosphate, selective 
functionalization of the terminal, exocyclic olefin in the presence of the internal olefin is 







































































of the bicyclic phosphite with DABCO followed by oxidation with either tBuOOH or 
elemental sulfure (S8) successfully generated both the bicyclic phosphate (P=O, 3.10.3) 
and thiophosphate (P=S, 3.10.4) from the phosphite borane precursor (3.9.4). This result 
was exciting, as a single synthetic strategy could first employ chemistry unique to the 
bicyclic phosphite borane and later, through oxidization of the P–BH3 to the 
corresponding P=O, take advantage of chemistry unique to the bicyclic phosphate; thus, 
these two tether systems could be used separately or in tandem to rapidly build molecular 
complexity.  
 
Scheme 3.10 Simple reactivity profile of bicyclo[4.3.1]phosphite borane complexes. 
 In addition to chemoselective hydrogenation, the exocyclic olefin of the bicyclic 
phosphite borane (in this case, 3.9.5) can be further functionalized via a selective cross-
metathesis reaction, as shown in Scheme 3.11. Cross metathesis was successful with a 
variety of Type I and Type II olefin cross partners, and yields were found to range from 
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homodimers of Type I olefins allowed for higher conversions and yields than the mono-
counterparts (for examples 3.11.1, 3.11.2, 3.11.3), and lower yields were often the result 
of lower conversion, as evident by improved yields based on recovered starting 
material—which could be re-isolated and re-used in other reactions (examples 3.11.2 and 
3.11.4).  
 
Scheme 3.11 Chemoselective cross-metathesis studies with Type I and Type II olefins. 
 Cross-metathesis product 3.11.3 was chosen as a model substrate for competitive 
SN2’-cuprate addition reactions and was treated with in-situ-generated dimethyl- and 
diethyl-cyanocuprates (1.5 equivalents and 3 equivalents, respectively) to generate 
bicyclic phosphite borane-containing alkylation products 3.12.1 and 3.12.2 in moderate 
yields (50% and 54%, respectively) and diastereomeric ratios of ~2:1 [major:minor] 
(Scheme 3.12). These results indicated that the bicyclic phosphite borane had only minor 
control over the stereoselectivity of the cuprate addition to the exocyclic olefin, and as 






































































displacement of an exocyclic leaving group on a stereogenic carbon would allow for the 
generation of either the syn- or anti-alkylated products. 
 
Scheme 3.12 Regioselective SN2’-cuprate displacement of an exocyclic leaving group. 
 With this goal in mind, we synthesized the bicyclic phosphite borane substrates 
bearing exocyclic allylic phosphates on stereogenic, secondary carbons as cuprate-
addition precursors (Scheme 3.13). Direct metathesis with the pre-formed allylic 
phosphates proved to be ineffective at generating large amounts of product; however, 
sequential cross metathesis of either (RP,R,R)-3.9.5 or (SP,S,S)-3.9.4 with chiral, non-
racemic R-3.8.3,28 followed by phosphorylation or phosphitylation-oxidation, provided 
the desired precursors (3.13.3 and 3.13.4) in excellent yields over two steps. While this 
strategy was sufficient as a proof of concept, a second generation synthesis of these 
precursors using an RCM-CM-phosphorylation strategy would allow for the facile 
formation of diastereomeric 3.13.3 and 3.13.4 in two pots from simple dienediol 
precursors (4 total pots, overall), and future efforts in our group will involve the 












































3.12.1, R = Me
3.12.2, R = Et
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tether to streamline syntheses of these intermediates en route to the total synthesis of 
natural products. 
 
Scheme 3.13 Synthesis of bicyclo[4.3.1]phosphite borane complexes bearing exocyclic 
allylic phosphates on stereogenic carbons. 
 Phosphite borane phosphates 3.13.1 and 3.13.2 were next subjected to 
dimethylcuprate substitution conditions, and each generated the desired anti- or syn-
alkylated bicyclic phosphite boranes 3.14.1 and 3.14.2 in moderate to excellent yields and 
excellent diastereoselectivities (dr > 20:1, Scheme 3.14). Though an iterative cuprate 
strategy resulting in the formation of 1,3-skipped polyol stereotetrads was the goal of this 
study, these mono-alkylated products are also useful intermediates in their own right, as 
3.14.1 was initially designed to serve as an intermediate en route to the total synthesis of 
franklinolide A (the applicable backbone of which is highlighted in Scheme 3.14). 
Finally, oxidation of diastereomeric 3.14.1 and 3.14.2 to the corresponding bicyclic 
phosphates (only 3.14.3 shown below) in nearly quantitative yield, followed by a second 
stereospecific SN2’-cuprate displacement of the bicyclic phosphate, methylation, and 
R

































































subsequent reductive tether removal, afforded the desired 1,3-skipped polyol 
stereotetrads 3.14.4 and 3.14.5 in 8 pots from simple dienediol precursors. This strategy 
highlights the synthetic utility of this electronically tunable phosphorus tether by 
employing both bicyclic phosphite borane tether reactivity in tandem with bicyclic 
phosphate tether chemistry to generate substrates that were previously inaccessible via 
phosphate tether methods alone. 
 
Scheme 3.14 Iterative SN2’-cuprate addition protocol to provide functionalized 1,3-
skipped polyol stereotetrads. 
3.3 Conclusions and Future Goals  
 In conclusion, this chapter presents the development of a new, electronically 
tunable P-tether system for the formation of 1,3-skipped polyol stereotetrads en route to 
































































































to chromatography, mild acid, and a number of hydride sources (and reductants other 
than Red-Al) and can be stored for extended periods of time at lower temperatures (>2 
years at <5 oC). In an iterative cuprate strategy, this P-tether method allows for the initial 
desymmetrization of the 1,3-anti-dienediol, the regioselectivity of the first cuprate (SN2’-
displacement of an exocyclic leaving group), and the regio- and diastereoselectivity of 
the second cuprate displacement of the modified P-tether to generate stereotetrads that 
were previously inaccessible via other traditional phosphate tether strategies alone. 
Future work will include the incorporation of more complex tether pieces in triene 
formation (via the use of bis(diisopropylamino)chlorophosphine for tripodal 
coupling/phosphitylation) and the development of phosphite borane tether-mediated, one-
pot sequential processes that will further streamline the facile formation of intermediates 
en route to the total synthesis of natural products. 
Figure 3.6 Future plans for phosphite borane tether-mediated one-pot sequential 
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Phosphate Tether Methods Toward the  





 Sanctolide A (4.1A) was isolated from a moderatively cytotoxic cell extract of 
cyanobacterium Oscillatoria sancta (SAG 74.79) by Orjala and coworkers in 2012 
(Figure 4.1).1 The 14-membered marine macrolide was found to possess a central 1,3-
anti-diol subunit, a lipophilic pentyl side-chain, and both a diester linkage and N-methyl 
enamide motif within the macrocyclic portion of the molecule. The polyketide/non-
ribosomal peptide hybrid 4.1A is part of a small class of cyclic N-methyl enamide-
containing natural products, including the laingolides,2 madangolide,2a and 
neuroprotective (+)-ent-palmyrolide A (4.1B).3 Though secondary cyclic enamides are 
well-represented in the literature (including >200 known cyclopeptide alkaloids with a 
range of biological activities),4 the cyclic tertiary enamide (in particular, the N-methyl 
enamide) is relatively rare, and biological evaluation of this class is somewhat limited—
outside that of palmyrolide A. For these reasons, this class of compounds are interesting 
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synthetic targets—particularly for the purpose of the generation of libraries of analogs for 
biological screening. 
 Sanctolide A (4.1A) was surprisingly labile, when compared to the remarkable 
stability of palmyrolide A (4.1B),3 and was found to undergo enamide hydrolysis in the 
presence of water under both acidic and neutral conditions. The authors proposed a 
mechanism for enamide hydrolysis of 4.1A carried out under neutral conditions based 
upon the previously proposed mechanism for the acid-catalyzed hydrolysis of 4.1B 
(Figure 4.2).3 Pereira and coworkers propose that a reversible, acid-catalyzed enamide 
tautomerization would provide an intermediate iminium, to which H2O could add to form 
a transient hemiaminal. Collapse of the hemiaminal, followed by amide tautomerization, 
then affords the corresponding ring-opened product (4.2A) containing both a secondary 
N-methyl amide and an aldehyde.3 While this mechanism seems feasible for hydrolysis of 
the N-methyl enamide moiety in strongly acidic conditions (6 M HCl), the exact 
mechanism of the enamide hydrolysis of 4.1A under neutral conditions remains unclear, 
as the first proposed step (enamide/imine tautomerization) would be difficult without 
facilitating acid and this particular mechanism would not necessarily explain the 
significant differences in the stability of 4.1A as compared to 4.1B. Thus, the generation 
of larger quantities of 4.1A, as well as a variety of analogs, may aid to elucidate the 
mechanism of enamide hydrolysis and pin-point origins of this hydrolytic instability.  In 
addition, as 4.1A was completely hydrolyzed to the acyclic product after stirring in the 
presence of water for 48 hours, Orjala and coworkers hypothesized that the biological 
activity observed for 4.1A (moderate cytotoxicity in brine shrimp toxicity assay, 23.5 
	
 112 
µM) was most likely attributed to degradation product—since hydrolysis was likely to 
occur under the conditions necessary for biological assay. Thus, synthetic strategies that 
would allow for the facile formation of analogs of sanctolide A— 
 Figure 4.2 Proposed mechanism for acid-catalyzed enamide hydrolysis of 4.1B. 
 
particularly those with enhanced hydrolytic stability—could serve as useful tools to 
facilitate a comprehensive understanding of the biological potential of this relatively rare 
class of PK-NRP hybrids. In this regard, we herein report our synthetic efforts toward the 
total synthesis of C2-epimer of sanctolide A—with potential applications to the total 
synthesis of the title natural product (4.1A). Investigations focus on the development of 
phosphate tether-mediated one-pot sequential protocols that would allow for a 
streamlined synthesis of the C1–C12-fragment of C2-epi-sanctolide A, with the potential 
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4.1.1 Total Synthesis of 2S-Sanctolide A 
 In 2014, Brimble and coworkers reported the total synthesis of 2S-sanctolide A 
(4.3A) via similar strategies involving a key RCM-olefin isomerization macrocyclization 
initially developed for the total synthesis of palmyrolide A (4.1B) (Figure 4.3).5 It should 
be noted that the authors did not intend to synthesize the C2-epimer of sanctolide A—as 
the exact stereochemistry of the C2-methyl group was undefined in the isolation report. 
However, this synthetic strategy did serve to define the C2-stereochemistry of the natural 
product. Retrosynthetic analysis of 2S-sanctolide A (4.3A) showed that the natural 
product could be synthesized via an RCM-olefin isomerization protocol of the ester 
derived from the coupling of alcohol 4.3B and carboxylic acid 4.3C (obtained in 2 steps 
from L-valine). Correspondingly, 4.3B could be generated from 1,3-anti-diol-containing 
lactone 4.3E, which could be formed from olefinic alcohol 4.3F via methacryloylation, 
RCM, and stereoselective hydrogenation of the intermediate α,β-unsaturated lactone. 



















































 Synthesis commenced with the epoxidation of hept-1-ene, which provided the 
corresponding epoxides (not shown) in 98% yield as a racemate; hydrolytic kinetic 
resolution (HKR) of the racemic mixture with Jacobsen’s (R,R)-salenCoIII-OAc catalyst6 
furnished known epoxide 4.1.17 in 43% (Scheme 4.1). Epoxide ring opening with vinyl-
magnesium bromide, in the presence of catalytic copper(I) iodide, afforded homo-allylic 
alcohol 4.1.2, and subsequent methylation with sodium hydride and methyl iodide 
provided 4.1.3 in excellent overall yield. Similarly, olefin 4.1.3 was expoxidized with m-
CPBA (95% yield, 1:1 mix of enantiomers) and exposed to HKR conditions to afford 1,3-
anti-diol product 4.1.4 in 35% yield as a single diastereomer. Finally, epoxide ring 
opening of 4.1.4, again with vinyl-magnesium bromide/catalytic CuI, then generated 
olefinic alcohol 4.3F in excellent yield. 
 
Scheme 4.1 Synthesis of intermediate 4.3F. 
 Intermediate 4.3F was acylated with methacryloyl chloride, in the presence of 
diispropyl(ethyl)amine (DIPEA), to afford diene 4.2.1 in 86% yield (Scheme 4.2). 
Treatment of 4.2.1 with Grubbs’ second-generation catalyst8 (G-II, 
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with H2 (30 bar) and Pd/C (10 mol %), generated the 3,6-syn-diastereomer of lactone 
4.3E in good overall yield. The authors note that the stereoselectivity of this 
hydrogenation is likely the result of the C6-substituent, which blocks the top Si-face 
approach of the palladium catalyst and allows for preferential addition of “H2” to the 
bottom Re-face of the reactive olefin. One-pot lactone ring-opening/amidation of 4.3E 
with in-situ-generated dimethylaluminum amide 4.2.29 furnished amide 4.3B in 63% 
yield. 
 
Scheme 4.2 Synthesis of intermediate 4.3B. 
 Next, acid 4.3C was generated via coupling of β-hydroxyisovaleric acid 4.3.1 
(commercially available or 1 step from L-valine)10 with acryloyl chloride (Scheme 4.3). 
Subsequent esterification of 4.3C with the in-situ-generated mixed anhydride of 2,4,6-
trichlorobenzoyl chloride and intermediate 4.3B provided RCM-precursor 4.3.2 in 92% 
yield. Exposure of 4.3B to G-II (30 mol %), in refluxing chloroform, furnished 
macrocyclic tertiary amide 4.3.3 in 50% yield, as a proposed 1:1 mixture of E- and Z-
isomers. Final Ru-hydride-mediated olefin isomerization of amide 4.3.3 (diastereomeric 
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The authors concluded that the final product (4.3A) was the C2-epimer of the desired 
natural product (sanctolide A, 4.1A) by comparative analysis of optical rotation and 1H 
NMR spectra. Overall, the synthetic strategy provided 4.3A in 13 longest linear steps 
(LLS) and 4% overall yield from known epoxide 4.1.1 (Scheme 4.1) and successfully laid 
the ground-work for future syntheses of sanctolide A (4.1A). 
 
Scheme 4.3 RCM-isomerization macrocyclization end-game strategy to 2S-sanctolide A. 
4.1.2 Total Synthesis of Sanctolide A 
 Recently, in 2015, Yadav, Suresh, and Srihari published the first and only total 
synthesis of sanctolide A (4.1A).11 The authors envisioned that 4.1A could be generated 
via a late-stage oxidation-condensation cyclization strategy from amide 4.4A, which 
could be derived in 4 steps from 4.4B (Figure 4.4). Correspondingly, diester 4.4B could 
be provided by the coupling of alcohol 4.4C with acid 4.4D (obtained in 3 steps from 







































































be generated via Noyori reduction,12 followed by alkyne reduction, of β-methoxy-ketone 
4.4E, which could be derived in 5 steps from hexanaldehyde 4.4F. 
Figure 4.4 Retrosynthetic analysis to sanctolide A. 
 
 Following this synthetic plan, the authors first set their sights on the generation of 
alcohol 4.4C. Asymmetric allylation of hexanaldehyde (4.4F) with allyltributyl tin and 
bis-(R)-Ti(IV) oxide catalyst provided the corresponding homoallylic alcohol (not 
shown) in 85% yield and 99% enantiomeric excess; this intermediate was smoothly 
methylated to afford 4.1.3 (Scheme 4.4). Upjohn dihydroxylation13 of 4.1.3 and oxidative 
cleavage of the resultant diol furnished a terminal aldehyde that was coupled with 
lithiated alkyne 4.4.1 to generate propargyl 1,3-skipped diol products syn-4.4.2 and the 
desired anti-4.4.3 in 90% yield, but as an unfavorable diastereomeric ratio (syn:anti = 
60:40). However, oxidation of syn-4.4.2 with Dess-Martin periodinane (DMP),14 
followed by diastereoselective Noyori reduction of the resultant ketone, furnished desired 





















































with an H-cube equipped with a Pd/C (10%) cartridge, under pressure (6 bar), afforded 
intermediate alcohol 4.4C in 98% yield. 
 
Scheme 4.4 Stereoselective synthesis of coupling partner 4.4C. 
 Alcohol 4.4C was coupled with acid 4.4D, obtained in 3 steps from 4.3.1, via 
conditions developed by Yamaguchi and coworkers (2,4,6-trichlorobenzoylchloride, 
DIPEA, DMAP),15 followed by silyl-deprotection with TBAF, to provide 4.5.1 in 
excellent overall yield (Scheme 4.5). DMP oxidation of the primary alcohol in 4.5.1, 
followed by Pinnick oxidation16 of the resultant aldehyde, furnished the corresponding 
acid (4.5.2) in 90% yield over 2 steps. Subsequent one-pot sequential mixed anhydride 
formation and amidation (with aqueous methyl amine) afforded 4.4A in near quantitative 
yield. Intermediate 4.4A was treated with H2, in the presence of Pd/C (10 mol %) in 
EtOAc, to unveal a primary alcohol, which was oxidized with DMP and stirred in 
refluxing benzene, in the presence of catalytic trifluoroacetic acid (TFA), for 3 days, to 
generate sanctolide A, albeit in low yield (19%, 58% based on recovered starting 




































































agreement with that reported in the isolation paper,1 this synthesis confirmed the absolute 
configuration of the natural product 2R-sanctolide A. 
 
Scheme 4.5 Esterification and macrocyclization to sanctolide A. 
4.2 Results and Discussion 
 Our retrosynthetic plan involved the formation of 2S-sanctolide A (4.3A) by the 
Yamaguchi esterification15a and late-stage macrocyclization copper-mediated coupling of 
amide alcohol 4.5A with vinyl-idodide-containing acid 4.5B that was inspired by the 
impressive synthetic efforts of Maio and coworkers to the total synthesis of palmyrolide 
A (4.1B) (Figures 4.1 and 4.5).15b We envisioned that acid 4.5B could be derived from 2-
β-hydroxyisovaleric acid and that amide alcohol 4.5A could be generated from triol 4.5C. 
Correspondingly, triol 4.5C could be furnished from bicyclo[5.4.1]phosphate 4.5D 
through a phosphate tether-mediated, one-pot sequential cross metathesis/global 
hydrogenation/tether removal strategy, similar to those previously reported by our group 













































































Figure 4.5 Retrosynthetic analysis to 2S-sanctolide A.  
 
 Based upon previous reports from our laboratory, we proposed that 
bicyclo[5.3.1]phosphate 4.5D could be generated via a phosphate tether-mediated double 
diastereotopic group differentiation of trienes 4.6.2, as was shown for the corresponding 
enantiomer of 4.5D (bicyclo[5.3.1]phosphate 4.6.4, Scheme 4.6).1819 In 2013, our group 
published a detailed study on the effects of stereochemical complexity, ring size, and 
olefin substitution on phosphate tether-mediated ring-closing metathesis which included 
the synthesis of bicyclo[5.3.1]phosphate 4.6.4. Chiral, racemic olefinic alcohol 4.6.1 was 
coupled with monochlorophosphate (S,S)-2.2A to provide trienes 4.6.3 as a 1:1 mixture 
of diastereomers. This mixture was treated with G-II (3 mol %), in refluxing methylene 
chloride, to provide bicyclo[5.3.1]phosphate 4.6.4 in 39% yield as a single diastereomer 
(along with diastereomerically enriched, unreacted starting material). The absolute 
configuration was confirmed by X-ray crystallographic analysis of 4.6.4, and a 
mechanistic rationale based upon proposed structures of intermediate Ru-







































































of the concave nature of the bicyclic phosphate, we proposed that only those 
metallocyclobutanes that formed on the exo-face of the forming olefin would be 
energetically feasible. When the allylic methyl substituent is also on the exo-face of the 
bicyclic phosphate (as in exo-exo-4.6.5), an unfavorable 1,2-steric interaction between the 
methyl group and the Ru-metallocyclobutane would exist, increasing the energy of this 
intermediate and impeding the RCM from taking place. When the allylic methyl 
substituent is on the opposite endo-face of the bicyclic phosphate (as in exo-endo-4.6.6), 
the unfavorable 1,2-steric interaction is avoided, and the reaction proceeds. 
 
Scheme 4.6 Plans for a kinetic resolution/double diastereotopic differentiation and 































































































mixture as a single diastereomer
	
 122 
 Thus, lithiated chiral, racemic homoallylic alcohol 4.6.1 was coupled with (R,R)-
2.2A, in THF, to provide trienes 4.6.2 in 80% yield (Scheme 4.7). Trienes 4.6.2 were 
exposed to RCM conditions (G-II, refluxing methylene chloride) to furnish the 
corresponding bicyclo[5.3.1]phosphate 4.5D as a single diastereomer in 38% yield. Then, 
a one-pot, sequential cross metathesis of 4.5D with cis-4-octene, in the presence of 
Hoveyda-Grubbs second-generation catalyst20 (HG-II, 6 mol %), followed by global 
hydrogenation of both endo- and exo-cyclic olefins catalyzed by residual HG-II (resulting 
in the transient formation of bicylic phosphate 4.7.1)21 and subsequent tether removal, 
generates triol 4.5C in 57% yield over 3 reactions in one pot (83% average per reaction). 
This strategy allows for the formation of advanced polyol intermediates (similar to 4.5C) 
in 6 total steps (or “pots”) with the modularity to incorporate a variety of diverse side-
chains (through cross-metathesis) for the facile synthesis of libraries of analogs from a 
common intermediate—a capability that is noticeably absent from the previously 
described synthesis of 4.1A and its C2-epimer. 
 
Scheme 4.7 Phosphate tether-mediated kinetic resolution and one-pot sequential 






























































 With triol 4.5C in hand, we turned our efforts toward identifying a protocol that 
would allow for the selective methylation of the C7-hydroxyl group and oxidation of the 
C1-alcohol en route to amide 4.5A. It was found that exposure of 4.5C to N-
chlorosuccinimide (NCS), in the presence of catalytic TEMPO (10 mol %) and 
facilitating tetrabutylammonium chloride, provided lactone 4.8.1 in 96% yield, with no 
observable over oxidation of C7 (Scheme 4.8).22 In this way, the oxidation state of C1 is 
successfully achieved, and the C5-hydroxyl group is protected to allow for selective 
methylation of the C7-hydroxyl group. Methylation of 4.8.1, followed by tandem ring-
opening/amide formation via protocols similar to those previously described (vide 
supra),5 would allow for the formation of amide 4.5A in 9 longest-linear pots and 
facilitate the synthesis of 2S-sanctolide A (4.3A), as well as provide precedence for other 
phosphate tether strategies to the synthesis of the natural product (4.1A) and its analogs. 
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4.3 Conclusions and Future Goals  
 In conclusion, efforts toward the synthesis of 2S-sanctolide A—in particular, the 
C1–C12 amide fragment—are described. Our strategy involves the use of a RCM that 
serves as a kinetic resolution to afford an 8-membered bicyclo[5.3.1]phosphate via a 
double diastereotopic group differentiation. In addition, a phosphate tether-mediated one-
pot sequential CM-global hydrogenation-tether removal protocol was developed to afford 
advanced polyol intermediates in 6 total pots. Oxidative lactonization of the resultant triol 
4.5C allows for a selective protection of the C5-hydroxyl group and allows the means to 
methylate the C7-hydroxyl group selectively. Future efforts will involve identification of 
a mild methylating technique that minimizes C2-epimerization and the application of a 
ring-opening/amide formation strategy, in a manner similar to that reported by Brimble 
and coworkers en route to 4.1B (vide supra).5 In addition, efforts will focus on the 
development of phosphate tether-mediated one-pot, sequential processes for the synthesis 
of 2R-sanctolide A and its analogs. We propose that the natural product could be 
generated via the coupling of amide 4.6A (the C2-epimer of 4.5A) and acid 4.5B, where 
4.6A is derived from RCM/CM/hydrogenation product bicylo[4.3.1]phosphate 4.6B 
(Figure 4.6). Two, one-pot sequential processes involving allylic 
transposition/methylation/tether removal and cross-metathesis/hydrogenation would then 
provide the analogous C2-epimer of triol 4.5D, again in 6 longest-linear pots, and allow 





Figure 4.6 Proposed phosphate-tether mediated, one-pot sequential protocols toward the 
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5.1.1 General Methods 
All reactions were carried out in oven- or flame-dried glassware under argon atmosphere 
using standard gas-tight syringes, cannulae, and septa.  Stirring was achieved with oven-
dried magnetic stir bars. Toluene, THF and CH2Cl2 were purified by passage through a 
purification system (Solv-Tek) employing activated Al2O3  (Grubbs, R. H.; Rosen. R. K.; 
Timmers, F. J. Organometallics 1996, 15, 1518–1520).  Et3N was purified by passage 
over basic alumina and stored over KOH.  Butyllithium was purchased from Aldrich and 
titrated prior to use.  All olefin metathesis catalysts were acquired from Materia and used 
without further purification.  Flash column chromatography was performed with Sorbent 
Technologies (30930M-25, Silica Gel 60A, 40-63 mm) and thin layer chromatography 
was performed on silica gel 60F254 plates (EM-5717, Merck).  Deuterated solvents were 
purchased from Cambridge Isotope laboratories. 1H, 13C, DEPT, COSY, HSQC, HMBC 
and NOESY NMR spectra were recorded in CDCl3 (unless otherwise mentioned) on a 
Bruker DRX-500 spectrometer operating at 500 MHz, and 125 MHz, respectively, 
calibrated to the solvent peak, and utilized to unambiguously assign proton and carbon 
signals. 31P NMR spectra was recorded on Bruker DRX-400 spectrometer operating at 
162 MHz. High-resolution mass spectrometry (HRMS) was recorded on a LCT Premier 
Spectrometer (Micromass UK Limited) operating on ESI (MeOH).  Observed rotations at 
589 nm, were measured using AUTOPOL IV Model automatic polarimeter.  IR was 




5.1.2 Experimental Section 
General procedure for Triene generation (1): To a solution of alcohol  (1.1 equiv) in 
THF (0.2 M), at -40 ºC under argon, was added n-BuLi (2.5 M in hexanes, 1 equiv), 
dropwise.  The mixture was allowed to stir for 5 minutes, at which point a solution of 
phosphate monochloride (1.2 equiv) in THF (1 mL) was slowly added to the reaction 
vessel via cannulation. The mixture stirred at –40 ºC for 2 hours (monitored by TLC) and 
was quenched with aqueous NH4Cl (sat.).  The biphasic solution was separated, and the 
aqueous layer was extracted EtOAc (3 x 5 mL).  The combined organic layers were 
washed with brine, dried (Na2SO4), and concentrated under reduced pressure.  
Purification via flash chromatography (silica, Hexanes:EtOAc eluent) provided triene-
containing monocyclic phosphate triester product. 
General procedure for RCM to provide bicyclo[n.3.1]phosphates (2): To a flask 
containing monocyclic phosphate triester (1 equiv.) in CH2Cl2 (dry, degassed, 0.001 M), 
equipped with an argon inlet and reflux condenser, was added p-benzoquinone (10 
mol %). Then, G-I or G-II catalyst [see reaction schemes] was added to the reaction 
[portion-wise in 1 mol % quantities over the allotted reaction time], and the reaction 
mixture was heated to reflux. Upon completion (monitored by TLC), the reaction was 
cooled to room temperature and concentrated under reduced pressure. Purification via 
flash chromatography (silica, Hexanes:EtOAc eluent) provided the corresponding 





2-oxide (2.7.2):  
 
Following General Procedure 1, monochlorophosphate (S,S)-2.2A 1  (0.102 g, 0.489 
mmol) and alcohol (R)-2.7.12 (0.0872 g, 0.489 mmol) were converted into triene 2.7.2 
(0.106 g, 0.301 mmol, 62% yield) which was isolated as a pale yellow oil.  
FTIR (neat): 2924, 2856, 1454, 1281, 1009, 741 cm-1. 
Optical Rotation: [α]D = +47.6 (c = 0.38, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.37–7.26 (m, 5H), 6.05 (ddd, J = 16.9, 10.6, 6.0 Hz, 
1H), 5.99–5.85 (m, 1H), 5.94 (ddd, J = 17.1, 10.6, 6.5 Hz, 1H), 5.46 (d, J = 6.7 Hz, 1H), 
5.42 (d, J = 6.8 Hz, 1H), 5.37 (d, J = 17.1 Hz, 1H), 5.32 (d, J = 4.6 Hz, 1H), 5.29 (d, J = 
4.6 Hz, 1H), 5.26 (d, J = 10.6 Hz, 1H), 5.11–4.95 (m, 3H), 4.62 (d, J = 12.1 Hz, 1H), 
4.57 (d, J = 12.1 Hz, 1H), 3.71–3.61 (m, 2H), 2.12 (ddddd, J = 16.4, 14.8, 10.8, 5.2, 1.7 
Hz, 2H). 
13C NMR (126 MHz, CDCl3) δ 137.9 (s), 135.2 (d, JCP = 3.3 Hz), 135.0 (s), 135.0 (s), 
133.8 (d, JCP = 4.1 Hz), 128.3 (s), 127.6 (s), 118.7 (s), 117.8 (s), 117.4 (s), 78.2 (d, JCP = 
5.6 Hz), 77.9 (d, JCP = 6.7 Hz), 76.0 (d, JCP = 6.1 Hz), 73.2 (s), 72.2 (d, JCP = 5.9 Hz), 
35.2 (d, JCP = 7.7 Hz). 
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Activation in Temporary Phosphate Tethers: A New Tether for Small Molecule 
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[2] Davoille, R. J.; Rutherford, D. T.; Christie, S. D. R. Homologation of Allylic 
Alcohols. An Approach to Cyclic and Acyclic Polyoxygenated Compounds. Tetrahedron 









31P NMR (162 MHz, CDCl3) δ -8.23. 
HRMS: cald. for [C18H23O5P]2Na (2M+Na)+ 723.2464; found 723.2456 (TOF MS ES+). 
 
(4R,6R)-2-(((R)-1-(benzyloxy)but-3-en-2-yl)oxy)-4,6-divinyl-1,3,2-dioxaphosphinane 
2-oxide (2.7.3):  
 
Following General Procedure 1, monochlorophosphate (R,R)-2.2A (0.105 g, 0.503 mmol) 
and alcohol (R)-2.7.1 (0.0900 g, 0.503 mmol) were converted into triene 2.7.3 (0.082 g, 
0.234 mmol, 46% yield) which was isolated as a colorless oil.  
FTIR (neat): 3085, 2922, 1427, 1285, 1007, 739 cm-1. 
Optical Rotation: [α]D = -53.9 (c = 1.7, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.36–7.27 (m, 5H), 6.09 (dddd, J = 17.1, 10.6, 6.4, 0.8 
Hz, 1H), 5.91 (ddd, J = 17.0, 10.7, 6.2 Hz, 1H), 5.82 (dddd, J = 17.3, 10.6, 5.2, 1.7 Hz, 
1H), 5.46 (ddd, J = 17.2, 1.2, 1.2 Hz, 1H), 5.38 (ddd, J = 4.7, 1.0, 1.0 Hz, 1H), 5.34 (ddd, 
J = 4.7, 1.1, 1.1 Hz, 1H), 5.31 (d, J = 10.9 Hz, 1H), 5.28 (ddd, J = 10.8, 1.0, 1.0 Hz, 1H), 
5.23 (ddd, J = 10.7, 1.0, 1.0 Hz, 1H), 5.10 – 4.97 (m, 3H), 4.61 (d, J = 11.9 Hz, 1H), 4.54 
(d, J = 11.9 Hz, 1H), 3.64–3.61 (m, 2H), 2.12 (dddd, J = 14.5, 8.0, 4.9, 1.6 Hz, 1H), 2.03 
(dddd, J = 14.8, 5.5, 3.7, 1.8 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 137.7 (s), 135.2 (s), 135.2 (d, JCP = 4.8 Hz), 133.4 (d, JCP 
= 4.0 Hz), 128.4 (s), 127.8 (s), 127.7 (s), 118.6 (s), 118.0 (s), 117.1 (s), 78.2 (d, JCP = 6.8 
Hz), 77.8 (d, JCP = 5.5 Hz), 75.9 (d, JCP = 6.1 Hz), 73.2 (s), 72.3 (d, JCP = 5.8 Hz), 35.3 








31P NMR (162 MHz, CDCl3) δ -8.37. 
HRMS: cald. for [C18H23O5P]2Na (2M+Na)+ 723.2464; found 723.2400 (TOF MS ES+). 
 
(1S,3R,6S,8S)-3-((benzyloxy)methyl)-8-vinyl-2,9,10-trioxa-1-phosphabicyclo[4.3.1]-
dec-4-ene 1-oxide (trans-2.7.4):  
 
Following General Procedure 2, triene 2.7.2 (20.0 mg, 0.0571 mmol) was exposed to G-II 
catalyst (6 mol %, added portion-wise over 6 h) in refluxing CH2Cl2 to provide the 
corresponding bicyclic phosphate trans-2.7.4 (10.0 mg, 0.0310 mmol, 54% yield, 72% 
based upon recovered starting material) as a white, crystalline solid, which was 
recrystallized (EtOAc:Hexanes) to afford X-ray quality crystals for X-ray 
crystallographic analysis.3 In addition to the title product, unreacted triene 2.7.2 (4.9 mg, 
0.014 mmol) was recovered during purification of the crude reaction mixture. 
FTIR (neat): 2924, 2866, 1454, 1300, 1086, 741 cm-1. 
Optical Rotation: [α]D =  +146. (c = 0.49, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.42–7.28 (m, 5H), 6.02 (ddd, J = 12.3, 5.9, 1.8 Hz, 1H), 
5.86 (dddd, J = 17.1, 10.5, 5.2, 1.7 Hz, 1H), 5.66 (dd, J = 12.5, 4.4 Hz, 1H), 5.44 (d, J = 
17.1 Hz, 1H), 5.28 (d, J = 10.6 Hz, 1H), 5.15 (ddd, J = 24.6, 4.2, 4.2 Hz, 1H), 5.02 (dd, J 
= 11.6, 4.6 Hz, 1H), 4.92 (ddd, J = 29.2, 12.5, 6.0 Hz, 1H), 4.71 (d, J = 12.0 Hz, 1H), 
                                                
[3] All X-ray crystallographic data has been submitted to the Cambridge Crystallographic 










4.60 (d, J = 12.0 Hz, 1H), 4.06 (dd, J = 10.3, 7.0 Hz, 1H), 3.84 (dd, J = 10.3, 5.9 Hz, 1H), 
2.26 (ddd, J = 14.5, 11.9, 6.1 Hz, 1H), 1.79 (d, J = 14.6 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 137.6 (s), 134.7 (d, JCP = 10.4 Hz), 129.8 (s), 128.9 (s), 
128.4 (s), 127.9 (s), 127.8 (s), 117.5 (s), 76.3 (d, JCP = 7.8 Hz), 75.9 (d, JCP = 6.6 Hz), 
75.8 (d, JCP = 6.8 Hz), 73.7 (s), 72.0 (s), 34.4 (d, JCP = 5.7 Hz). 
31P NMR (162 MHz, CDCl3) δ -7.86. 
HRMS: cald. for [C16H19O5P]2Na (2M+Na)+ 667.1838; found 667.1848 (TOF MS ES+). 
  
(1R,3R,6R,8R)-3-((benzyloxy)methyl)-8-vinyl-2,9,10-trioxa-1-phosphabicyclo[4.3.1]-
dec-4-ene 1-oxide (cis-2.7.5):  
 
Following General Procedure 2, triene 2.7.3 (35.0 mg, 0.100 mmol) was exposed to G-II 
catalyst (3 mol %) in refluxing CH2Cl2 to provide the corresponding bicyclic phosphate 
cis-2.7.5 (24.6 mg, 0.0763 mmol, 76% yield) as a pale yellow oil. 
FTIR (neat): 2924, 2854, 1454, 1298, 968, 764 cm-1. 
Optical Rotation: [α]D = -17.6 (c = 0.42, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.41–7.28 (m, 5H), 6.04 (ddd, J = 11.9, 2.5, 2.5 Hz, 1H), 
5.84 (ddd, J = 10.6, 5.9, 2.0 Hz, 1H), 5.61 (ddd, J = 11.9, 3.9, 2.4 Hz, 1H), 5.43 (d, J = 
17.2 Hz, 1H), 5.33–5.27 (m, 1H), 5.27 (d, J = 10.6 Hz, 1H), 5.27–5.16 (m, 1H), 5.04 (dd, 
J = 11.9, 5.3 Hz, 1H), 4.64 (dd, J = 12.1 Hz, 1H), 4.59 (dd, J = 12.1 Hz, 1H), 3.72 (ddd, J 
= 10.2, 5.0, 1.0 Hz, 1H), 3.63 (dd, J = 10.3, 6.0 Hz, 1H), 2.23 (ddd, J = 14.7, 12.1, 6.2 









13C NMR (126 MHz, CDCl3) δ 137.5 (s), 134.7 (d, JCP = 10.4 Hz), 130.1 (s), 129.4 (s), 
128.5 (s), 127.9 (s), 127.7 (s), 117.4 (s), 77.1 (s), 76.2 (d, JCP = 6.0 Hz), 73.5 (s), 72.2 (d, 
JCP = 5.9 Hz), 71.2 (d, JCP = 12.1 Hz), 34.9 (d, JCP = 5.9 Hz). 
31P NMR (162 MHz, CDCl3) δ -5.74. 
HRMS: cald. for [C16H19O5P]2Na (2M+Na)+ 667.1838; found 667.1835 (TOF MS ES+). 
 
(4S,6S)-2-(((R)-1-(benzyloxy)pent-4-en-2-yl)oxy)-4,6-divinyl-1,3,2-dioxaphosphinane 
2-oxide (2.8.2):  
 
Following General Procedure 1, monochlorophosphate (S,S)-2.2A (0.102 g, 0.489 mmol) 
and alcohol (R)-2.8.14 (0.0970 g, 0.489 mmol) were converted into triene 2.8.2 (0.116 g, 
0.318 mmol, 65% yield) which was isolated as a colorless oil.  
FTIR (neat): 2924, 2858, 1454, 1283, 1007, 739 cm-1. 
Optical Rotation: [α]D = +37.9 (c = 0.33, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.36–7.27 (m, 5H), 6.04 (ddd, J = 17.2, 10.7, 6.1 Hz, 
1H), 5.90 (dddd, J = 17.3, 10.6, 5.2, 1.7 Hz, 1H), 5.80 (ddt, J = 17.2, 10.1, 7.1 Hz, 1H), 
5.45 (ddd, J = 17.2, 1.3, 1.3 Hz, 1H), 5.35 (ddd, J = 17.2, 1.3, 1.3 Hz, 1H), 5.30 (ddd, J = 
10.6, 1.2, 1.2 Hz, 1H), 5.23 (ddd, J = 10.6, 1.2, 1.2 Hz, 1H), 5.15 (dd, J = 17.1, 1.7 Hz, 
1H), 5.12–5.08 (m, 1H), 5.08–4.96 (m, 2H), 4.71–4.62 (m, 1H), 4.59 (d, J = 12.0 Hz, 
                                                
[4] Hashimura, K. Tomita, S.; Hiroya, K.; Ogasawara, K. A Stereocontrolled Route to 
Both Enantiomers of the Necine Base Dihydroxyheliotridane via Intramolecular 1,3-









1H), 4.54 (d, J = 12.0 Hz, 1H), 3.70–3.59 (m, 2H), 2.62–2.45 (m, 2H), 2.18–2.02 (m, 
2H).  
13C NMR (126 MHz, CDCl3) δ 138.0 (s), 135.2 (d, JCP = 3.2 Hz), 135.1 (s), 135.0 (s), 
133.0 (s), 128.3 (s), 127.6 (s), 118.4 (s), 117.8 (s), 117.3 (s), 77.9 (d, JCP = 6.8 Hz), 77.2 
(s), 75.9 (d, JCP = 6.1 Hz), 73.22 (s), 71.2 (d, JCP = 4.4 Hz), 36.7 (d, JCP = 4.9 Hz), 35.2 
(d, JCP = 7.6 Hz). 
31P NMR (162 MHz, CDCl3) δ -8.26. 
HRMS: cald. for [C19H25O5P]2Na (2M+Na)+ 751.2777; found 751.2770 (TOF MS ES+). 
 
(4R,6R)-2-(((R)-1-(benzyloxy)but-3-en-2-yl)oxy)-4,6-divinyl-1,3,2-dioxaphosphinane 
2-oxide (2.8.3):  
 
Following General Procedure 1, monochlorophosphate (R,R)-2.2A (0.105 g, 0.503 mmol) 
and alcohol (R)-2.8.1 (0.0970 g, 0.503 mmol) were converted into triene 2.8.3 (0.102 g, 
0.280 mmol, 56% yield) which was isolated as a colorless oil.  
FTIR (neat): 2924, 2862, 1454, 1283, 1004, 740 cm-1. 
Optical Rotation: [α]D = -57.6 (c = 0.46, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.38–7.26 (m, 5H), 6.08 (ddd, J = 17.0, 10.6, 6.2 Hz, 
1H), 5.87–5.74 (m, 2H), 5.36 (d, J = 11.0 Hz, 1H), 5.32 (d, J = 11.0 Hz, 1H), 5.28 (d, J = 
10.6 Hz, 1H), 5.22 (d, J = 10.6 Hz, 1H), 5.13 (dd, J = 17.03, 1.6 Hz, 1H), 5.10 (d, J = 9.8, 








Hz, 1H), 3.65–3.55 (m, 2H), 2.60–2.47 (m, 2H), 2.09 (ddd, J = 8.1, 4.9, 1.6 Hz, 1H), 2.01 
(dddd, J = 14.7, 5.4, 3.9, 1.9 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 137.8 (s), 135.2 (d, JCP = 6.4 Hz), 135.2 (d, JCP = 1.0 
Hz), 132.7 (s), 128.3 (s), 127.7 (s), 127.7 (s), 118.4 (s), 117.9 (s), 117.0 (s), 78.1 (d, JCP = 
6.8 Hz), 77.0 (d, JCP = 6.3 Hz), 75.7 (d, JCP = 6.0 Hz), 73.2 (s), 71.3 (d, JCP = 4.9 Hz), 
36.7 (d, JCP = 4.3 Hz), 35.3 (d, JCP = 7.6 Hz). 
31P NMR (162 MHz, CDCl3) δ -8.19. 
HRMS: cald. for [C19H25O5P]2Na (2M+Na)+ 751.2777; found 751.2760 (TOF MS ES+). 
 
(1S,3R,7S,9S,Z)-3-((benzyloxy)methyl)-9-vinyl-2,10,11-trioxa-1-
phosphabicyclo[5.3.1]undec-5-ene 1-oxide (trans-2.8.4):  
 
Following General Procedure 2, triene 2.8.2 (33.6 mg, 0.0923 mmol) was exposed to G-II 
catalyst (3 mol %) in refluxing CH2Cl2 to provide the corresponding bicyclic phosphate 
trans-2.8.4 (22.0 mg, 0.0654 mmol, 71% yield) as a pale yellow oil. 
FTIR (neat): 2926, 2854, 1454, 1283, 1020, 756 cm-1. 
Optical Rotation: [α]D =  +61.8 (c = 0.45, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.38–7.28 (m, 5H), 5.89–5.80 (m, 2H), 5.53 (d, J = 11.8 
Hz, 1H), 5.41 (ddd, J = 17.0, 1.1, 1.1 Hz, 1H), 5.35–5.23 (m, 1H), 5.26 (ddd, J = 10.5, 
0.9, 0.9 Hz, 1H), 5.06–4.99 (m, 1H), 4.67 (d, J = 11.9 Hz, 1H), 4.58 (d, J = 11.9 Hz, 1H), 








9.8, 6.4 Hz, 1H), 3.17–3.07 (m, 1H), 2.36 (ddd, J = 14.0, 8.7, 2.9 Hz, 1H), 2.20 (ddd, J = 
14.5, 11.9, 6.0 Hz, 1H), 1.81 (ddd, J = 14.5, 3.7, 1.9 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 13C NMR (126 MHz, CDCl3) δ 137.9 (s), 135.0 (d, JCP 
= 10.2 Hz), 131.2 (s), 128.4 (s), 127.8 (s), 127.7 (s), 126.8 (s), 117.2 (d, JCP = 1.4 Hz), 
78.3 (d, JCP = 7.2 Hz), 76.9 (d, JCP = 6.0 Hz), 76.0 (d, JCP = 5.9 Hz), 73.6 (s), 72.2 (s), 
36.0 (d, JCP = 6.4 Hz), 29.5 (s). 
31P NMR (162 MHz, CDCl3) δ -10.79 (dd, J = 30.4, 24.7 Hz). 
HRMS: cald. for [C17H21O5P]2Na (2M+Na)+ 695.2151; found 695.2125 (TOF MS ES+). 
  
(1R,3R,7R,9R,Z)-3-((benzyloxy)methyl)-9-vinyl-2,10,11-trioxa-1-
phosphabicyclo[5.3.1]undec-5-ene 1-oxide (cis-2.8.5):  
 
Following General Procedure 2, triene 2.8.3 (30.0 mg, 0.0824 mmol) was exposed to G-II 
catalyst (3 mol %) in refluxing CH2Cl2 to provide the corresponding bicyclic phosphate 
cis-2.8.5 (16.1 mg, 0.0479 mmol, 58% yield) as a colorless oil. 
FTIR (neat): 2924, 2854, 1454, 1292, 1018, 743 cm-1. 
Optical Rotation: [α]D =  +3.5 (c = 0.46, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.40–7.28 (m, 5H), 5.84 (dddd, J = 17.1, 10.7, 5.3, 2.1 
Hz, 1H), 5.73 (ddd, J = 20.5, 8.7, 2.8 Hz, 1H), 5.50 (dd, J = 11.8, 1.8 Hz, 1H), 5.41 (dd, J 
= 17.2, 1.3 Hz, 1H), 5.34–5.23 (m, 1H), 5.26 (dd, J = 10.7, 1.0 Hz, 1H), 5.03 (dd, J = 
11.9, 5.0 Hz, 1H), 4.73 (ddd, J = 12.7, 6.8, 2.3 Hz, 1H), 4.59 (d, J = 12.0 Hz, 1H), 4.54 







3.38–3.29 (m, 1H), 2.38 (dd, J = 14.1, 8.7 Hz, 1H), 2.19 (ddd, J = 14.6, 12.0, 5.9 Hz, 
1H), 1.81 (dd, J = 14.6, 1.9 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 137.7 (s), 135.0 (d, JCP = 10.0 Hz), 131.2 (s), 128.4 (s), 
127.8 (s), 127.6 (s), 125.3 (s), 117.2 (d, JCP = 1.3 Hz), 78.3 (d, JCP = 7.1 Hz), 77.1 (d, JCP 
= 6.1 Hz), 73.2 (s), 72.4 (d, JCP = 4.8 Hz), 70.4 (d, JCP = 15.1 Hz), 36.2 (d, JCP = 6.5 Hz), 
27.4 (s). 
31P NMR (162 MHz, CDCl3) δ -9.29. 
HRMS: cald. for [C17H21O5P]2Na (2M+Na)+ 695.2151; found 695.2162 (TOF MS ES+). 
  
(4R,6R)-2-(hex-5-en-1-yloxy)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide (2.10.1):  
 
Following General Procedure 1, monochlorophosphate (R,R)-2.2A (0.624 g, 2.99 mmol) 
and 5-hexen-1-ol (0.272 g, 2.719 mmol) were converted into triene 2.10.1 (0.517 g, 1.90 
mmol, 70% yield) which was isolated as a colorless oil.  
FTIR (neat): 3078, 2935, 1429, 1283, 1119, 1011, 926, 874, 845 cm-1; 
Optical Rotation: [α]D = –50.4° (c = 1.66 , CHCl3). 
1H NMR (500 MHz, CDCl3) δ 6.02 (dddd, J = 17.3, 10.6, 6.0, 0.6 Hz, 1H, H2C=CH-
CHO(P)CH2), 5.92 (dddd, J = 17.4, 10.6, 5.2, 1.6 Hz, 1H, H2C=CH-CHO(P)CH2), 5.79 
(ddt, J = 17.0, 10.2, 6.7 Hz, 1H, H2C=CH-CH2-CH2-CH2-CH2-O(P)), 5.46 (ddd, J = 17.1, 
1.5, 1.0 Hz, 1H, HaHbC=CH-CHO(P)CH2), 5.38 (ddd, J = 17.2, 1.4, 1.0Hz, 1H, 
HaHbC=CH-CHO(P)CH2), 5.31 (ddd, J = 4.6, 1.3, 1.3 Hz, 1H, HaHbC=CH-CHO(P)CH2), 









H2C=CH-CH2-CH2-CH2-CH2-O(P), H2C=CH-CHO(P)CH2, H2C=CH-CHO(P)CH2), 4.11 
(dtd, J = 7.7, 6.5, 2.5 Hz, 2H, H2C=CH-CH2-CH2-CH2-CH2-O(P)), 2.17 (dddd, J = 14.7, 
8.1, 4.9, 1.5 Hz, 1H, H2C=CH-CHO(P)CHaHbCHO[P]), 2.12 – 2.02 (m, 3H, H2C=CH-
CHO(P)CHaHbCHO[P], H2C=CH-CH2-CH2-CH2-CH2-O(P)), 1.75 – 1.67 (m, 2H, 
H2C=CH-CH2-CH2-CH2-CH2-O(P)), 1.53 – 1.45 (m, 2H, H2C=CH-CH2-CH2-CH2-CH2-
O(P)). 
13C NMR (126 MHz, CDCl3) δ 138.2, 135.0 (d, JCP = 4.2 Hz), 135.0, 118.0, 117.4, 
114.9, 77.5 (d, J = 6.7 Hz), 76.1 (d, JCP = 6.1 Hz), 67.8 (d, JCP = 5.9 Hz), 35.2 (d, JCP = 
7.6 Hz), 33.1, 29.6 (d, JCP = 6.6 Hz), 24.7. 
31P NMR (162 MHz, CDCl3) δ –7.55; 





Following General Procedure 2, triene 2.10.1 (50.0 mg, 0.184 mmol) was exposed to G-II 
catalyst (2 mol %, portion-wise over 5 hours) in refluxing CH2Cl2 to provide the 
corresponding bicyclic phosphate 2.10.2 (18.8 mg, 0.0770 mmol, 42% yield, 74% based 
upon recovered starting material, colorless oil), along with unreacted 2.10.1 (21.7 mg, 
0.080mmol). 
Yield: 42% (74% brsm). 








Optical Rotation: [α]D = –33.0° (c = 0.46, CHCl3). 
1H NMR (500 MHz, CDCl3) δ 6.28 (dddd, J = 16.4, 9.7, 5.2, 1.7 Hz, 1H, H2C-HC=CH-
CHO(P)CH2), 5.92 – 5.83 (m, 2H, H2C-HC=CH-CHO(P)CH2, H2C=CH-CHO[P]), 5.44 
(ddd, J = 17.2, 1.3, 1.3 Hz, 1H, HaHbC=CH-CHO[P]), 5.27 (ddd, J = 10.6, 1.2, 1.2 Hz, 
1H, HaHbC=CH-CHO[P]), 5.22 – 5.09 (m, 2H, HC=CH-CHO(P)CH2, HC=CH-
CHO(P)CH2), 4.22 (ddd, J = 10.4, 6.7, 2.6 Hz, 1H, HC=CH-CH2-CH2-CH2-CHaHb-
O(P)), 3.82 – 3.77 (m, 1H, HC=CH-CH2-CH2-CH2-CHaHb-O(P)), 2.40 – 2.31 (m, 1H, 
HC=CH-CHaHb-CH2-CH2-CH2-O(P)), 2.24 (ddd, J = 14.6, 12.0, 5.2 Hz, 1H, HC=CH-
CHO(P)CHaHbCHO[P]), 2.20 – 2.11 (m, 1H, HC=CH-CHaHb-CH2-CH2-CH2-O(P)), 2.00 
– 1.88 (m, 2H, HC=CH-CH2-CHaHb-CH2-CH2-O(P), HC=CH-CH2-CH2-CHaHb-CH2-
O(P)), 1.85 (ddd, J = 14.5, 3.6, 2.0 Hz, 1H, HC=CH-CHO(P)CHaHbCHO[P]), 1.64 – 1.56 
(m, 2H, HC=CH-CH2-CHaHb-CH2-CH2-O(P), HC=CH-CH2-CH2-CHaHb-CH2-O(P)). 
13C NMR (126 MHz, CDCl3) δ 138.9, 135.3 (d, JCP = 10.1 Hz), 127.8, 117.1 (d, JCP = 
1.3 Hz), 76.4 (d, JCP = 6.4 Hz), 75.3 (d, JCP = 7.2 Hz), 66.2 (d, JCP = 5.5 Hz), 35.2 (d, JCP 
= 6.0 Hz), 32.4, 29.0 (d, JCP = 10.1 Hz), 28.6. 
31P NMR (162 MHz, CDCl3) δ –8.44; 





oxide ((S,S,S)-2.10.3):  
 
Following General Procedure 1, monochlorophosphate (S,S)-2.2A (0.104 g, 0.497 mmol) 
and alcohol (S)-2.10.55 (0.131 g, 0.596 mmol) were converted into triene 2.10.3 (0.071 g, 
0.181 mmol, 36% yield) which was isolated as a colorless oil.  
FTIR (neat): 3074, 3030, 2932, 2862, 1454, 1285, 1119, 1070, 1004, 926, 737, 700 cm-1; 
Optical Rotation: [α]D = +49.9° (c = 1.35, CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.21 (m, 5H, aromatic C–H), 6.01 (dddd, J = 17.0, 
10.6, 6.3, 0.8 Hz, 1H, H2C=CH-CHO(P)CH2), 5.81 – 5.68 (m, 2H, H2C=CH-
CHO(P)CH2, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 5.31 (ddd, J = 4.2, 1.3, 1.3 Hz, 
1H, HaHbC=CH-CHO(P)CH2), 5.28 (ddd, J = 4.2, 1.2, 1.2 Hz, 1H, HaHbC=CH-
CHO(P)CH2), 5.22 (dt, J = 10.6, 1.2 Hz, 1H, HaHbC=CH-CHO(P)CH2), 5.17 (ddd, J = 
10.6, 1.2, 1.2 Hz, 1H, HaHbC=CH-CHO(P)CH2), 5.00 – 4.92 (m, 3H, H2C=CH-CH2-
CH2-CH2, H2C=CH-CHO(P)CH2), 4.90 (ddt, J = 10.2, 2.3, 1.2 Hz, 1H, H2C=CH-
CHO(P)CH2), 4.59 – 4.43 (m, 1H, CHO(P)CH2OBn), 4.52 (d, J = 12.0 Hz, 1H, 
OCHaHbPh), 4.45 (d, J = 12.0 Hz, 1H, OCHaHbPh), 3.57 – 3.49 (m, 2H, 
CHO(P)CH2OBn), 2.08 – 2.00 (m, 3H, H2C=CH-CH2-CH2-CH2, H2C=CH-
CHO(P)CHaHbCHO[P]), 1.96 (dddd, J = 14.7, 5.5, 3.9, 1.8 Hz, 1H H2C=CH-
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CHO(P)CHaHbCHO[P]), 1.76 – 1.60 (m, 2H, H2C=CH-CH2-CH2-CH2-
CHO(P)CH2OBn), 1.52 – 1.37 (m, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn). 
13C NMR (126 MHz, CDCl3) δ 138.24, 137.88, 135.2 (d, JCP = 7.8 Hz), 135.2 (d, JCP = 
3.2 Hz), 128.3 (2C), 127.68 (2C), 127.65, 117.8, 117.0, 114.8, 78.0 (d, JCP = 6.1 Hz), 
77.9 (d, JCP = 6.6 Hz), 75.7 (d, JCP = 6.1 Hz), 73.2, 71.8 (d, JCP = 4.4 Hz), 35.3 (d, JCP = 
7.4 Hz), 33.4, 31.7 (d, JCP = 4.8 Hz), 24.18. 
31P NMR (162 MHz, CDCl3) δ – 7.89; 
HRMS: cald. for C21H29O5P (M+Na)+ 415.1650; found 415.1649 (TOF MS ES+). 
 
(4R,6R)-2-(((S)-1-(benzyloxy)hept-6-en-2-yl)oxy)-4,6-divinyl-1,3,2-dioxaphosphinane 
2-oxide ((S,S,R)-2.10.4):  
 
Following General Procedure 1, monochlorophosphate (S,S)-2.2A (0.104 g, 0.497 mmol) 
and alcohol (S)-2.10.5 (0.131 g, 0.596 mmol) were converted into triene 2.10.4 (0.0923 g, 
0.235 mmol, 47% yield) which was isolated as a pale yellow oil.  
FTIR (neat): 3076, 3030, 2930, 2862, 1722, 1641, 1454,1429, 1283, 1119, 1070, 1003, 
927, 872, 735, 698 cm-1; 
Optical Rotation: [α]D = –37.2° (c = 0.58 , CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.38 – 7.25 (m, 5H, aromatic C–H), 6.02 (dddd, J = 17.2, 
10.6, 6.0, 0.6 Hz, 1H, H2C=CH-CHO(P)CH2), 5.92 (dddd, J = 17.3, 10.6, 5.3, 1.6 Hz, 











CH2-CHO(P)CH2OBn), 5.46 (ddd, J = 17.1, 1.2, 1.2 Hz, 1H, HaHbC=CH-CHO(P)CH2), 
5.36 (ddd, J = 17.2, 1.2, 1.2 Hz, 1H, HaHbC=CH-CHO(P)CH2), 5.30 (ddd, J = 10.6, 1.2, 
1.2 Hz, 1H, HaHbC=CH-CHO(P)CH2), 5.23 (ddd, J = 10.6, 1.2, 1.2 Hz, 1H, HaHbC=CH-
CHO(P)CH2), 5.08 – 4.94 (m, 4H, H2C=CH-CH2-CH2-CH2, H2C=CH-CHO(P)CH2, 
H2C=CH-CHO(P)CH2), 4.67 – 4.61 (m, 1H, CHO(P)CH2OBn), 4.60 (d, J = 12.0 Hz, 1H, 
OCHaHbPh), 4.54 (d, J = 12.0 Hz, 1H, OCHaHbPh), 3.62 (dd, J = 4.8, 1.9 Hz, 2H, 
CHO(P)CH2OBn), 2.19 – 2.04 (m, 4H, H2C=CH-CH2-CH2-CH2, H2C=CH-
CHO(P)CH2CHO[P]), 1.77 – 1.71 (m, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 
1.58 – 1.42 (m, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn). 
13C NMR (126 MHz, CDCl3) δ 138.2, 138.1, 135.3 (d, JCP = 3.7 Hz), 135.1 (d, JCP = 7.2 
Hz), 128.3 (2C), 127.61 (2C), 127.59, 117.7, 117.4, 114.9, 78.4 (d, JCP = 6.4 Hz), 77.5 (d, 
JCP = 6.5 Hz), 76.1 (d, JCP = 6.2 Hz), 73.2, 71.7 (d, JCP = 4.0 Hz), 35.3 (d, JCP = 7.5 Hz), 
33.4, 31.6 (d, JCP = 5.0 Hz), 24.2. 
31P NMR (162 MHz, CDCl3) δ – 8.00; 
HRMS: cald. for C21H29O5P (M+Na)+ 415.1650; found 415.1634 (TOF MS ES+). 
 
(1S,3S,9S,11S,E)-3-((benzyloxy)methyl)-11-vinyl-2,12,13-trioxa-1-
phosphabicyclo[7.3.1]tridec-7-ene 1-oxide (cis-2.10.6):  
 
Following General Procedure 2, triene 2.10.3 (25.0 mg, 0.0637 mmol) was exposed to G-
II catalyst (3 mol %, portion-wise over 5 hours) in refluxing CH2Cl2 to provide the 







crystalline solid. The solid was re-crystallized via vapor diffusion method 
(EtOAc:Hexanes, -5oC, overnight) to obtain X-ray quality crystals. 6  Note: Several 
recrystallization procedures were attempted to try to improve the crystal size, as most 
attempts resulted in crystals that were very thin. Vapor-diffusion was decidedly the best 
procedure, and as such, was used for the recrystallization of other large-ring containing 
bicyclic phosphates described herein (vide infra). 
m.p. 114 – 116 °C 
FTIR (neat): 3029, 2928, 2856, 1285, 1122, 1097, 984, 960, 897, 852, 698 cm-1; 
Optical Rotation: [α]D = +57.3° (c = 0.11, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.36 – 7.27 (m, 5H, aromatic C-H), 6.23 (dddd, J = 15.5, 
10.9, 4.6, 1.7 Hz, 1H, H2C-HC=CH-CHO(P)CH2), 5.92 – 5.82 (m, 2H, H2C-HC=CH-
CHO(P)CH2, H2C=CH-CHO[P]), 5.44 (ddd, J = 17.1, 1.3, 1.3 Hz, 1H, HaHbC=CH-
CHO[P]), 5.27 (ddd, J = 10.6, 1.1, 1.1 Hz, 1H, HaHbC=CH-CHO[P]), 5.19 – 5.10 (m, 2H, 
HC=CH-CHO(P)CH2, HC=CH-CHO(P)CH2), 4.59 (d, J = 11.9 Hz, 1H, OCHaHbPh), 
4.55 (d, J = 12.2 Hz, 1H, OCHaHbPh), 4.14 – 4.08 (m, 1H, CHO(P)CH2OBn), 3.85 (dd, J 
= 9.7, 3.4 Hz, 1H, CHO(P)CHaHbOBn), 3.67 (dd, J = 9.7, 6.9 Hz, 1H, 
CHO(P)CHaHbOBn), 2.49 – 2.43 (m, 1H, H2C=CH-CHaHb-CH2-CH2), 2.29 – 2.17 (m, 
2H, H2C=CH-CHO(P)CHaHbCHO[P], H2C=CH-CH2-CH2-CHaHb-CHO(P)CH2OBn), 
2.08 – 1.98 (m, 1H, H2C=CH-CHaHb-CH2-CH2), 1.92 – 1.86 (m, 1H, H2C=CH-CH2-
CHaHb-CH2), 1.83 (ddd, J = 14.6, 3.7, 2.3 Hz, 1H, H2C=CH-CHO(P)CHaHbCHO[P]), 
                                                
[6] All X-ray crystallographic data has been submitted to the Cambridge Crystallographic 





1.54 – 1.44 (m, 2H, H2C=CH-CH2-CH2-CHaHb-CHO(P)CH2OBn, H2C=CH-CH2-CHaHb-
CH2-). 
13C NMR (126 MHz, CDCl3) δ 139.3, 138.2, 135.3 (d, JCP = 10.1 Hz), 128.3 (2C), 
128.2, 127.7 (2C), 127.6, 117.1, 78.0 (d, JCP = 5.9 Hz), 76.3 (d, JCP = 6.3 Hz), 75.5 (d, JCP 
= 7.2 Hz), 73.5, 72.3, 35.3 (d, JCP = 5.9 Hz), 33.8, 32.8 (d, JCP = 9.1 Hz), 27.8. 
31P NMR (162 MHz, CDCl3) δ – 9.80. 
HRMS: cald. for C19H25O5P (M+Na)+ 387.1337; found 387.1325 (TOF MS ES+). 
 
(4R,6R)-2-(hex-5-yn-1-yloxy)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide (2.11.3) 
 
 Following General Procedure 1, monochlorophosphate (R,R)-2.2A (0.4210 g, 2.018 
mmol) and 5-hexyn-1-ol (0.1816 g, 1.850 mmol) were converted to phosphate triene 
2.11.3 (0.3562 g, 1.318 mmol, 65%) which was isolated as a colorless oil.  
FTIR (neat): 3296, 3234, 2955, 2939, 2870, 1431, 1281, 1119, 1020, 993, 932, 874, 847, 
725, 644, 548 cm-1;  
Optical Rotation: [α]D = –49.1 (c 1.96, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 6.00 (ddd, J = 16.9, 10.6, 6.0 Hz, 1H, H2C=CH-
CHO(P)CH2), 5.89 (dddd, J = 17.3, 10.6, 5.2, 1.6 Hz, 1H, H2C=CH-CHO(P)CH2), 5.44 
(ddd, J = 17.0, 1.2, 1.2 Hz, 1H, H-HC=CH-CHO(P)CH2), 5.36 (ddd, J = 17.2, 1.2, 1.2 
Hz, 1H, H-HC=CH-CHO(P)CH2), 5.31–5.26 (m, 2H, H-HC=CH-CHO(P)CH2, H-
HC=CH-CHO(P)CH2), 5.06–4.93 (m, 2H, H2C=CH-CHO(P)CH2, H2C=CH-









2H, (P)OCH2CH2CH2CH2CCH), 2.15 (dddd, J = 14.7, 8.2, 4.9, 1.6 Hz, 1H, H2C=CH-
CHO(P)CHaHbCHO[P]), 2.03 (dddd, J = 14.8, 5.5, 3.6, 1.9 Hz, 1H, H2C=CH-
CHO(P)CHaHbCHO[P]), 1.94 (t, J = 2.6 Hz, 1H, (P)OCH2CH2CH2CH2CCH), 1.79 (dt, J 
= 12.5, 6.4 Hz, 2H, (P)OCH2CH2CH2CH2CCH), 1.61 (p, J = 7.2 Hz, 2H, 
(P)OCH2CH2CH2CH2CCH);  
13C NMR (126 MHz, CDCl3) δ ppm 134.86 (d, JCP = 10.9 Hz, CH), 134.85 (CH), 118.1 
(CH2), 117.4 (CH2), 83.6 (C), 77.5 (d, JCP = 6.7 Hz, CH), 76.1 (d, JCP = 6.2 Hz, CH), 68.7 
(CH), 67.2 (d, JCP = 5.9 Hz, CH2), 35.0 (d, JCP = 7.7 Hz, CH2), 29.1 (d, JCP = 6.9 Hz, 
CH2), 24.4 (CH2), 17.8 (CH2);  
31P NMR (162 MHz, CDCl3) δ ppm –7.66 (dq, JPH = 13.9, 6.9 Hz);  





Following General Procedure 1, monochlorophosphate (S,S)-2.2A (0.3380 g, 1.620 
mmol) and 5-methyl-5-penten-1-ol (0.1700 g, 1.485 mmol) were converted to phosphate 
triene 2.11.2 (0.2634 g, 0.9200 mmol, 68%) which was isolated as a colorless oil.  
FTIR (neat): 2937, 2868, 1429, 1412, 1283, 1119, 1018, 926, 876, 849, 725, 646, 546 
cm-1;  









1H NMR (500 MHz, CDCl3) δ ppm 6.03 (ddd, J = 16.9, 10.6, 6.0 Hz, 1H, H2C=CH-
CHO(P)CH2), 5.91 (ddddd, J = 17.3, 10.7, 5.3, 1.5, 1.5  Hz, 1H, H2C=CH-CHO(P)CH2), 
5.46 (dd, J = 17.2, 1.3 Hz, 1H, H-HC=CH-CHO(P)CH2), 5.37 (dd, J = 17.2, 1.3 Hz, 1H, 
H-HC=CH-CHO(P)CH2), 5.31 (dd, J = 4.3, 1.2 Hz, 1H, H-HC=CH-CHO(P)CH2), 5.29 
(dd, J = 4.3, 1.2 Hz, 1H, H-HC=CH-CHO(P)CH2), 5.07–5.01 (m, 1H, H2C=CH-
CHO(P)CH2), 5.00–4.94 (m, 1H, H2C=CH-CHO(P)CH2), 4.71 (d, J = 2.1 Hz, 1H, 
(P)OCH2CH2CH2CH2C(CH3)=CHaHb), 4.67–4.66 (m, 1H, 
(P)OCH2CH2CH2CH2C(CH3)=CHaHb), 4.13–4.08 (m, 2H, 
(P)OCH2CH2CH2CH2C(CH3)=CH2), 2.21–2.13 (m, 1H, H2C=CH-
CHO(P)CHaHbCHO[P]),), 2.07–2.01 (m, 3H, H2C=CH-CHO(P)CHaHbCHO[P], 
(P)OCH2CH2CH2CH2C(CH3)=CH2), 1.71–1.66 (m, 5H, 
(P)OCH2CH2CH2CH2C(CH3)=CH2, (P)OCH2CH2CH2CH2C(CH3)=CH2), 1.53 (dtd, J = 
8.8, 7.3, 5.5 Hz, 2H, (P)OCH2CH2CH2CH2C(CH3)=CH2);  
13C NMR (126 MHz, CDCl3) δ ppm 145.2 (C), 135.0 (d, JCP = 4.7 Hz, CH), 134.96 
(CH), 118.0 (CH2), 117.4 (CH2), 110.2 (CH2), 77.5 (d, JCP = 6.8 Hz, CH), 76.1 (d, JCP = 
6.0 Hz, CH), 67.8 (d, JCP = 6.0 Hz, CH2), 37.1 (CH2), 35.1 (d, JCP = 7.6 Hz, CH2), 29.8 
(d, JCP = 6.8 Hz, CH2), 23.3 (CH2), 22.2 (CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –7.55 (dd, JPH = 14.2, 7.1 Hz);  





2-oxide (2.11.1):  
 
To a clean, dry round bottom flask, equipped with a magnetic stirbar, was added 2.11.3 
(0.0720 g, 0.2664 mmol) and CH2Cl2 (dry, degassed, 3 mL) under Ar. The flask was 
cooled to 0 °C, where (Cp*Ru[MeCN]3)PF6 (6.7 mg, 0.01332 mmol, 5 mol %) was added 
in two portions. The flask was removed from the cooling bath and warmed to room 
temperature. The reaction stirred at room temperature for 1 hour (monitored by TLC) 
and, upon completion, concentrated under reduced pressure. The crude mixture was 
separated via flash chromatography (silica, 0% to 50% EtOAc in Hexanes) to afford 
2.11.1 (0.0791 g, 0.1820 mmol, 68%) as a colorless oil. 2.11.1 was stored in dry, 
degassed toluene under Ar in a flammable freezer for further use, as storage neat under 
Ar at lower temperatures resulted in decomposition after 2 weeks.  
FTIR (neat): 2974, 2925, 2895, 1285, 1101, 1078, 1020, 991, 960, 781, 752, 550 cm-1; 
Optical Rotation: [α]D = –28.6 (c 0.37, benzene);  
1H NMR (500 MHz, CDCl3) δ ppm 6.01 (ddd, JPH = 16.7, 10.4, 5.9 Hz, 1H, H2C=CH-
CHO(P)CH2), 5.89 (dddd, J = 17.2, 10.6, 5.2, 2.0 Hz, 1H, H2C=CH-CHO(P)CH2), 5.70 
(dd, J = 3.6, 1.8 Hz, 1H, –C[Si(OEt)3]=CHaHb), 5.62 (d, J = 3.2 Hz, 1H–
C[Si(OEt)3]=CHaHb), 5.45 (dd, J = 16.9, 1.9 Hz, 1H, H-HC=CH-CHO(P)CH2), 5.36 (dd, 
J = 17.2, 0.7 Hz, 1H, H-HC=CH-CHO(P)CH2), 5.31–5.26 (m, 2H, H-HC=CH-
CHO(P)CH2, H-HC=CH-CHO(P)CH2), 5.05–4.99 (m, 1H,  H2C=CH-CHO(P)CH2), 










(P)OCH2CH2CH2CH2C[Si(OEt)3]=CH2), 3.80 (dtt, J = 9.3, 4.5, 2.2 Hz, 6H, –
Si(OCH2CH3)3), 2.21–2.11 (m, 3H,  H2C=CH-CHO(P)CHaHbCHO[P]), 
(P)OCH2CH2CH2CH2C[Si(OEt)3]=CH2), 2.06–2.00 (m, 1H, H2C=CH-
CHO(P)CHaHbCHO[P]), 1.68 (q, J = 7.0, 6.4 Hz, 2H, 
(P)OCH2CH2CH2CH2C[Si(OEt)3]=CH2), 1.54 (tt, J = 9.6, 6.3 Hz, 2H, 
(P)OCH2CH2CH2CH2C[Si(OEt)3]=CH2), 1.21 (td, J = 7.0, 2.0 Hz, 9H, –Si(OCH2CH3)3).; 
13C NMR (126 MHz, CDCl3) δ ppm 143.0 (C), 134.98 (d, JCP = 9.6 Hz, CH), 134.96 
(CH), 129.4 (CH2), 118.0 (CH2), 117.4 (CH2), 77.5 (d, JCP = 6.8 Hz, CH), 76.0 (d, JCP = 
6.0 Hz, CH), 67.8 (d, JCP = 6.0 Hz, CH2), 58.4 (3 x CH2), 35.3 (CH2), 35.1 (d, JCP = 7.7 
Hz, CH2), 29.9 (d, JCP = 6.8 Hz, CH2), 24.5 (CH2), 18.1 (3 x CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –7.58 (dd, JPH = 13.9, 7.0 Hz);  






2-oxide (2.12.1):  
 
Following General Procedure 1, monochlorophosphate (S,S)-2.12.37  (0.182 g, 0.769 
mmol) and alcohol (S)-2.12.48 (0.145 g, 0.705 mmol) were converted into 2.12.1 (0.211 
g, 0.519 mmol, 81%) which was isolated as a pale yellow oil.  
FTIR (neat): 2976, 2930, 2860, 1452, 1362, 1286, 1097, 997, 918, 739, 698, 629, 505 
cm-1;  
Optical Rotation: [α]D = –34.4 (c 1.85, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.37–7.26 (m, 5H, Aromatic C-H), 5.86–5.69 (m, 
3H, H2C=CH-CH2-CH2-CHO(P)CH2OBn, H2C=CH-CH2-CHO(P)CH2, H2C=CH-CH2-
CHO(P)CH2), 5.16 (dd, J = 8.7, 2.1 Hz, 1H, HaHbC=CH-CH2CHO(P)CH2), 5.14–5.11 
(m, 2H, HaHbC=CH-CH2CHO(P)CH2, HaHbC=CH-CH2CHO(P)CH2), 5.10 (dd, J = 3.2, 
1.6 Hz, 1H, HaHbC=CH-CH2CHO(P)CH2), 5.05 (dq, J = 17.2, 1.5 Hz, 1H, HaHbC=CH-
CH2-CH2-CHO(P)CH2OBn), 4.99 (dt, J = 10.2, 1.5 Hz, 1H, HaHbC=CH-CH2-CH2-
CHO(P)CH2OBn), 4.66–4.48 (m, 5H, H2C=CHCH2-CHO(P)CH2, H2C=CHCH2-
CHO(P)CH2, CHO(P)CH2OBn, OCH2Ph), 3.63–3.60 (m, 2H, CHO(P)CH2OBn), 2.66–
2.52 (m, 2H, H2C=CH-CH2CHO(P)CH2, H2C=CH-CH2CHO(P)CH2), 2.39 (dt, J = 14.6, 
                                                
[7] Chegondi, R.; Maitra, S.; Markley, J. L.; Hanson, P. R. Phosphate-Tether-Mediated 
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7.4 Hz, 2H, H2C=CH-CH2CHO(P)CH2, H2C=CH-CH2CHO(P)CH2), 2.23–2.09 (m, 2H, 
H2C=CH-CH2-CH2-CHO(P)CH2OBn), 2.03–1.95 (m, 1H, H2C=CHCH2-
CHO(P)CHaHbCHO[P]), 1.89 (dqd, J = 14.5, 3.8, 1.8 Hz, 1H, H2C=CHCH2-
CHO(P)CHaHbCHO[P]), 1.85–1.79 (m, 2H, H2C=CH-CH2-CH2-CHO(P)CH2OBn);  
13C NMR (126 MHz, CDCl3) δ ppm 138.0 (C), 137.4 (CH), 132.6 (CH), 132.3 (CH), 
128.3 (2 x CH), 127.61 (2 x CH), 127.59 (CH), 118.9 (CH2), 118.7 (CH2), 115.2 (CH2), 
77.8 (d, JCP = 6.3 Hz, CH), 76.8 (d, JCP = 7.9 Hz, CH), 75.5 (d, JCP = 6.6 Hz, CH), 73.2 
(CH2), 71.6 (d, JCP = 4.0 Hz, CH2), 39.9 (d, JCP = 7.3 Hz, CH2), 39.1 (d, JCP = 3.9 Hz, 
CH2), 33.1 (d, JCP = 6.7 Hz, CH2), 31.4 (d, JCP = 5.0 Hz, CH2), 29.2 (CH2);  
31P NMR (162 MHz, CDCl3) δ ppm –7.04 (dt, JPH = 13.7, 6.9 Hz);  
HRMS (TOF MS ES+) calcd for (C22H31O5P)2Na (2M+Na)+ 835.3716; found 835.3748. 
 
(1R,3S,9S,11S,Z)-11-allyl-3-((benzyloxy)methyl)-2,12,13-trioxa-1-
phosphabicyclo[7.3.1]tridec-6-ene 1-oxide (trans-2.12.5, Z-product [major]):  
 
Following General Procedure 2, triene 2.12.1 (40.0 mg, 0.0984 mmol) was exposed to G-
I catalyst (6 mol %, over 7 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphates trans-2.12.5 (22.8 mg, 0.0603 mmol, 61% combined yield) as a 2:1 
mixture of Z:E-stereoisomers. Purification by flash chromatography provided clean Z-
product (16.0 mg, 0.0422 mmol, 43%) as a colorless oil.  











Optical Rotation: [α]D = –40.5 (c 0.83, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.34 (d, J = 4.5 Hz, 4H, Aromatic C-H), 7.32–7.28 
(m, 1H, Aromatic C-H), 5.80 (dddd, J = 17.2, 10.2, 7.9, 6.0 Hz, 1H, 
CH2(P)OCHCH2CH=CH2), 5.63–5.53 (m, 2H, CH2(P)OCHCH2CH=CHCH2), 5.22–5.14 
(m, 2H, CH2(P)OCHCH2CH=CH2), 4.92–4.86 (m, 1H, CH2(P)OCHCH2CH=CHCH2), 
4.66 (dtdd, J = 14.5, 7.2, 6.1, 3.7 Hz, 1H, CH2(P)OCHCH2CH=CH2), 4.58 (d, J = 11.9 
Hz, 1H, –OCHaHbPh), 4.55 (d, J = 11.9 Hz, 1H, –OCHaHbPh), 4.24 (tdd, J = 9.1, 7.5, 4.5 
Hz, 1H, -HC=CHCH2CH2CHO(P)CH2OBn), 3.66 (dd, J = 10.1, 5.7 Hz, 1H, -
CHO(P)CHaHbOBn), 3.50 (dd, J = 10.1, 6.4 Hz, 1H, -CHO(P)CHaHbOBn), 2.80–2.70 
(m, 3H, CH2(P)OCHCHaHbCH=CH2, CH2(P)OCHCHaHbCH=CHCHaHb-), 2.49 (dt, J = 
14.8, 7.7 Hz, 1H, CH2(P)OCHCHaHbCH=CH2), 2.28 (d, J = 18.2 Hz, 1H, 
CH2(P)OCHCHaHbCH=CHCH2-), 2.16–2.05 (m, 2H, 
CH2(P)OCHCH2CH=CHCHaHbCH2, H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.96–1.87 
(m, 1H, H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.87–1.80 (m, 2H, 
CH2(P)OCHCH2CH=CHCH2CH2CHO[P]);  
13C NMR (126 MHz, CDCl3) δ ppm 138.0 (C), 135.7 (CH), 132.3 (CH), 128.3 (2 x CH), 
127.66 (2 x CH), 127.62 (CH), 123.8 (CH), 119.0 (CH2), 78.0 (d, JCP = 6.3 Hz, CH), 76.5 
(d, JCP = 8.3 Hz, 2 x CH), 73.5 (CH2), 72.7 (d, JCP = 5.9 Hz, CH2), 39.0 (d, JCP = 3.5 Hz, 
CH2), 32.1 (d, JCP = 4.5 Hz, CH2), 31.3 (d, JCP = 3.0 Hz, CH2), 31.1 (CH2), 23.8 (CH2); 
31P NMR (162 MHz, CDCl3) δ ppm –14.14 (dt, JPH = 13.9, 7.0 Hz);  





phosphabicyclo[7.3.1]tridec-6-ene 1-oxide (E-trans-2.12.5, E-product [minor]):  
 
Following General Procedure 2, triene 2.12.1 (40.0 mg, 0.0984 mmol) was exposed to G-
I catalyst (6 mol %, over 7 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphates trans-2.12.5 (22.8 mg, 0.0603 mmol, 61% combined yield) as a 2:1 
mixture of Z:E-stereoisomers. Purification by flash chromatography provided clean E-
product (6.8 mg, 0.0180 mmol, 18%) as a colorless oil.  
FTIR (neat): 2924, 2853, 1452, 1364, 1273, 1097, 1024, 982, 932, 698 cm-1;  
Optical Rotation [α]D = –77.6  (c 0.21, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.35 (d, J = 4.4 Hz, 4H, Aromatic C-H), 7.32–7.28 
(m, 1H, Aromatic C-H), 5.87–5.71 (m, 2H, CH2(P)OCHCH2CH=CH2, 
CH2(P)OCHCH2CH=CHCH2), 5.50 (dddd, J = 15.3, 10.1, 5.5, 1.7 Hz, 1H, 
CH2(P)OCHCH2CH=CHCH2), 5.24–5.15 (m, 2H, CH2(P)OCHCH2CH=CH2), 4.94–4.84 
(m, 1H, CH2(P)OCHCH2CH=CHCH2), 4.69–4.51 (m, 3H, CH2(P)OCHCH2CH=CH2, -
OCH2Ph), 4.14 (dddd, J = 13.8, 9.8, 6.5, 1.1 Hz, 1H, -HC=CHCH2CH2CHO(P)CH2OBn), 
3.66 (dd, J = 9.7, 5.3 Hz, 1H, -HC=CHCH2CH2CHO(P)CHaHbOBn), 3.46 (dd, J = 9.7, 
7.4 Hz, 1H, HC=CHCH2CH2CHO(P)CHaHbOBn), 2.72 (dddt, J = 14.5, 7.4, 6.1, 1.5 Hz, 
1H, CH2(P)OCHCHaHbCH=CH2), 2.63 (ddd, J = 14.5, 10.1, 4.9 Hz, 1H, 
CH2(P)OCHCHaHbCH=CHCH2), 2.52–2.43 (m, 2H, CH2(P)OCHCHaHbCH=CHCH2, 
CH2(P)OCHCH2CH=CHCHaHbCH2), 2.17–2.11 (m, 1H, 










CHO(P)CH2CHO[P]), 1.75 (dddd, J = 15.1, 13.0, 8.5, 4.5 Hz, 1H, 
CH2(P)OCHCH2CH=CHCH2CHaHbCHO[P]CH2OBn);  
13C NMR (126 MHz, CDCl3) δ ppm 138.8 (CH), 138.0 (C), 132.2 (CH), 128.4 (2 x CH), 
127.8 (2 x CH), 127.7 (CH), 122.1 (CH), 119.1 (CH2), 78.8 (d, JCP = 9.5 Hz, CH), 78.0 
(d, JCP = 6.4 Hz, CH), 77.8 (d, JCP = 9.5 Hz, CH), 73.6 (CH2), 72.6 (d, JCP = 1.7 Hz, 
CH2), 39.3 (d, JCP = 3.7 Hz, CH2), 36.8 (CH2), 32.0 (CH2), 31.9 (d, JCP = 9.5 Hz, CH2), 
31.0 (d, JCP = 7.5 Hz, CH2);  
31P NMR (162 MHz, CDCl3) δ ppm –15.94 (d, JPH = 12.8 Hz);  
HRMS (TOF MS ES+) calcd for (C20H27O5P)2Na (2M+Na)+ 779.3090; found 779.3069. 
 
(4S,6S)-4,6-diallyl-2-(((R)-1-(benzyloxy)hex-5-en-2-yl)oxy)-1,3,2-dioxaphosphinane 
2-oxide (2.12.2):  
 
Following General Procedure 1, monochlorophosphate (S,S)-2.12.3 (0.182 g, 0.769 
mmol) and alcohol (R)-2.12.49 (0.145 g, 0.705 mmol) were converted into 2.12.2 (0.175 
g, 0.430 mmol, 67%) which was isolated as a colorless oil.  
FTIR (neat): 2930, 2862, 1452, 1366, 1286, 1097, 1078, 997, 976, 916, 816, 739, 629, 
550 cm-1;  
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Optical Rotation: [α]D = –38.2 (c 0.60, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.38–7.28 (m, 5H, Aromatic C-H), 5.86–5.63 (m, 
3H, H2C=CH-CH2-CH2-CHO(P)CH2OBn, H2C=CH-CH2-CH2-CHO(P)CH2OBn), 5.15–
5.10 (m, 3H, H2C=CH-CH2CHO(P)CH2, HaHbC=CH-CH2CHO(P)CH2), 5.08 (d, J = 1.4 
Hz, 1H, HaHbC=CH-CH2CHO(P)CH2), 5.04 (dq, J = 17.1, 1.7 Hz, 1H, HaHbC=CH-CH2-
CH2-CHO(P)CH2OBn), 4.98 (dq, J = 10.2, 1.4 Hz, 1H, HaHbC=CH-CH2-CH2-
CHO(P)CH2OBn), 4.66–4.47 (m, 5H, H2C=CHCH2-CHO(P)CH2, H2C=CHCH2-
CHO(P)CH2, CHO(P)CH2OBn, OCH2Ph), 3.66–3.53 (m, 2H, CHO(P)CH2OBn), 2.68 
(dddt, J = 13.5, 7.5, 6.3, 1.5 Hz, 1H, H2C=CH-CHaHbCHO(P)CH2), 2.49–2.43 (m, 1H, 
H2C=CH-CHaHbCHO(P)CH2), 2.43–2.35 (m, 1H, H2C=CH-CHaHbCHO(P)CH2), 2.34–
2.27 (m, 1H, H2C=CH-CHaHbCHO(P)CH2), 2.17 (tddd, J = 7.8, 6.5, 5.1, 1.4 Hz, 2H, 
H2C=CH-CH2-CH2-CHO(P)CH2OBn), 1.97 (dddd, J = 14.8, 8.6, 5.0, 1.4 Hz, 1H, 
H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.91–1.76 (m, 3H, H2C=CHCH2-
CHO(P)CHaHbCHO[P], H2C=CH-CH2-CH2-CHO(P)CH2OBn);  
13C NMR (126 MHz, CDCl3) δ ppm 137.9 (C), 137.5 (CH), 132.8 (CH), 132.3 (CH), 
128.4 (2 x CH), 127.7 (CH), 127.6 (2 x CH), 118.7 (CH2), 118.6 (CH2), 115.2 (CH2), 
77.4 (d, JCP = 2.4 Hz, CH), 77.4 (d, JCP = 3.3 Hz, CH), 75.0 (d, JCP = 6.7 Hz, CH), 73.2 
(CH2), 71.8 (d, JCP = 4.2 Hz, CH2), 40.0 (d, JCP = 7.8 Hz, CH2), 38.9 (d, JCP = 3.2 Hz, 
CH2), 33.0 (d, JCP = 6.8 Hz, CH2), 31.5 (d, JCP = 4.9 Hz, CH2), 29.2 (CH2);  
31P NMR (162 MHz, CDCl3) δ ppm –7.18 (s);  





phosphabicyclo[7.3.1]tridec-6-ene 1-oxide (cis-2.12.6):  
 
Following General Procedure 2, triene 2.12.2 (30.0 mg, 0.0738 mmol) was exposed to G-
I catalyst (3 mol %, over 4 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphate cis-2.12.6 (24.6 mg, 0.0650 mmol, 88%) as a colorless oil.  
FTIR (neat): 2924, 2858, 1454, 1364, 1285, 1096, 978, 735, 698, 559 cm-1;  
Optical Rotation [α]D = –14.9 (c 1.01, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.33 (d, J = 4.4 Hz, 4H, Aromatic C-H), 7.30–7.25 
(m, 1H, Aromatic C-H), 5.83 (ddt, J = 16.6, 10.8, 7.1 Hz, 1H, CH2(P)OCHCH2CH=CH2), 
5.63–5.53 (m, 2H, CH2(P)OCHCH2CH=CHCH2), 5.18 (dd, J = 6.8, 1.5 Hz, 1H, 
CH2(P)OCHCH2CH=CHaHb), 5.15 (d, J = 1.4 Hz, 1H, CH2(P)OCHCH2CH=CHaHb), 
4.79 (dtd, J = 12.1, 6.2, 1.9 Hz, 1H, CH2(P)OCHCH2CH=CHCH2), 4.72–4.60 (m, 2H, 
CH2(P)OCHCH2CH=CH2, –OCHaHbPh), 4.52 (d, J = 12.0 Hz, 1H, –OCHaHbPh), 4.37 
(dtt, J = 12.0, 5.9, 2.9 Hz, 1H, -HC=CHCH2CH2CHO(P)CH2OBn), 3.94 (dd, J = 10.2, 
5.7 Hz, 1H, -CHO(P)CHaHbOBn), 3.79 (dd, J = 10.1, 2.7 Hz, 1H, -CHO(P)CHaHbOBn), 
3.23 (q, J = 12.5, 11.7 Hz, 1H, CH2(P)OCHCHaHbCH=CHCH2), 2.62 (tq, J = 13.1, 10.8, 
4.9 Hz, 1H, CH2(P)OCHCH2CH=CHCHaHbCH2), 2.53 (dtd, J = 14.2, 6.4, 1.5 Hz, 1H, 
CH2(P)OCHCHaHbCH=CH2), 2.45–2.35 (m, 1H, CH2(P)OCHCHaHbCH=CH2), 2.25 
(ddd, J = 14.6, 11.9, 5.6 Hz, 1H, H2C=CHCH2-CHO(P)CHaHbCHO[P]), 2.09 (dddd, J = 











13.1 Hz, 1H, CH2(P)OCHCH2CH=CHCHaHbCH2), 1.94 (d, J = 14.0 Hz, 1H, 
CH2(P)OCHCHaHbCH=CHCH2), 1.80–1.74 (m, 1H, 
CH2(P)OCHCH2CH=CHCH2CHaHbCHO[P]), 1.70 (dq, J = 14.7, 1.9 Hz, 1H, 
H2C=CHCH2-CHO(P)CHaHbCHO[P]);  
13C NMR (126 MHz, CDCl3) δ ppm 138.3 (C), 131.9 (CH), 130.2 (CH), 128.3 (2 x CH), 
127.7 (2 x CH), 127.5 (CH), 126.0 (CH), 119.1 (CH2), 76.9 (d, JCP = 7.7 Hz, CH), 75.7 
(d, JCP = 7.3 Hz, CH), 74.7 (d, JCP = 2.7 Hz, CH), 73.5 (CH2), 71.9 (CH2), 40.6 (d, JCP = 
9.0 Hz, CH2), 34.3 (d, JCP = 6.9 Hz, CH2), 31.5 (CH2), 29.8 (d, JCP = 9.6 Hz, CH2), 21.9 
(CH2);  
31P NMR (162 MHz, CDCl3) δ ppm –9.76 (d, JPH = 23.5 Hz);  





Following General Procedure 1, (R,R)-monochlorophosphate 2.13.27 (0.145 g, 0.548 
mmol) and 4-penten-1-ol (43.2 mg, 0.502 mmol) were converted to phosphate triene 
2.13.1 (0.115 g, 0.366 mmol, 80%) which was isolated as a colorless oil.  
FTIR (neat): 2966, 2939, 1445, 1377, 1288.4, 1011, 970, 893, 814, 799, 542 cm-1;  
Optical Rotation [α]D = +44.1 (c 0.88, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 5.80 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H, 









(P)OCH2CH2CH2CH=CHaHb), 5.00 (dq, J = 10.2, 1.5 Hz, 1H, 
(P)OCH2CH2CH2CH=CHaHb), 4.87 (q, J = 1.5 Hz, 2H, HaHbC=C(CH3)-
CH2CHO(P)CH2, HaHbC=C(CH3)-CH2CHO(P)CH2), 4.78 (d, J = 5.94 Hz, 2H, 
HaHbC=C(CH3)-CH2CHO(P)CH2, HaHbC=C(CH3)-CH2CHO(P)CH2), 4.77–4.71 (m, 1H, 
H2C=C(CH3)-CH2CHO(P)CH2), 4.63 (dtdd, J = 8.7, 6.8, 5.2, 3.6 Hz, 1H, H2C=C(CH3)-
CH2CHO(P)CH2), 4.10 (q, J = 6.7 Hz, 2H, (P)OCH2CH2CH2CH=CH2), 2.62 (dd, J = 
14.2, 7.0 Hz, 1H, H2C=C(CH3)-CHaHbCHO(P)CH2), 2.56 (dd, J = 14.3, 6.9 Hz, 1H, 
H2C=C(CH3)-CHaHbCHO(P)CH2), 2.41–2.30 (m, 2H, H2C=C(CH3)-CHaHbCHO(P)CH2, 
H2C=C(CH3)-CHaHbCHO(P)CH2), 2.16 (dt, J = 8.0, 6.7 Hz, 2H, 
(P)OCH2CH2CH2CH=CH2), 2.01 (dddd, J = 14.8, 8.5, 5.0, 1.4 Hz, 1H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P]), 1.87 (dddd, J = 14.7, 5.1, 3.5, 1.8 Hz, 1H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P]), 1.83–1.78 (m, 2H, (P)OCH2CH2CH2CH=CH2), 1.76 (dd, J = 
5.3, 1.1 Hz, 6H, H2C=C(CH3)-CH2CHO(P)CH2);  
13C NMR (126 MHz, CDCl3) δ ppm 140.3 (C), 140.2 (C), 137.2 (CH), 115.4 (CH2), 
114.2 (2 x CH2), 75.8 (d, JCP = 6.8 Hz, CH), 74.5 (d, JCP = 6.5 Hz, CH), 67.2 (d, JCP = 5.9 
Hz, CH2), 43.7 (d, JCP = 7.2 Hz, CH2), 42.7 (d, JCP = 3.2 Hz, CH2), 33.4 (d, JCP = 6.9 Hz, 
CH2), 29.6 (CH2), 29.5 (d, JCP = 6.7 Hz, CH2), 22.6 (CH3), 22.3 (CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –6.71 (d, JPH = 7.2 Hz);  





phosphabicyclo[7.3.1]tridec-6-ene 1-oxide (2.13.3):  
 
Following General Procedure 2, triene 2.13.1 (20.0 mg, 0.0636 mmol) was exposed to G-
II catalyst (2 mol %, over 2 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphate 2.13.3 (15.8 mg, 0.0552 mmol, 87%) as a white, crystalline solid, 
which was recrystallized via vapor-diffusion method (EtOAc:Hexanes) to obtain X-ray 
quality crystals for X-ray crystallographic analysis (which confirmed stereochemical 
olefin assignment as Z).10  
FTIR (neat): 2964, 2926, 2860, 1435, 1379, 1279, 1221, 1101, 1086, 1069, 1024, 984, 
953, 914, 843, 791, 764, 546 cm-1;  
Optical Rotation [α]D = –18.7 (c 0.70, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 5.25 (ddt, J = 10.6, 3.4, 1.6 Hz, 1H, 
CH2(P)OCHCH2C(CH3)=CHCH2), 4.91–4.79 (m, 4H, H2C=C(CH3)CH2-CHO(P)CH2, 
H2C=C(CH3)CH2-CHO(P)CH2CHO[P]), 4.04 (dt, J = 7.9, 1.8 Hz, 2H, 
(P)OCH2CH2CH2CH=C(CH3)CH2), 3.35 (t, J = 13.5 Hz, 1H, 
CH2(P)OCHCHaHbC(CH3)=CHCH2), 2.57–2.44 (m, 2H, H2C=C(CH3)CHaHb-
CHO(P)CH2, CH2(P)OCHCH2C(CH3)=CHCHaHbCH2), 2.30 (ddd, J = 14.3, 6.4, 2.8 Hz, 
1H, H2C=C(CH3)CHaHb-CHO(P)CH2), 2.22 (ddd, J = 14.6, 11.8, 5.6 Hz, 1H, 
                                                
[ 10 ] All X-ray crystallographic data has been submitted to the Cambridge 
Crystallographic Data Centre, and the structures were assigned the following deposition 









H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P]), 1.99 (ddt, J = 14.2, 9.8, 4.3 Hz, 2H, 
CH2(P)OCHCH2C(CH3)=CHCHaHbCH2, (P)OCH2CHaHbCH2CH=C(CH3)CH2), 1.80 (s, 
3H, CH2(P)OCHCH2C(CH3)=CHCH2), 1.79 (dd, J = 1.1, 1.1 Hz, 3H, H2C=C(CH3)CH2-
CHO(P)CH2), 1.75 (dd, J = 14.1, 2.3 Hz, 1H, CH2(P)OCHCHaHbC(CH3)=CHCH2), 1.70 
(d, J = 14.7 Hz, 1H, H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P]), 1.51 (dddd, J = 17.2, 
10.4, 5.4, 3.2 Hz, 1H, (P)OCH2CHaHbCH2CH=C(CH3)CH2);  
13C NMR (126 MHz, CDCl3) δ ppm 140.0 (C), 132.8 (C), 125.0 (CH), 114.3 (CH2), 
75.2 (d, JCP = 7.5 Hz, CH), 74.8 (d, JCP = 7.0 Hz, CH), 64.2 (d, JCP = 5.0 Hz, CH2), 44.4 
(d, JCP = 9.1 Hz, CH2), 34.9 (CH2), 34.7 (d, JCP = 6.7 Hz, CH2), 26.8 (d, JCP = 10.1 Hz, 
CH2), 22.9 (CH3), 22.5 (CH2), 22.0 (CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –8.16 (d, JPH = 23.5 Hz);  
HRMS (TOF MS ES+) calcd for (C14H23O4P)2Na (2M+Na)+ 595.2566; found 595.2538. 
 
(4R,6R)-2-(((S)-1-(benzyloxy)hex-5-en-2-yl)oxy)-4,6-bis(2-methylallyl)-1,3,2-
dioxaphosphinane 2-oxide (2.13.4):  
 
Following General Procedure 1, monochlorophosphate (R,R)-2.13.2 (0.180 g, 0.680 
mmol) and alcohol (S)-2.12.4 (0.129 g, 0.623 mmol) were converted into phosphate 
triene 2.13.4 (0.194 g, 0.447 mmol, 79%) which was isolated as a colorless oil.  
FTIR (neat): 2964, 2936, 2860, 1454, 1377, 1367, 1288, 1101, 1072, 990, 895, 814, 737, 
698, 552 cm-1;  











1H NMR (500 MHz, CDCl3) δ ppm 7.36–7.27 (m, 5H, Aromatic C-H), 5.80 (ddt, J = 
16.9, 10.2, 6.6 Hz, 1H, H2C=CH-CH2-CH2-CHO(P)CH2OBn), 5.03 (dd, J = 17.2, 1.7 Hz, 
1H, HaHbC=CH-CH2-CH2-CHO(P)CH2OBn), 4.97 (dd, J = 10.2, 1.7 Hz, 1H, 
HaHbC=CH-CH2-CH2-CHO(P)CH2OBn), 4.85 (d, J = 1.7 Hz, 1H, HaHbC=C(CH3)-
CH2CHO(P)CH2), 4.82 (dd, J = 1.7, 1.7 Hz, 1H, HaHbC=C(CH3)-CH2CHO(P)CH2), 
4.76–4.74 (m, 2H, HaHbC=C(CH3)-CH2CHO(P)CH2, HaHbC=C(CH3)-CH2CHO(P)CH2), 
4.73–4.65 (m, 2H, H2C=C(CH3)-CH2CHO(P)CH2, H2C=C(CH3)-CH2CHO(P)CH2), 
4.63–4.51 (m, 3H, H2C=CH-CH2-CH2-CHO(P)CH2OBn, OCH2Ph), 3.62–3.55 (m, 2H, 
H2C=CH-CH2-CH2-CHO(P)CH2OBn), 2.67–2.61 (m, 1H, H2C=C(CH3)-
CHaHbCHO(P)CH2), 2.49 (dd, J = 14.1, 6.5 Hz, 1H, H2C=C(CH3)-CHaHbCHO(P)CH2), 
2.36 (dd, J = 14.2, 7.4 Hz, 1H, H2C=C(CH3)-CHaHbCHO(P)CH2), 2.29 (ddt, J = 14.1, 
7.3, 1.2 Hz, 1H, H2C=C(CH3)-CHaHbCHO(P)CH2), 2.16 (dddd, J = 15.6, 9.1, 7.1, 4.0 Hz, 
2H, H2C=CH-CH2-CH2-CHO(P)CH2OBn), 1.96 (dddd, J = 14.5, 8.2, 4.9, 1.4 Hz, 1H, 
H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P]), 1.90–1.76 (m, 3H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P], H2C=CH-CH2-CH2-CHO(P)CH2OBn), 1.74 (t, J = 1.0 Hz, 3H, 
H2C=C(CH3)-CH2CHO(P)CH2), 1.69 (t, J = 1.1 Hz, 3H, H2C=C(CH3)-CH2CHO(P)CH2); 
13C NMR (126 MHz, CDCl3) δ ppm 140.4 (C), 140.3 (C), 137.8(C), 137.5 (CH), 128.3 
(2 x CH), 127.7 (CH), 127.6 (2 x CH), 115.1 (CH2), 114.1 (2 x CH2), 77.4 (d, JCP = 6.2 
Hz, CH), 76.0 (d, JCP = 6.8 Hz, CH), 74.3 (d, JCP = 6.6 Hz, CH), 73.1 (CH2), 71.7 (d, JCP 
= 4.2 Hz, CH2), 43.7 (d, JCP = 7.4 Hz, CH2), 42.8 (d, JCP = 3.5 Hz, CH2), 33.3 (d, JCP = 
6.9 Hz, CH2), 31.4 (d, JCP = 4.7 Hz, CH2), 29.1 (CH2), 22.6 (CH3), 22.3 (CH3);  
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31P NMR (162 MHz, CDCl3) δ ppm –7.13 (m);11 
HRMS (TOF MS ES+) calcd for (C24H35O5P)2Na (2M+Na)+ 891.4342; found 891.4326. 
 
(1S,3S,9R,11R,Z)-3-((benzyloxy)methyl)-7-methyl-11-(2-methylallyl)-2,12,13-trioxa-
1-phosphabicyclo[7.3.1]tridec-6-ene 1-oxide (cis-2.13.6):  
 
Following General Procedure 2, triene 2.13.4 (30.0 mg, 0.0690 mmol) was exposed to G-
II catalyst (2 mol %, over 2 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphate cis-2.13.6 (22.6 mg, 0.0556 mmol, 81%) as a colorless oil.  
FTIR (neat): 2966, 2920, 1454, 1377, 1285, 1099, 1072, 980, 916, 793, 698, 546 cm-1; 
Optical Rotation: [α]D = –4.6 (c 0.67, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.34 (d, J = 4.5 Hz, 4H, Aromatic C-H), 7.30–7.25 
(m, 1H, Aromatic C-H), 5.28 (ddt, J = 10.6, 3.2, 1.5 Hz, 1H, 
CH2(P)OCHCH2C(CH3)=CHCH2), 4.93–4.78 (m, 4H, H2C=C(CH3)CH2-CHO(P)CH2, 
H2C=C(CH3)CH2-CHO(P)CH2CHO[P]), 4.62 (d, J = 12.0 Hz, 1H, -OCHaHbPh), 4.53 (d, 
J = 12.0 Hz, 1H, -OCHaHbPh), 4.36 (dtt, J = 12.0, 5.9, 2.8 Hz, 1H, 
CH2(CH3)C=CHCH2CH2CHO(P)CH2OBn), 3.92 (dd, J = 10.2, 5.8 Hz, 1H, 
CH2CHO(P)CHaHbOBn), 3.80 (dd, J = 10.1, 2.7 Hz, 1H, CH2CHO(P)CHaHbOBn), 3.32 
(t, J = 13.5 Hz, 1H, CH2(P)OCHCHaHbC(CH3)=CHCH2), 2.52 (tdd, J = 16.9, 9.3, 4.4 Hz, 
                                                
[11] Due to complex PH coupling, some 31P NMR for new compounds appear as a single 











2H, CH2(CH3)C=CHCHaHbCH2CHO(P)CH2OBn, H2C=C(CH3)CHaHb-CHO(P)CH2), 
2.32 (ddd, J = 14.3, 7.1, 2.2 Hz, 1H, H2C=C(CH3)CHaHb-CHO(P)CH2), 2.23 (ddd, J = 
14.5, 11.8, 5.8 Hz, 1H, H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P]), 2.09–1.97 (m, 2H, 
CH2(CH3)C=CHCHaHbCHaHbCHO(P)CH2OBn), 1.79 (d, J = 1.4 Hz, 6H), 1.72 (ddt, J = 
16.9, 14.7, 2.4 Hz, 3H, CH2(P)OCHCHaHbC(CH3)=CHCH2, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P], CH2(CH3)C=CHCH2CHaHbCHO(P)CH2OBn);  
13C NMR (126 MHz, CDCl3) δ ppm 140.0 (C), 138.3 (C), 131.9 (C), 128.3 (2 x CH), 
127.7 (2 x CH), 127.5 (CH), 125.9 (CH), 114.4 (CH2), 75.0 (d, J = 7.8 Hz, CH), 74.6 (d, 
J = 5.7 Hz, CH), 74.6 (CH), 73.5 (CH2), 72.0 (CH2), 44.3 (d, J = 9.1 Hz, CH2), 35.1 
(CH2), 34.5 (d, J = 6.8 Hz, CH2), 30.2 (d, J = 9.7 Hz, CH2), 22.9 (CH3), 22.7 (CH2), 22.0 
(CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –9.52 (d, JPH = 23.3 Hz);  
HRMS (TOF MS ES+) calcd for (C22H31O5P)2Na (2M+Na)+ 835.3716; found 835.3714. 
 
(4R,6R)-2-(((R)-1-(benzyloxy)hex-5-en-2-yl)oxy)-4,6-bis(2-methylallyl)-1,3,2-
dioxaphosphinane 2-oxide (2.13.5):  
 
Following General Procedure 1, monochlorophosphate (R,R)-2.13.2 (0.180 g, 0.680 
mmol) and alcohol (R)-2.12.4 (0.129 g, 0.623 mmol) were converted into phosphate 
triene 2.13.5 (0.201 g, 0.463 mmol, 82%) which was isolated as a pale yellow oil.  
FTIR (neat): 2964, 2936, 2860, 1452, 1375, 1366, 1285, 1099, 1070, 999, 899, 810, 737, 











Optical Rotation [α]D = +31.7 (c 1.29, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.34 (d, J = 4.4 Hz, 4H, aromatic C-H), 7.29 (dd, J 
= 4.9, 3.8 Hz, 1H, aromatic C-H), 5.81 (ddt, J = 16.9, 10.2, 6.5 Hz, 1H, H2C=CH-CH2-
CH2-CHO(P)CH2OBn), 5.04 (dq, J = 17.1, 1.7 Hz, 1H, HaHbC=CH-CH2-CH2-
CHO(P)CH2OBn), 4.99 (dd, J = 10.2, 1.6 Hz, 1H, HaHbC=CH-CH2-CH2-
CHO(P)CH2OBn), 4.85 (dt, J = 13.5, 1.7 Hz, 2H, H2C=C(CH3)-CH2CHO(P)CH2), 4.79–
4.74 (m, 2H, H2C=C(CH3)-CH2CHO(P)CH2), 4.74–4.61 (m, 3H, H2C=C(CH3)-
CH2CHO(P)CH2, H2C=C(CH3)-CH2CHO(P)CH2, H2C=CH-CH2-CH2-CHO(P)CH2OBn), 
4.59 (d, J = 12.0 Hz, 1H, OCHaHbPh), 4.53 (d, J = 12.0 Hz, 1H, OCHaHbPh), 3.61 (dd, J 
= 4.8, 2.6 Hz, 2H, H2C=CH-CH2-CH2-CHO(P)CH2OBn), 2.57 (td, J = 14.5, 6.8 Hz, 2H, 
H2C=C(CH3)-CHaHbCHO(P)CH2, H2C=C(CH3)-CHaHbCHO(P)CH2), 2.40–2.30 (m, 2H, 
H2C=C(CH3)-CHaHbCHO(P)CH2, H2C=C(CH3)-CHaHbCHO(P)CH2), 2.24–2.08 (m, 2H, 
H2C=CH-CH2-CH2-CHO(P)CH2OBn), 1.98 (dddd, J = 14.3, 8.0, 4.8, 1.4 Hz, 1H, 
H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P],), 1.89 (dddd, J = 14.7, 5.7, 4.0, 1.7 Hz, 1H, 
H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P],), 1.82 (dddd, J = 8.8, 7.4, 6.2, 1.6 Hz, 2H, 
H2C=CH-CH2-CH2-CHO(P)CH2OBn), 1.75 (d, J = 1.1 Hz, 3H, H2C=C(CH3)-
CH2CHO(P)CH2), 1.72 (d, J = 1.1 Hz, 3H, H2C=C(CH3)-CH2CHO(P)CH2);  
13C NMR (126 MHz, CDCl3) δ ppm 140.4 (C), 140.2 (C), 138.0 (C), 137.4 (CH), 128.3 
(2 x CH), 127.59 (2 x CH), 127.57 (CH), 115.2 (CH2), 114.24 (CH2), 114.15 (CH2), 77.7 
(d, JCP = 6.3 Hz, CH), 75.6 (d, JCP = 6.7 Hz, CH), 74.6 (d, JCP = 6.5 Hz, CH), 73.2 (CH2), 
71.6 (d, JCP = 3.9 Hz, CH2), 43.7 (d, JCP = 7.1 Hz, CH2), 43.0 (d, JCP = 4.1 Hz, CH2), 33.3 
(d, JCP = 6.7 Hz, CH2), 31.4 (d, JCP = 5.1 Hz, CH2), 29.2 (CH2), 22.6 (CH3), 22.3 (CH3); 
31P NMR (162 MHz, CDCl3) δ ppm –6.95 (m);  
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HRMS (TOF MS ES+) calcd for (C24H35O5P)2Na (2M+Na)+ 891.4342; found 891.4314. 
 
(1S,3R,9R,11R,Z)-3-((benzyloxy)methyl)-7-methyl-11-(2-methylallyl)-2,12,13-trioxa-
1-phosphabicyclo[7.3.1]tridec-6-ene 1-oxide (trans-2.13.7):  
 
Following General Procedure 2, triene 2.13.5 (30.0 mg, 0.0690 mmol) was exposed to G-
II catalyst (2 mol %, over 2 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphate trans-2.13.7 (24.5 mg, 0.0603 mmol, 87%) as a pale yellow oil. Full 
characterization in CDCl3 and DMSO-d6 at ambient temperature—even after extended 
scan times—provided incomplete information for 13C and carbon-related 2D NMR. As 
such, full characterization of trans-2.13.7 required elevated temperatures (95 °C) to fully 
identify short, broad carbon signals and correlate these 13C signals to 1H signals (HSQC, 
HMBC).  
FTIR (neat): 2928, 2855, 1450, 1377, 1281, 1103, 1020, 972, 957, 907, 791, 745, 698 
cm-1;  
Optical Rotation [α]D = +57.5 (c 0.36, CHCl3);  
1H NMR (500 MHz, 95 °C, DMSO-d6) δ ppm 7.37–7.26 (m, 5H, aromatic C-H), 5.33 (t, 
J = 8.2 Hz, 1H, CH2(P)OCHCH2C(CH3)=CHCH2), 4.96–4.78 (m, 4H, H2C=C(CH3)CH2-
CHO(P)CH2, H2C=C(CH3)CH2-CHO(P)CH2CHO[P]), 4.51 (s, 2H, -OCH2Ph), 4.24 (q, J 
= 8.8, 5.9 Hz, 1H, CH2(CH3)C=CHCH2CH2CHO(P)CH2OBn), 3.61 (dd, J = 10.3, 5.8 Hz, 
1H, CH2CHO(P)CHaHbOBn), 3.48 (dd, J = 10.4, 5.7 Hz, 1H, CH2CHO(P)CHaHbOBn), 











H2C=C(CH3)CH2-CHO(P)CH2), 2.18 (s, 1H, 
CH2(CH3)C=CHCHaHbCH2CHO(P)CH2OBn), 1.99 (q, J = 5.9, 5.1 Hz, 2H, 
H2C=C(CH3)CH2-CHO(P)CH2CHO[P]), 1.75 (m, J = 6.8 Hz, 7H, 
CH2(CH3)C=CHCH2CHaHbCHO(P)CH2OBn, CH2(P)OCHCH2C(CH3)=CHCH2, 
H2C=C(CH3)CH2-CHO(P)CH2), 1.63 (tt, J = 10.2, 5.1 Hz, 1H, 
CH2(CH3)C=CHCH2CHaHbCHO(P)CH2OBn);  
13C NMR (126 MHz, 95 °C, DMSO-d6) δ ppm 140.3 (C), 138.0 (C), 130.7 (C), 128.3 
(CH), 127.8 (2 x CH), 127.03 (2 x CH), 126.95 (CH), 113.2 (CH2), 76.6 (s, br, CH), 76.0 
(d, JCP = 6.7 Hz, CH), 75.5 (d, JCP = 8.3 Hz, CH), 72.01 (CH2), 71.98 (CH2), 42.3 (d, JCP 
= 4.5 Hz, CH2), 35.8 (CH2), 32.0 (s, br, CH2), 30.7 (d, JCP = 3.7 Hz, CH2), 24.9 (s, br, 
CH3), 23.9 (CH2), 21.9 (CH3);  
31P NMR (162 MHz, 95 °C, DMSO-d6) δ ppm –14.7 (s);  





Following General Procedure 1, monochlorophosphate (S,S)-2.12.3 (0.2593 g, 1.096 
mmol) and 4-methyl-4-penten-1-ol (0.1006 g, 1.005 mmol) were converted into 2.14.1 









FTIR (neat): 2959, 2937, 1443, 1373, 1286, 1096, 1078, 1015, 974, 918, 898, 814, 631, 
509 cm-1;  
Optical Rotation [α]D = –35.2 (c 0.84, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 5.84–5.72 (m, 2H, H2C=CH-CH2CHO(P)CH2, 
H2C=CH-CH2CHO(P)CH2), 5.18–5.12 (m, 4H, H2C=CH-CH2CHO(P)CH2, H2C=CH-
CH2CHO(P)CH2), 4.76–4.73 (m, 1H, HaHbC=C(CH3)-CH2-CH2-CH2O(P)), 4.69 (dt, J = 
2.3, 1.1 Hz, 1H, HaHbC=C(CH3)-CH2-CH2-CH2O(P)), 4.61 (dddd, J = 14.4, 12.0, 7.0, 5.0 
Hz, 1H, H2C=CHCH2-CHO(P)CH2), 4.54–4.46 (m, 1H, H2C=CHCH2-CHO(P)CH2), 4.09 
(dt, J = 8.1, 6.6 Hz, 2H, H2C=C(CH3)-CH2-CH2-CH2O(P)), 2.66 (ddd, J = 7.0, 13.9, 7.0 
Hz, 1H, H2C=CHCHaHb-CHO(P)CH2), 2.56 (ddd, J = 7.0, 13.9, 7.0 Hz, 1H, 
H2C=CHCHaHb-CHO(P)CH2), 2.39 (ddd, J = 7.0, 14.1, 7.0 Hz 2H, H2C=CHCHaHb-
CHO(P)CH2, H2C=CHCHaHb-CHO(P)CH2), 2.09 (dd, J = 7.33, 7.33 Hz, 2H, 
H2C=C(CH3)-CH2-CH2-CH2O(P)), 2.02 (dddd, J = 14.9, 8.6, 5.0, 1.4 Hz, 1H, 
H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.90–1.80 (m, 3H, H2C=CHCH2-
CHO(P)CHaHbCHO[P], H2C=C(CH3)-CH2-CH2-CH2O(P)), 1.74–1.69 (m, 3H, 
H2C=C(CH3)-CH2-CH2-CH2O(P));  
13C NMR (126 MHz, CDCl3) δ ppm 144.4 (C), 132.6 (CH), 132.2 (CH), 119.0 (CH2), 
118.8 (CH2), 110.6 (CH2), 77.0 (d, JCP = 6.8 Hz, CH), 75.5 (d, JCP = 6.6 Hz, CH), 67.5 (d, 
JCP = 5.9 Hz, CH2), 40.0 (d, JCP = 7.4 Hz, CH2), 38.9 (d, JCP = 3.2 Hz, CH2), 33.6 (CH2), 
33.1 (d, JCP = 6.8 Hz, CH2), 28.3 (d, JCP = 6.6 Hz, CH2), 22.4 (CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –6.77  (dd, JPH = 14.3, 7.0 Hz);  





1-oxide (2.14.3):  
 
To a clean, dry, round bottom flask, equipped with a stirbar, was added triene 2.14.1 
(25.0 mg, 0.0832 mmol), toluene (dry, degassed, 84 mL), and Ru-2.14.2 catalyst (3.3 mg, 
0.00416 mmol, 5 mol %). High vacuum was applied to the flask (1 min), and the flask 
was charged with Ar (repeated 5 times). The flask was equipped with an Ar inlet and 
heated to 35 °C. The reaction stirred at 35 °C for 2.5 hours, where another 5 mol % of 
Ru-2.14.2 (3.3 mg, 0.00416 mmol) was added. The reaction continued to stir for 1 hour 
(monitored by TLC), at which point 5 drops of DMSO were added, and the solvent was 
removed under reduced pressure. The crude mixture was separated by flash 
chromatography (silica, 0%-50% EtOAc in hexanes) to provide 2.14.3 (5.8 mg, 0.0213 
mmol, 26%) as a colorless oil.  
FTIR (neat): 2961, 2928, 1464, 1433, 1281, 1223, 1105, 1072, 1013, 978, 912, 866, 804, 
552 cm-1;  
Optical Rotation [α]D = –33.5 (c 0.19, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 5.89–5.78 (m, 1H, CH2(P)OCHCH2CH=CH2), 5.37 
(dd, J = 11.5, 2.4 Hz, 1H, CH2(P)OCHCH2CH=C(CH3)CH2), 5.20–5.17 (m, 1H, 
CH2(P)OCHCH2CH=CHaHb), 5.16 (t, J = 1.3 Hz, 1H, CH2(P)OCHCH2CH=CHaHb), 4.78 
(dtd, J = 12.2, 6.2, 2.0 Hz, 1H, CH2(P)OCHCH2CH=CH2), 4.70–4.59 (m, 1H, 
CH2(P)OCHCH2CH=C(CH3)CH2), 4.06 (ddd, J = 9.9, 4.6, 1.6 Hz, 1H, 









(P)OCHaHbCH2CH2C(CH3)=CHCH2), 3.16 (dt, J = 14.3, 12.5 Hz, 1H, 
CH2(P)OCHCHaHbCH=C(CH3)CH2), 2.72 (td, J = 13.1, 5.3 Hz, 1H, 
(P)OCH2CH2CHaHbC(CH3)=CHCH2), 2.57–2.46 (m, 1H, CH2(P)OCHCHaHbCH=CH2), 
2.44–2.33 (m, 1H, CH2(P)OCHCHaHbCH=CH2), 2.22 (dddd, J = 14.6, 12.0, 5.5, 0.8 Hz, 
1H, H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.95 (dddt, J = 15.0, 10.1, 5.1, 2.7 Hz, 2H, 
CH2(P)OCHCHaHbCH=C(CH3)CH2, (P)OCH2CHaHbCH2C(CH3)=CHCH2), 1.89–1.81 
(m, 1H, (P)OCH2CH2CHaHbC(CH3)=CHCH2), 1.78–1.72 (m, 1H, 
(P)OCH2CHaHbCH2C(CH3)=CHCH2), 1.71 (dd, J = 1.7, 1.7 Hz, 3H, 
CH2(P)OCHCH2CH=C(CH3)CH2), 1.70–1.66 (m, 1H, H2C=CHCH2-
CHO(P)CHaHbCHO[P]);  
13C NMR (126 MHz, CDCl3) δ ppm 135.2 (C), 132.0 (CH), 122.2 (CH2), 119.0 (CH2), 
77.5 (d, JCP = 7.3 Hz, CH), 75.9 (d, JCP = 7.3 Hz, CH), 63.9 (d, JCP = 4.9 Hz, CH2), 40.6 
(d, JCP = 9.0 Hz, CH2), 34.5 (d, JCP = 6.7 Hz, CH2), 32.6 (CH2), 26.1 (CH2), 24.9 (d, JCP = 
10.0 Hz, CH2), 22.5 (CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –8.22  (d, JPH = 24.1 Hz);  





2-oxide (2.15.1):  
 
Following General Procedure 1, monochlorophosphate (S,S)-2.12.3 (0.117 g, 0.494 
mmol) and alcohol (S)-2.15.35 (0.0990 g, 0.450 mmol) were converted into 2.15.1 (0.109 
g, 0.259 mmol, 58%) which was isolated as a pale yellow oil.  
FTIR (neat): 2932, 2862, 1454, 1435, 1362, 1286, 1097, 1007, 976, 916, 797, 739, 698, 
629, 513 cm-1;  
Optical Rotation [α]D = –33.2 (c 1.13, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.34 (d, J = 4.4 Hz, 4H, aromatic C-H), 7.32–7.27 
(m, 1H, aromatic C-H), 5.85–5.68 (m, 3H, H2C=CH-CH2CHO(P)CH2, H2C=CH-
CH2CHO(P)CH2, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 5.16 (dt, J = 9.0, 1.5 Hz, 
1H, HaHbC=CH-CH2CHO(P)CH2), 5.13 (dt, J = 3.6, 1.3 Hz, 2H, HaHbC=CH-
CH2CHO(P)CH2, HaHbC=CH-CH2CHO(P)CH2), 5.10 (q, J = 1.6 Hz, 1H, HaHbC=CH-
CH2CHO(P)CH2), 5.04–4.99 (m, 1H, HaHbC=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 4.97 
(ddd, J = 10.2, 2.2, 1.1 Hz, 1H, HaHbC=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 4.65–4.48 
(m, 5H, H2C=CHCH2-CHO(P)CH2, H2C=CHCH2-CHO(P)CH2, CHO(P)CH2OBn, 
OCH2Ph), 3.61 (dd, J = 4.9, 3.5 Hz, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 
2.63 (ddd, J = 6.7, 13.9, 6.7 Hz, 1H, H2C=CH-CHaHbCHO(P)CH2), 2.56 (m, ddd, J = 6.3, 
13.5, 6.3 Hz, 1H, H2C=CH-CHaHbCHO(P)CH2), 2.43–2.33 (m, 2H, H2C=CH-











2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 2.00 (dddd, J = 14.6, 8.4, 5.0, 1.3 Hz, 
1H, H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.89 (dddd, J = 14.6, 5.7, 4.0, 1.7 Hz, 1H, 
H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.73 (dt, J = 8.6, 6.8 Hz, 2H, H2C=CH-CH2-CH2-
CH2-CHO(P)CH2OBn), 1.57–1.42 (m, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn); 
13C NMR (126 MHz, CDCl3) δ ppm 138.2 (CH), 138.0 (C), 132.6 (CH), 132.3 (CH), 
128.3 (CH), 127.62 (2 x CH), 127.59 (2 x CH), 118.8 (CH2), 118.7 (CH2), 114.9 (CH2), 
78.2 (d, JCP = 6.3 Hz, CH), 76.8 (d, JCP = 6.9 Hz, CH), 75.4 (d, JCP = 6.8 Hz, CH), 73.2 
(CH2), 71.7 (d, JCP = 4.1 Hz, CH2), 40.0 (d, JCP = 7.3 Hz, CH2), 39.1 (d, JCP = 4.0 Hz, 
CH2), 33.4 (CH2), 33.1 (d, JCP = 6.7 Hz, CH2), 31.6 (d, JCP = 4.9 Hz, CH2), 24.3 (CH2); 
31P NMR (162 MHz, CDCl3) δ ppm –6.96 (dt, JPH = 13.6, 7.0 Hz);  
HRMS (TOF MS ES+) calcd for (C23H33O5P)2Na (2M+Na)+ 863.4029; found 863.4056. 
 
(1R,3S,10S,12S,Z)-12-allyl-3-((benzyloxy)methyl)-2,13,14-trioxa-1-
phosphabicyclo[8.3.1]tetradec-7-ene 1-oxide (trans-2.15.4):  
 
Following General Procedure 2, triene 2.15.1 (20.0 mg, 0.0476 mmol) was exposed to G-
I catalyst (2 mol %, over 3 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphate trans-2.15.4 (11.8 mg, 0.0301 mmol, 63%) as a colorless oil.  
FTIR (neat): 2922, 2860, 1452, 1364, 1273, 1097, 1012, 972, 953, 920, 791, 735, 698, 
554 cm-1;  










1H NMR (500 MHz, CDCl3) δ ppm 7.39–7.32 (m, 4H, Aromatic C-H), 7.32–7.27 (m, 
1H, Aromatic C-H), 5.80 (dddd, J = 16.9, 10.2, 7.5, 6.5 Hz, 1H, 
CH2(P)OCHCH2CH=CH2), 5.58–5.47 (m, 2H, CH2(P)OCHCH2CH=CHCH2), 5.16 (dq, J 
= 17.2, 1.6 Hz, 1H, CH2(P)OCHCH2CH=CHaHb), 5.12 (ddt, J = 10.2, 2.1, 1.2 Hz, 1H, 
CH2(P)OCHCH2CH=CHaHb), 4.72–4.61 (m, 3H, CH2(P)OCHCH2CH=CHCH2, 
CH2(P)OCHCH2CH=CH2, –OCHaHbPh), 4.57 (d, J = 11.8 Hz, 1H, –OCHaHbPh), 4.38–
4.27 (m, 1H, -CH2HC=CHCH2CH2CH2CHO(P)CH2OBn), 3.72–3.55 (m, 2H, 
CH2CHO(P)CH2OBn), 2.98–2.89 (m, 1H, CH2(P)OCHCHaHbCH=CHCH2), 2.62–2.45 
(m, 2H, CH2(P)OCHCHaHbCH=CH2, H2C=CHCH2-CHO(P)CHaHbCHO[P]), 2.45–2.34 
(m, 2H, CH2(P)OCHCHaHbCH=CH2, CH2HC=CHCHaHbCH2CH2CHO(P)), 2.00–1.86 
(m, 3H, CH2(P)OCHCHaHbCH=CHCH2, CH2HC=CHCH2CHaHbCH2CHO(P), 
CH2HC=CHCHaHbCH2CH2CHO(P)), 1.83 (dtd, J = 15.1, 2.8, 1.5 Hz, 1H, H2C=CHCH2-
CHO(P)CHaHbCHO[P]), 1.62–1.57 (m, 1H, CH2HC=CHCH2CHaHbCH2CHO(P)), 1.53 
(dqd, J = 10.7, 5.3, 3.6 Hz, 2H, CH2HC=CHCH2CH2CH2CHO(P));  
13C NMR (126 MHz, CDCl3) δ ppm 138.1 (C), 132.8 (CH), 132.1 (CH), 128.3 (2 x CH), 
127.7 (2 x CH), 127.6 (CH), 125.1 (CH), 118.9 (CH2), 77.5 (d, JCP = 8.4 Hz, CH), 76.9 
(d, JCP = 6.5 Hz, CH), 76.4 (d, JCP = 6.1 Hz, CH), 73.6 (CH2), 72.3 (d, JCP = 6.8 Hz, 
CH2), 40.9 (d, JCP = 4.6 Hz, CH2), 34.5 (d, JCP = 12.0 Hz, CH2), 33.1 (d, JCP = 3.1 Hz, 
CH2), 28.9 (CH2), 24.1 (CH2), 23.8 (CH2);  
31P NMR (162 MHz, CDCl3) δ ppm –10.13 (m);  







 Following General Procedure 1, monochlorophosphate (S,S)-2.12.3 (0.117 g, 0.494 
mmol) and alcohol (R)-2.15.312 (0.0990 g, 0.450 mmol) were converted into 2.15.2 
(0.120 g, 0.259 mmol, 63%) which was isolated as a colorless oil.  
FTIR (neat): 2930, 2862, 1454, 1435, 1362, 1288, 1099, 1078, 999, 974, 916, 800, 739, 
698, 629, 548 cm-1;  
Optical Rotation [α]D = –39.7 (c 1.08, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.36–7.28 (m, 5H, aromatic C-H), 5.83–5.73 (m, 
2H, H2C=CH-CH2CHO(P)CH2, H2C=CH-CH2CHO(P)CH2), 5.73–5.63 (m, 1H, 
H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 5.14–5.10 (m, 2H, HaHbC=CH-
CH2CHO(P)CH2, HaHbC=CH-CH2CHO(P)CH2), 5.10–5.07 (m, 2H, HaHbC=CH-
CH2CHO(P)CH2, HaHbC=CH-CH2CHO(P)CH2), 5.01 (dq, J = 17.1, 1.7 Hz, 1H, 
HaHbC=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 4.95 (ddt, J = 10.2, 2.3, 1.2 Hz, 1H, 
HaHbC=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 4.61–4.50 (m, 5H, H2C=CHCH2-
CHO(P)CH2, H2C=CHCH2-CHO(P)CH2, CHO(P)CH2OBn, OCH2Ph), 3.62–3.54 (m, 2H, 
H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 2.72–2.64 (m, 1H, H2C=CH-
CHaHbCHO(P)CH2), 2.48–2.41 (m, 1H, H2C=CH-CHaHbCHO(P)CH2), 2.41–2.34 (m, 
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1H, H2C=CH-CHaHbCHO(P)CH2), 2.34–2.25 (m, 1H, H2C=CH-CHaHbCHO(P)CH2), 
2.12–2.04 (m, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 1.96 (dddd, J = 14.8, 8.7, 
5.0, 1.4 Hz, 1H, H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.82 (dddd, J = 14.6, 5.1, 3.7, 1.8 
Hz, 1H, H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.78–1.66 (m, 2H, H2C=CH-CH2-CH2-
CH2-CHO(P)CH2OBn), 1.58–1.41 (m, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn); 
13C NMR (126 MHz, CDCl3) δ ppm 138.3 (CH), 137.9 (C), 132.8 (CH), 132.3 (CH), 
128.3 (2 x CH), 127.7 (CH), 127.6 (2 x CH), 118.7 (CH2), 118.6 (CH2), 114.8 (CH2), 
77.8 (d, JCP = 6.2 Hz, CH), 77.4 (d, JCP = 6.9 Hz, CH), 74.9 (d, JCP = 6.5 Hz, CH), 73.2 
(CH2), 71.9 (d, JCP = 4.5 Hz, CH2), 40.0 (d, JCP = 7.8 Hz, CH2), 38.8 (d, JCP = 3.2 Hz, 
CH2), 33.4 (CH2), 33.0 (d, JCP = 6.7 Hz, CH2), 31.7 (d, JCP = 4.5 Hz, CH2), 24.2 (CH2); 
31P NMR (162 MHz, CDCl3) δ ppm –7.15 (dt, JPH = 13.0, 5.4 Hz);  
HRMS (TOF MS ES+) calcd for (C23H33O5P)2Na (2M+Na)+ 863.4029; found 863.4053. 
 
(1R,3R,10S,12S,Z)-12-allyl-3-((benzyloxy)methyl)-2,13,14-trioxa-1-
phosphabicyclo[8.3.1]tetradec-7-ene 1-oxide (cis-2.15.5, Z-product [major]):  
 
Following General Procedure 2, triene 2.15.2 (25.0 mg, 0.0595 mmol) was exposed to G-
I catalyst (3 mol %, over 4 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphates cis-2.15.5 (13.8 mg, 0.0352 mmol, 59% combined yield, colorless 
oil) as 2:1 mixture of Z/E-isomers, which was further purified to a 10:1 mixture of Z/E-









FTIR (neat): 2930, 2862, 1452, 1362, 1283, 1101, 1078, 1042, 997, 974, 918, 826, 795, 
739, 698, 557 cm-1;  
Optical Rotation [α]D = –41.0 (c 0.20, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.38–7.33 (m, 4H, Aromatic C-H), 7.32–7.28 (m, 
1H, Aromatic C-H), 5.79 (dddd, J = 17.0, 10.2, 7.5, 6.5 Hz, 1H, 
CH2(P)OCHCH2CH=CH2), 5.49 (dddd, J = 10.8, 10.8, 3.3, 2.0 Hz, 1H, 
CH2(P)OCHCH2CH=CHCH2), 5.47 (dddd, J = 11.0, 11.0, 3.2, 1.9 Hz, 1H, 
CH2(P)OCHCH2CH=CHCH2), 5.14 (dq, J = 17.1, 1.6 Hz, 1H, 
CH2(P)OCHCH2CH=CHaHb), 5.10 (ddd, J = 10.2, 2.0, 1.0 Hz, 1H, 
CH2(P)OCHCH2CH=CHaHb), 5.06 (dtd, J = 9.9, 4.8, 2.5 Hz, 1H, CH2CHO(P)CH2OBn), 
4.72–4.65 (m, 1H, CH2(P)OCHCH2CH=CH2), 4.61 (m, 2H, 
CH2(P)OCHCH2CH=CHCH2, -OCHaHbPh), 4.56 (d, J = 12.3 Hz, 1H, -OCHaHbPh), 
3.70–3.65 (m, 1H, CH2CHO(P)CHaHbOBn), 3.58 (ddd, J = 10.5, 5.3, 2.0 Hz, 1H, 
CH2CHO(P)CHaHbOBn), 3.19 (ddd, J = 14.5, 12.6, 10.5 Hz, 1H, 
CH2(P)OCHCHaHbCH=CHCH2), 2.63–2.53 (m, 1H, -
CH2HC=CHCHaHbCH2CH2CHO(P)), 2.48 (dddd, J = 12.8, 7.8, 4.9, 1.4 Hz, 1H, 
CH2(P)OCHCHaHbCH=CH2), 2.40–2.32 (m, 1H, CH2(P)OCHCHaHbCH=CH2), 2.25–
2.16 (m, 1H, H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.95 (ddt, J = 15.6, 12.9, 2.9 Hz, 
2H, -CH2HC=CHCHaHbCH2CHaHbCHO(P)), 1.87 (dt, J = 14.8, 2.7 Hz, 1H, 
CH2(P)OCHCHaHbCH=CHCH2), 1.78 (tdd, J = 16.0, 6.1, 3.5 Hz, 1H, -
CH2HC=CHCH2CHaHbCH2CHO(P)), 1.73–1.65 (m, 2H, 
CH2HC=CHCH2CH2CHaHbCHO(P), H2C=CHCH2-CHO(P)CHaHbCHO[P]), 1.45 (ddtd, 
J = 14.6, 12.2, 4.8, 2.8 Hz, 1H, -CH2HC=CHCH2CHaHbCH2CHO(P));  
 
 181 
13C NMR (126 MHz, CDCl3) δ ppm 138.1 (C), 132.5 (CH), 132.1 (CH), 128.3 (2 x CH), 
127.6 (CH), 127.5 (2 x CH), 125.3 (CH), 118.8 (CH2), 78.1 (d, JCP = 7.8 Hz, CH), 77.9 
(d, JCP = 6.8 Hz, CH), 75.0 (d, JCP = 7.2 Hz, CH), 72.9 (CH2), 70.3 (d, JCP = 6.6 Hz, 
CH2), 40.6 (d, JCP = 9.0 Hz, CH2), 34.4 (d, JCP = 6.7 Hz, CH2), 32.4 (CH2), 28.4 (d, JCP = 
2.2 Hz, CH2), 25.8 (CH2), 22.9 (CH2);  
31P NMR (162 MHz, CDCl3) δ ppm –8.85 (dd, JPH = 23.8, 9.5 Hz);  





Following General Procedure 1, (R,R)-monochlorophosphate 2.13.2 (0.215 g, 0.812 
mmol) and 5-hexen-1-ol (74.6 mg, 0.745 mmol) were converted to phosphate triene 
2.16.1 (0.193 g, 0.5877 mmol, 87%) which was isolated as a colorless oil.  
FTIR (neat): 2964, 2936, 2858, 1443, 1377, 1288, 1026, 1007, 970, 893, 799, 546 cm-1; 
Optical Rotation [α]D = +44.3 (c 0.14, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 5.79 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H, 
(P)OCH2CH2CH2CH2CH=CH2), 5.02 (dd, J = 17.2, 1.9 Hz, 1H, 
(P)OCH2CH2CH2CH=CHaHb), 4.97 (dd, J = 10.3, 1.7 Hz, 1H, 
(P)OCH2CH2CH2CH=CHaHb), 4.87 (q, J = 1.7 Hz, 2H, 
(P)OCH2CH2CH2C(CH3)=CHaHb, (P)OCH2CH2CH2C(CH3)=CHaHb), 4.79–4.77 (m, 2H, 









1H, H2C=C(CH3)-CH2CHO(P)CH2), 4.63 (dtdd, J = 8.7, 6.9, 5.1, 3.6 Hz, 1H, 
H2C=C(CH3)-CH2CHO(P)CH2), 4.08 (q, J = 6.8 Hz, 2H, 
(P)OCH2CH2CH2CH2CH=CH2), 2.62 (dd, J = 14.2, 7.0 Hz, 1H, H2C=C(CH3)-
CHaHbCHO(P)CH2), 2.55 (dd, J = 14.2, 6.9 Hz, 1H, H2C=C(CH3)-CHaHbCHO(P)CH2), 
2.40–2.30 (m, 2H, H2C=C(CH3)-CHaHbCHO(P)CH2, H2C=C(CH3)-CHaHbCHO(P)CH2), 
2.09 (q, J = 7.1 Hz, 2H, (P)OCH2CH2CH2CH=CH2), 2.01 (dddd, J = 13.5, 8.6, 5.0, 1.3 
Hz, 1H, H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P]), 1.86 (dddd, J = 14.7, 5.2, 3.5, 1.8 
Hz, 1H, H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P]), 1.76 (d, J = 5.9 Hz, 6H, 
(P)OCH2CH2CH2C(CH3)=CH2, (P)OCH2CH2CH2C(CH3)=CH2), 1.74–1.67 (m, 2H, 
H2C=CH-CH2-CH2-CH2-CHO(P)), 1.49 (p, J = 7.5 Hz, 2H, H2C=CH-CH2-CH2-CH2-
CHO(P));  
13C NMR (126 MHz, CDCl3) δ ppm 140.3 (C), 140.2 (C), 138.2 (CH), 114.9 (CH2), 
114.18 (CH2), 114.17 (CH2), 75.8 (d, JCP = 6.8 Hz, CH), 74.5 (d, JCP = 6.5 Hz, CH), 67.7 
(d, JCP = 5.9 Hz, CH2), 43.7 (d, JCP = 7.3 Hz, CH2), 42.7 (d, JCP = 3.2 Hz, CH2), 33.4 (d, 
JCP = 6.8 Hz, CH2), 33.1 (CH2), 29.7 (d, JCP = 6.7 Hz, CH2), 24.8 (CH2), 22.6 (CH3), 22.3 
(CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –6.67 (s);  





tetradec-7-ene 1-oxide (2.16.2):  
 
Following General Procedure 2, triene 2.16.1 (20.0 mg, 0.0609 mmol) was exposed to G-
II catalyst (7 mol %, over 9 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphate 2.16.2 (14.8 mg, 0.0493 mmol, 81%) as a colorless oil.  
FTIR (neat): 2963, 2916, 1855, 1443, 1377, 1103, 1072, 1053, 1020, 1005, 978, 943, 
924, 897, 793, 762, 544 cm-1;  
Optical Rotation [α]D = +37.3 (c 0.15, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 5.18 (ddd, J = 12.0, 3.4, 1.7 Hz, 1H, 
(P)OCHCH2C(CH3)=CHCH2), 4.93–4.83 (m, 2H, (P)OCHCH2C(CH3)=CHaHb), 4.83–
4.76 (m, 2H, (P)OCHCH2C(CH3)=CHaHb, (P)OCHCH2C(CH3)=CHCH2), 4.74–4.68 (m, 
1H, (P)OCHaHbCH2CH2CH2CH=C(CH3)CH2), 3.89 (dddd, J = 19.0, 11.7, 10.6, 1.2 Hz, 
1H, (P)OCHaHbCH2CH2CH2CH=C(CH3)CH2), 3.31 (dd, J = 14.1, 13.0 Hz, 1H, 
(P)OCHCHaHbC(CH3)=CHCH2), 2.60 (dddd, J = 14.2, 11.9, 9.4, 6.3 Hz, 1H, 
(P)OCH2CH2CH2CHaHbCH=C(CH3)CH2), 2.51 (dd, J = 14.2, 6.7 Hz, 1H, 
(P)OCHCHaHbC(CH3)=CH2), 2.29 (dddd, J = 14.3, 6.5, 2.8, 1.0 Hz, 1H, 
(P)OCHCHaHbC(CH3)=CH2), 2.25–2.16 (m, 1H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P]), 2.03–1.96 (m, 1H, (P)OCH2CH2CH2CHaHbCH=C(CH3)CH2), 
1.90–1.81 (m, 1H, (P)OCH2CHaHbCH2CH2CH=C(CH3)CH2), 1.79 (dt, J = 3.9, 1.1 Hz, 









(P)OCH2CH2CH2CH2CH=C(CH3)CH2), 1.59–1.53 (m, 1H, 
(P)OCH2CHaHbCH2CH2CH=C(CH3)CH2);  
13C NMR (126 MHz, CDCl3) δ ppm 140.1 (C), 130.2 (C), 128.8 (CH), 114.2 (CH2), 
75.8 (d, JCP = 8.0 Hz, CH), 74.0 (d, JCP = 6.9 Hz, CH), 71.6 (d, JCP = 6.6 Hz, CH2), 44.4 
(d, JCP = 8.8 Hz, CH2), 36.0 (CH2), 34.7 (d, JCP = 7.0 Hz, CH2), 28.6 (CH2), 27.4 (CH2), 
26.0 (CH2), 22.9 (CH3), 22.2 (CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –7.95 (td, JPH = 20.5, 9.7 Hz);  
HRMS (TOF MS ES+) calcd for (C15H25O4P)2Na (2M+Na)+ 623.2879; found 623.2889. 
 
(4R,6R)-2-(((S)-1-(benzyloxy)hept-6-en-2-yl)oxy)-4,6-bis(2-methylallyl)-1,3,2-
dioxaphosphinane 2-oxide (2.16.3):  
 
Following General Procedure 1, monochlorophosphate (R,R)-2.13.2 (0.180 g, 0.679 
mmol) and alcohol (S)-2.15.3 (0.137 g, 0.622 mmol) were converted into 2.16.3 (0.158 g, 
0.352 mmol, 62%) which was isolated as a colorless oil.  
FTIR (neat): 2936, 2862, 1452, 1375, 1366, 1286, 1207, 1003, 1101, 1070, 1003, 970, 
8945, 812, 739, 698, 553 cm-1;  
Optical Rotation [α]D = +34.9 (c = 0.93, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.34 (d, J = 3.7 Hz, 4H, aromatic C-H), 7.32–7.28 
(m, 1H, aromatic C-H), 5.78 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H, H2C=CH-CH2-CH2-CH2-











CHO(P)CH2OBn), 4.95 (ddt, J = 10.2, 2.2, 1.2 Hz, 1H, HaHbC=CH-CH2-CH2-CH2-
CHO(P)CH2OBn), 4.84 (dt, J = 14.7, 1.6 Hz, 2H, H2C=C(CH3)-CH2CHO(P)CH2), 4.77–
4.66 (m, 4H, H2C=C(CH3)-CH2CHO(P)CH2, H2C=C(CH3)-CH2CHO(P)CH2, 
H2C=C(CH3)-CH2CHO(P)CH2), 4.62–4.51 (m, 3H, H2C=CH-CH2-CH2-CH2-
CHO(P)CH2OBn, OCH2Ph), 3.58 (dd, J = 4.8, 1.2 Hz, 2H, -CH2OBn), 2.63 (ddd, J = 
14.2, 7.1, 1.2 Hz, 1H, H2C=C(CH3)-CHaHbCHO(P)CH2), 2.49 (dd, J =  14.2, 6.4 Hz, 1H, 
H2C=C(CH3)-CHaHbCHO(P)CH2), 2.36 (dd, J =  14.1, 7.4 Hz, 1H, H2C=C(CH3)-
CHaHbCHO(P)CH2), 2.29 (ddt, J = 14.2, 7.4, 1.3 Hz, 1H, H2C=C(CH3)-
CHaHbCHO(P)CH2), 2.07 (qdd, J = 6.4, 2.9, 1.4 Hz, 2H, H2C=CH-CH2-CH2-CH2-
CHO(P)CH2OBn), 1.96 (dddd, J = 14.5, 8.1, 4.9, 1.4 Hz, 1H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P]), 1.86 (dddd, J = 14.6, 5.4, 3.8, 1.7 Hz, 1H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P]), 1.75 (s, 3H, H2C=C(CH3)CH2-CHO(P)), 1.74–1.70 (m, 2H, 
H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 1.69 (t, J = 1.2 Hz, 3H, H2C=C(CH3)CH2-
CHO(P)), 1.57–1.41 (m, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn);  
13C NMR (126 MHz, CDCl3) δ ppm 140.5 (C), 140.3 (C), 138.3 (CH), 137.9 (C), 128.4 
(2 x CH), 127.7 (CH), 127.6 (2 x CH), 114.8 (CH2), 114.12 (CH2), 114.11 (CH2), 77.9 (d, 
J = 6.2 Hz, CH), 76.0 (d, J = 6.8 Hz, CH), 74.3 (d, J = 6.5 Hz, CH), 73.2 (CH2), 71.9 (d, 
J = 4.5 Hz, CH2), 43.8 (d, J = 7.5 Hz, CH2), 42.8 (d, J = 3.6 Hz, CH2), 33.5 (CH2), 33.3 
(d, J = 6.8 Hz, CH2), 31.7 (d, J = 4.5 Hz, CH2), 24.2 (CH2), 22.6 (CH3), 22.4 (CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –7.07 (dt, JPH = 13.1, 6.0 Hz);  





trioxa-1-phosphabicyclo[8.3.1]tetradec-7-ene 1-oxide (cis-2.16.5):  
 
Following General Procedure 2, triene 2.16.3 (30.0 mg, 0.0669 mmol) was exposed to G-
II catalyst (4 mol %, over 5 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphate cis-2.16.5 (19.2 mg, 0.0457 mmol, 68%) as a colorless oil.  
FTIR (neat): 2963, 2936, 2920, 2862, 1452, 1377, 1283, 1103, 1074, 1003, 972, 918, 
797, 698, 550 cm-1; [α]D = +32.4 (c 0.17, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.37–7.33 (m, 4H, Aromatic C-H), 7.32–7.28 (m, 
1H, Aromatic C-H), 5.20 (ddt, J = 11.8, 3.2, 1.5 Hz, 1H, (P)OCHCH2C(CH3)=CHCH2), 
5.05 (ddtd, J = 10.0, 7.7, 4.9, 3.0 Hz, 1H, (P)OCHCH2C(CH3)=CHCH2), 4.88 (ddt, J = 
15.8, 9.5, 4.4 Hz, 1H, (P)OCHCH2C(CH3)=CH2), 4.83–4.76 (m, 3H, 
(P)OCHCH2C(CH3)=CH2, CH2(CH3)C=CHCH2CH2CH2CHO(P)CH2OBn), 4.59 (d, J = 
12.0 Hz, 1H, -OCHaHbPh), 4.56 (d, J = 12.0 Hz, 1H, -OCHaHbPh), 3.66 (dd, J = 10.4, 7.3 
Hz, 1H, CH2CHO(P)CHaHbOBn), 3.56 (ddd, J = 10.4, 5.2, 1.9 Hz, 1H, 
CH2CHO(P)CHaHbOBn), 3.29 (t, J = 13.6 Hz, 1H, (P)OCHCHaHbC(CH3)=CHCH2), 
2.58–2.50 (m, 1H, CH2(CH3)C=CHCHaHbCH2CH2CHO(P)), 2.47 (dd, J = 14.4, 7.0 Hz, 
1H, (P)OCHCHaHbC(CH3)=CH2), 2.28 (dddd, J = 14.5, 6.2, 3.0, 1.0 Hz, 1H, 
(P)OCHCHaHbC(CH3)=CH2), 2.24–2.16 (m, 1H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P]), 1.94 (ddt, J = 15.5, 5.7, 2.9 Hz, 2H, 
CH2(CH3)C=CHCHaHbCH2CH2CHO(P), 











(P)OCHCH2C(CH3)=CH2), 1.72–1.65 (m, 3H, (P)OCHCHaHbC(CH3)=CHCH2, 
H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P], 
CH2(CH3)C=CHCH2CH2CHaHbCHO(P)CH2OBn), 1.42 (ddtd, J = 14.6, 12.5, 5.1, 2.7 Hz, 
1H, CH2(CH3)C=CHCH2CHaHbCH2CHO(P)CH2OBn);  
13C NMR (126 MHz, CDCl3) δ ppm 140.2 (C), 138.1 (C), 130.3 (C), 128.6 (CH), 128.3 
(2 x CH), 127.53 (CH), 127.52 (2 x CH), 114.0 (CH2), 78.1 (d, JCP = 6.9 Hz, CH), 75.7 
(d, JCP = 8.1 Hz, CH), 73.9 (d, JCP = 6.9 Hz, CH), 72.9 (CH2), 70.5 (d, JCP = 6.3 Hz, 
CH2), 44.3 (d, JCP = 8.9 Hz, CH2), 36.0 (CH2), 34.7 (d, JCP = 6.7 Hz, CH2), 28.3 (d, JCP = 
2.3 Hz, CH2), 26.5 (CH2), 23.3 (CH2), 22.8 (CH3), 22.2 (CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –8.71 (dd, JPH = 23.2, 9.4 Hz);  
HRMS (TOF MS ES+) calcd for (C23H33O5P)2Na (2M+Na)+ 863.4029; found 863.4021. 
 
(4R,6R)-2-(((R)-1-(benzyloxy)hept-6-en-2-yl)oxy)-4,6-bis(2-methylallyl)-1,3,2-
dioxaphosphinane 2-oxide (2.16.4):  
 
Following General Procedure 1, monochlorophosphate (R,R)-2.13.2 (0.180 g, 0.679 
mmol) and alcohol (R)-2.15.3 (0.137 g, 0.622 mmol) were converted into 2.16.4 (0.118 g, 
0.263 mmol, 47%) which was isolated as a colorless oil.  
FTIR (neat): 2936, 2860, 1452, 1377, 1366, 1285, 1101, 1069, 1003, 897, 847, 808, 739, 











Optical Rotation [α]D = +30.5 (c 1.00, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.34 (d, J = 4.4 Hz, 4H, aromatic C-H), 7.31–7.27 
(m, 1H, aromatic C-H), 5.79 (ddt, J = 16.9, 10.1, 6.7 Hz, 1H, H2C=CH-CH2-CH2-CH2-
CHO(P)CH2OBn), 5.02 (dq, J = 17.1, 1.6 Hz, 1H, HaHbC=CH-CH2-CH2-CH2-
CHO(P)CH2OBn), 4.96 (ddt, J = 10.2, 2.2, 1.2 Hz, 1H, HaHbC=CH-CH2-CH2-CH2-
CHO(P)CH2OBn), 4.87 (t, J = 1.7 Hz, 1H, HaHbC=C(CH3)-CH2CHO(P)CH2), 4.85–4.83 
(m, 1H, HaHbC=C(CH3)-CH2CHO(P)CH2), 4.79 (dq, J = 1.9, 0.9 Hz, 1H, 
HaHbC=C(CH3)-CH2CHO(P)CH2), 4.76–4.70 (m, 2H, HaHbC=C(CH3)-CH2CHO(P)CH2, 
H2C=C(CH3)-CH2CHO(P)CH2), 4.67–4.57 (m, 3H, H2C=C(CH3)-CH2CHO(P)CH2, 
H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn, OCHaHbPh), 4.53 (d, J = 12.0 Hz, 1H, 
OCHaHbPh), 3.61 (t, J = 4.9 Hz, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 2.64–
2.51 (m, 2H, H2C=C(CH3)-CH2CHO(P)CH2), 2.40–2.31 (m, 2H, H2C=C(CH3)-
CH2CHO(P)CH2), 2.09 (dtdt, J = 7.9, 6.5, 3.6, 1.3 Hz, 2H, H2C=CH-CH2-CH2-CH2-
CHO(P)CH2OBn), 1.98 (dddd, J = 14.4, 8.0, 4.9, 1.5 Hz, 1H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P]), 1.89 (dddd, J = 14.6, 5.6, 3.9, 1.7 Hz, 1H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P]), 1.78–1.69 (m, 8H, H2C=C(CH3)-CH2CHO(P)CH2, 
H2C=C(CH3)-CH2CHO(P)CH2, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn), 1.57–1.41 
(m, 2H, H2C=CH-CH2-CH2-CH2-CHO(P)CH2OBn);  
13C NMR (126 MHz, CDCl3) δ ppm 140.4 (C), 140.3 (C), 138.2 (CH), 138.1 (C), 128.3 
(2 x CH), 127.60 (2 x CH), 127.57 (CH), 114.9 (CH2), 114.20 (CH2), 114.15 (CH2), 78.2 
(d, J = 6.3 Hz, CH), 75.6 (d, J = 6.6 Hz, CH), 74.6 (d, J = 6.7 Hz, CH), 73.2 (CH2), 71.7 
(d, J = 4.1 Hz, CH2), 43.7 (d, J = 7.1 Hz, CH2), 43.0 (d, J = 4.1 Hz, CH2), 33.4 (CH2), 
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33.3 (d, J = 6.7 Hz, CH2), 31.6 (d, J = 4.9 Hz, CH2), 24.3 (CH2), 22.6 (CH3), 22.3 (CH3); 
31P NMR (162 MHz, CDCl3) δ ppm –6.90 (dt, JPH = 13.5, 6.8 Hz);  
HRMS (TOF MS ES+) calcd for (C25H37O5P)2Na (2M+Na)+ 919.4655; found 919.4681. 
 
(1S,3R,10R,12R,Z)-3-((benzyloxy)methyl)-8-methyl-12-(2-methylallyl)-2,13,14-
trioxa-1-phosphabicyclo[8.3.1]tetradec-7-ene 1-oxide (trans-2.16.6):  
 
Following General Procedure 2, triene 2.16.4 (20.0 mg, 0.0446 mmol) was exposed to G-
II catalyst (2 mol %, over 3 hours) in refluxing CH2Cl2 to provide the corresponding 
bicyclic phosphate trans-2.16.6 (13.5 mg, 0.0321 mmol, 72%) as a white, crystalline 
solid, which was recrystallized via vapor-diffusion method (EtOAc:Hexanes) to afford X-
ray quality crystals for X-ray crystallographic analysis (which confirmed stereochemical 
olefin assignment as Z).10  
FTIR (neat): 2961, 2924, 2858, 1452, 1378, 1273, 1105, 1094, 1076, 1020, 974, 951, 
908, 783, 739, 698, 542 cm-1;  
Optical Rotation [α]D = +54.4 (c 0.86, CHCl3);  
1H NMR (500 MHz, CDCl3) δ ppm 7.38–7.32 (m, 4H, Aromatic C-H), 7.29 (dt, J = 6.8, 
3.0 Hz, 1H, Aromatic C-H), 5.29 (dd, J = 12.3, 4.0 Hz, 1H, 
CH2(P)OCHCH2C(CH3)=CHCH2), 4.89–4.82 (m, 2H, CH2(P)OCHCH2C(CH3)=CHCH2, 
CH2(P)OCHCH2C(CH3)=CHaHb), 4.80 (dd, J = 2.1, 1.0 Hz, 1H, 
CH2(P)OCHCH2C(CH3)=CHaHb), 4.76 (ddd, J = 11.3, 6.5, 2.5 Hz, 1H, 










Hz, 1H, -OCHaHbPh), 4.31 (dddd, J = 14.0, 11.5, 6.8, 4.6 Hz, 1H, 
CH2(CH3)C=CHCH2CH2CH2CHO(P)CH2OBn), 3.63 (dd, J = 10.8, 6.6 Hz, 1H, 
CH2CHO(P)CHaHbOBn), 3.58 (ddd, J = 10.7, 3.9, 2.4 Hz, 1H, CH2CHO(P)CHaHbOBn), 
3.12–3.05 (m, 1H, CH2(P)OCHCHaHbC(CH3)=CHCH2), 2.57 (dd, J = 14.2, 6.6 Hz, 1H, 
CH2(P)OCHCHaHbC(CH3)=CH2), 2.50 (ddd, J = 15.1, 11.3, 6.2 Hz, 1H, 
H2C=C(CH3)CH2-CHO(P)CHaHbCHO[P]), 2.35 (ddt, J = 14.3, 6.8, 1.3 Hz, 1H, 
CH2(P)OCHCHaHbC(CH3)=CH2), 2.32–2.25 (m, 1H, 
CH2(CH3)C=CHCHaHbCH2CH2CHO(P)CH2OBn), 1.93–1.80 (m, 3H, H2C=C(CH3)CH2-
CHO(P)CHaHbCHO[P], CH2(CH3)C=CHCHaHbCH2CHaHbCHO(P)CH2OBn), 1.76 (dt, J 
= 10.3, 1.4 Hz, 7H, CH2(P)OCHCHaHbC(CH3)=CHCH2, 
CH2(P)OCHCH2C(CH3)=CHCH2, CH2(P)OCHCH2C(CH3)=CH2), 1.53 (dddd, J = 25.2, 
12.3, 6.8, 3.4 Hz, 3H, CH2(CH3)C=CHCH2CH2CHaHbCHO(P)CH2OBn);  
13C NMR (126 MHz, CDCl3) δ ppm 140.3 (C), 138.1 (C), 130.1 (C), 128.6 (CH), 128.3 
(2 x CH), 127.7 (2 x CH), 127.6 (CH), 114.1 (CH2), 77.1 (d, JCP = 8.6 Hz, CH), 75.8 (d, 
JCP = 6.1 Hz, CH), 74.3 (d, JCP = 6.4 Hz, CH), 73.6 (CH2), 72.4 (d, JCP = 7.0 Hz, CH2), 
44.5 (d, JCP = 4.9 Hz, CH2), 37.4 (d, JCP = 4.2 Hz, CH2), 34.8 (d, JCP = 11.8 Hz, CH2), 
29.1 (d, JCP = 1.9 Hz, CH2), 25.0 (CH2), 23.9 (CH2), 23.0 (CH3), 22.8 (CH3);  
31P NMR (162 MHz, CDCl3) δ ppm –9.90 (d, JPH = 9.8 Hz);  




5.1.3 NMR Spextra 
(4S,6S)-2-(((R)-1-(benzyloxy)but-3-en-2-yl)oxy)-4,6-divinyl-1,3,2-dioxaphosphinane 
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5.2.1 General Methods 
All reactions were carried out in oven- or flame-dried glassware under argon atmosphere 
using standard gas-tight syringes, cannulae, and septa.  Stirring was achieved with oven-
dried magnetic stir bars. Et2O, THF and CH2Cl2 were purified by passage through a 
purification system (Solv-Tek) employing activated Al2O3  (Grubbs, R. H.; Rosen, R. K.; 
Timmers, F. J. Organometallics 1996, 15, 1518–1520).  Et3N was purified by passage 
over basic alumina and stored over KOH.  Butyllithium was purchased from Aldrich and 
titrated prior to use.  All olefin metathesis catalysts were acquired from Materia and used 
without further purification.  Flash column chromatography was performed with Sorbent 
Technologies (30930M-25, Silica Gel 60A, 40-63 mm) and thin layer chromatography 
was performed on silica gel 60F254 plates (EM-5717, Merck).  Deuterated solvents were 
purchased from Cambridge Isotope laboratories. 1H, 13C, and corresponding 2D NMR 
spectra were recorded in CDCl3 (unless otherwise mentioned) on a Bruker DRX-500 
spectrometer operating at 500 MHz, and 125 MHz, respectively and calibrated to the 
solvent peak. 31P and 1H-decoupled 31P NMR spectra were recorded on a Bruker DRX-
400 spectrometer operating at 162 MHz, and 11B NMR spectra was recorded on on a 
Bruker DRX-400 spectrometer operating at 160 MHz. High-resolution mass spectrometry 
(HRMS) was recorded on a LCT Premier Spectrometer (Micromass UK Limited) 
operating on ESI-positive mode (MeOH) and reported for the parent molecule [(RO)3P-
BH3], the corresponding phosphite fragment [(RO)3P], or the oxidized parent molecule 
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[(RO)3P=O].1  HRMS spectra for thiophosphate 3.10.4 was acquired on a Q-Tof-2 
(Micromass Ltd ,Manchester UK) hybrid mass spectrometer operated in MS mode and 
acquiring data with the time of flight analyzer (Hexanes APCI-MS).   Observed rotations 
at 589 nm, were measured using AUTOPOL IV Model automatic polarimeter.  IR was 
recorded on Shimadzu FTIR-8400S instrument. 
5.2.2 Experimental Section 
(4S,6S)-2-(allyloxy)-4,6-divinyl-1,3,2-dioxaphosphite 1-borane (C10H18BO3P, 3.9.2) 
 
In the glovebox (under argon) was added allyl tetraisopropylphosphorodiamidite (0.926 
g, 4.06 mmol) to an oven-dried round bottom flask equipped with a magnetic stirbar. The 
flask was capped with a rubber septum, removed from the glovebox, and equipped with 
an argon inlet. To the phosphorodiamidite, under argon, was added dry, degassed 
acetonitrile (25 mL), then 1H-tetrazole (0.481 g, 6.87 mmol), and the mix stirred at room 
temperature for 10 minutes (white solids formed and the mix became heterogeneous). To 
                                                
[1] For many of the bicyclic phosphite-borane molecules reported in this publication, the 
fragmentation pattern resulting from electrospray ionization was complex, though 
typically the phosphite fragment m/z, the parent molecule m/z, and/or the oxidized form 
(phosphate) m/z were observed (in ranges of 2–20 ppm difference from the calculated 
mass). In these cases, the microgram scale oxidation of the phosphite-borane was carried 
out via the deprotection-oxidation protocol reported below (see preparation of 3.10.3), 









the stirring mixture was added (3S,5S)-hepta-1,6-diene-3,5-diol2 (3.9.1, 0.400 g, 3.12 
mmol) in acetonitrile (6.2 mL), dropwise. The heterogeneous mix stirred at room 
temperature for 3.5 hours (complete by TLC), and BH3•THF (9.4 mL, 1.0 M in THF) was 
added dropwise over 5 minutes (Note: the reaction cleared during addition of borane-
THF complex). The reaction stirred at room temperature for 1 hour (complete by TLC), 
where excess borane was quenched by the addition of H2O (~10 mL) and the mix was 
concentrated under reduced pressure to 1/3 its original volume. The cloudy solution was 
partitioned between equal portions of EtOAc and water (30 mL:30 mL), and the biphasic 
solution was separated. The aqueous layer was extracted with EtOAc (3 x 20 mL), and 
the organic layers were combined, washed with brine, dried over anhydrous sodium 
sulfate, filtered and concentrated under reduced pressure. The crude mix was purified by 
flash, filter column (silica, 15% EtOAc in hexanes) to provide clean triene 3.9.2 (0.514 g, 
2.26 mmol, 72% yield) as a clear, colorless liquid. Note: Extended column times resulted 
in partial triene decomposition, even with the addition of triethylamine to column eluent 
(5-10%). The triene was stored under argon in the freezer for extended store times. 
FTIR (neat): 3088, 2934, 2401, 1425, 1120, 1096, 1005, 987, 926, 852, 729, 663 cm-1; 
Optical Rotation: [α]D = +93.9 (c = 0.17, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.10 (ddd, J = 17.1, 10.5, 6.5 Hz, 1H, CH2=CH–), 5.98–
5.85 (m, 2H, CH2=CH–, CH2=CH–), 5.45 (dt, J = 17.1, 1.3 Hz, 1H, CHaHb=CH–), 5.38 
(dt, J = 3.4, 1.4 Hz, 1H, CHaHb=CH–), 5.35 (dt, J = 3.3, 1.4 Hz, 1H, CHaHb=CH–), 5.32 
                                                
[2] Rychnovsky, S. D.; Griesgraber, G.; Powers, J. P. Org. Synth. 2000, 77, 1–11. 
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(dd, J = 1.3, 1.3 Hz, 1H, CHaHb=CH–), 5.30 (dd, J = 1.3, 1.3 Hz, 1H, CHaHb=CH–), 5.26 
(dd, J = 10.4, 1.4 Hz, 1H, CHaHb=CH–), 5.02 (dqt, J = 8.8, 3.5, 1.7 Hz, 1H, CH2=CH-
CH-O(P)-CH2–), 4.93 (dddd, J = 13.1, 6.5, 5.0, 3.5 Hz, 1H, CH2=CH-CH-O(P)-CH2–), 
4.54 (tdd, J = 7.2, 3.5, 1.5 Hz, 2H, (P)-O-CH2-CH=CH2), 2.25 (dddd, J = 14.7, 8.4, 5.0, 
1.2 Hz, 1H, CH2=CH-CH-O(P)-CHaHb-O(P)-CH–), 2.15 (dddd, J = 14.7, 5.1, 3.5, 1.7 Hz, 
1H, CH2=CH-CH-O(P)-CHaHb-O(P)-CH–), 0.85 – 0.19 (m, 3H, -BH3). 
13C NMR (126 MHz, CDCl3) δ 135.6 (d, JCP = 1.5 Hz, CH), 135.1 (d, JCP = 5.7 Hz, CH), 
132.5 (d, JCP = 6.1 Hz, CH), 118.3 (CH2), 118.1 (CH2), 117.5 (CH2), 76.3 (d, JCP = 9.5 
Hz, CH), 72.3 (d, JCP = 7.8 Hz, CH), 67.5 (CH2), 35.5 (d, JCP = 9.3 Hz, CH2); 
31P NMR (162 MHz, CDCl3) δ 110.8 – 108.4 (short, br, m); 
11B NMR (160 MHz, CDCl3) δ -42.5 (dq, J = 98.1, 98.1 Hz); 
HRMS cald for oxidized parent molecule C10H15O4PNa (M+Na)+ 253.0606; found 
253.0610 (TOF MS ES+). 
 
(4R,6R)-2-(allyloxy)-4,6-divinyl-1,3,2-dioxaphosphite 1-borane (C10H18BO3P, 3.9.3) 
 
In the glovebox (under argon) was added allyl tetraisopropylphosphorodiamidite (0.852 
g, 3.74 mmol) to an oven-dried round bottom flask equipped with a magnetic stirbar. The 
flask was capped with a rubber septum, removed from the glovebox, and equipped with 









acetonitrile (21 mL), then 1H-tetrazole (0.443 g, 6.32 mmol), and the mix stirred at room 
temperature for 10 minutes (white solids formed and the mix became heterogeneous). To 
the stirring mixture was added (3R,5R)-hepta-1,6-diene-3,5-diol2 (3.9.1, 0.368 g, 2.87 
mmol) in acetonitrile (8 mL), dropwise. The heterogeneous mix stirred at room 
temperature for 3.5 hours (complete by TLC), and BH3•THF (8.6 mL, 1.0 M in THF) was 
added dropwise over 5 minutes (Note: the reaction cleared during addition of borane-
THF complex). The reaction stirred at room temperature for 1 hour (complete by TLC), 
where excess borane was quenched by the addition of H2O (~10 mL) and the mix was 
concentrated under reduced pressure to 1/3 its original volume. The cloudy solution was 
partitioned between equal portions of EtOAc and water (30 mL:30 mL), and the biphasic 
solution was separated. The aqueous layer was extracted with EtOAc (3 x 20 mL), and 
the organic layers were combined, washed with brine, dried over anhydrous sodium 
sulfate, filtered and concentrated under reduced pressure. The crude mix was purified by 
flash, filter column (silica, 15% EtOAc in hexanes) to provide clean triene 3.9.3 (0.479 g, 
2.10 mmol, 73% yield) as a clear, colorless liquid. Note: Extended column times resulted 
in partial triene decomposition, even with the addition of triethylamine to column eluent 
(5-10%). The triene was stored under argon in the freezer for extended store times. 
FTIR (neat): 3086, 2930, 2399, 1425, 1409, 1124, 1005, 987, 926, 852, 729, 663 cm-1; 
Optical Rotation: [α]D = –89.0 (c = 0.39, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.10 (ddd, J = 17.1, 10.5, 6.5 Hz, 1H, CH2=CH–), 5.99–
5.85 (m, 2H, CH2=CH–, CH2=CH–), 5.45 (dt, J = 17.1, 1.2 Hz, 1H, CHaHb=CH–), 5.39 
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(p, J = 1.4 Hz, 1H, CHaHb=CH–), 5.35 (p, J = 1.4 Hz, 1H, CHaHb=CH–), 5.33 (q, J = 1.1 
Hz, 1H, CHaHb=CH–), 5.30 (q, J = 1.1 Hz, 1H, CHaHb=CH–), 5.26 (dd, J = 10.4, 1.4 Hz, 
1H, CHaHb=CH–), 5.02 (dqd, J = 8.7, 3.7, 1.9 Hz, 1H, CH2=CH-CH-O(P)-CH2–), 4.93 
(dddd, J = 13.1, 6.5, 5.0, 3.5 Hz, 1H, CH2=CH-CH-O(P)-CHaHb-O(P)-CH–), 4.55 (dtt, J 
= 8.5, 5.9, 1.4 Hz, 2H, (P)-O-CH2-CH=CH2), 2.25 (dddd, J = 14.7, 8.5, 5.0, 1.1 Hz, 1H, 
CH2=CH-CH-O(P)-CHaHb-O(P)-CH–), 2.15 (dddd, J = 14.7, 5.1, 3.5, 1.6 Hz, 1H, 
CH2=CH-CH-O(P)-CHaHb-O(P)-CH–), 0.88 – 0.19 (m, 3H, -BH3). 
13C NMR (126 MHz, CDCl3) δ 135.6 (d, JCP = 1.6 Hz, CH), 135.2 (d, JCP = 5.9 Hz, CH), 
132.5 (d, JCP = 6.2 Hz, CH), 118.3 (CH2), 118.2 (CH2), 117.6 (CH2), 76.3 (d, JCP = 9.3 
Hz, CH), 72.3 (d, JCP = 7.8 Hz, CH), 67.6 (CH2), 35.5 (d, JCP = 9.2 Hz, CH2); 
31P NMR (162 MHz, CDCl3) δ 113.3 – 106.8 (short, br, m); 
11B NMR (160 MHz, CDCl3) δ -42.6 (dq, J = 98.2, 98.2 Hz); 
HRMS cald for oxidized parent molecule C10H15O4PNa (M+Na)+ 253.0606; found 








To an oven-dried, round bottom flask equipped with a reflux condenser and magnetic 
stirbar, under argon, was added triene 3.9.2 (0.420 g, 1.84 mmol), methylene chloride 
(dry, degassed, 263 mL), and (ImesH2)(PCy3)(Cl)2Ru=CHPh3 (G-II, 47.0 mg, 0.055 
mmol, 3 mol %), sequentially. The flask was heated to reflux and stirred at reflux for 2 
hours (complete by TLC). The solvent was removed under reduced pressure, and the 
crude mix was purified via flash chromatography (silica, 0% - 50% EtOAc in hexanes) to 
provide bicyclic phosphite-borane 3.9.4 (0.306 g, 1.53 mmol, 83% yield) as an off-white 
solid.4 Note: the bicyclic phosphite-borane can be stored for extended periods of time (>2 
years) at lower temperatures (<5 oC). Some decomposition was observed for samples 
stored at ambient temperature for greater than 1 month. 
Avg. Yield: 81–85% 
M.P.  103–104 oC 
FTIR (neat): 2995, 2937, 2424, 2394, 1418, 1394, 1259, 1236, 1081, 1045, 1020, 991, 
943, 912, 871, 787, 771, 731, 656, 608 cm-1; 
                                                
[3] Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953–956.  
[4]All X-ray crystallographic data has been submitted to the Cambridge Crystallographic 
Data Centre, and the structures for this work were assigned the following deposition 









Optical Rotation: [α]D = + 148. (c = 0.90, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.08 (dddd, J = 11.7, 6.6, 3.2, 1.9 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.86 (ddd, J = 17.2, 10.6, 5.7 Hz, 1H, -CH=CH2), 5.66 (ddd, J = 
11.6, 4.0, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.40 (dt, J = 17.1, 1.2 Hz, 1H, -
CH=CHaHb), 5.28 (dt, J = 10.6, 1.2 Hz, 1H, -CH=CHaHb), 5.19 (dddt, J = 16.0, 6.0, 4.0, 
2.0 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.05 – 4.99 (m, 1H, -CH2-(P)O-CH-
CH=CH2), 4.92 (dddd, J = 14.8, 5.7, 3.9, 2.6 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.45 (ddd, 
J = 22.9, 14.7, 6.6 Hz, 1H, (P)O-CHaHb-CH=CH-), 2.40 (ddd, J = 14.7, 12.0, 6.0 Hz, 1H, 
(P)O-CH-CHaHb-CH-O(P)), 1.85 (dq, J = 14.6, 1.8 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 
0.86 – 0.17 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 135.0 (d, JCP = 7.3 Hz, CH), 130.8 (CH), 128.8 (CH), 
117.8 (d, JCP = 1.8 Hz, CH2), 77.4 (d, JCP = 8.8 Hz, CH), 70.7 (d, JCP = 6.9 Hz, CH), 63.4 
(d, JCP = 8.1 Hz, CH2), 35.6 (d, JCP = 5.9 Hz, CH2); 
31P NMR (162 MHz, CDCl3) δ 112.8 (short, d (br), J = 124.8 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.7 (dq, J = 98.5, 98.5 Hz); 
HRMS cald for oxidized parent molecule C8H11O4PNa (M+Na)+ 225.0293; found 







To an oven-dried, round bottom flask equipped with a reflux condenser and magnetic 
stirbar, under argon, was added triene 3.9.3 (0.420 g, 1.84 mmol), methylene chloride 
(dry, degassed, 263 mL), and (ImesH2)(PCy3)(Cl)2Ru=CHPh (G-II, 47.0 mg, 0.055 
mmol, 3 mol %), sequentially. The flask was heated to reflux and stirred at reflux for 2 
hours (complete by TLC). The solvent was removed under reduced pressure, and the 
crude mix was purified via flash chromatography (silica, 0% - 50% EtOAc in hexanes) to 
provide bicyclic phosphite-borane 3.9.5 (0.306 g, 1.53 mmol, 83% yield) as an off-white 
solid.4 Note: the bicyclic phosphite-borane can be stored for extended periods of time (>2 
years) at lower temperatures (<5 oC). Some decomposition was observed for samples 
stored at ambient temperature for greater than 1 month. 
Avg. Yield: 81–85% 
M.P.  102–103 oC 
FTIR (neat): 2995,2937, 2424, 2394, 1458, 1429, 1418, 1394, 1259, 1236, 1082, 1045, 
1020, 991, 943, 912, 831, 787, 771, 658, 579 cm-1; 
Optical Rotation: [α]D = –146. (c = 0.68, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.08 (dddd, J = 11.7, 6.6, 3.2, 2.0 Hz, 1H, (P)O-CH-









11.6, 4.0, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.40 (dt, J = 17.1, 1.2 Hz, 1H, -
CH=CHaHb), 5.28 (dt, J = 10.6, 1.1 Hz, 1H, -CH=CHaHb), 5.19 (dtt, J = 15.9, 4.0, 2.0 Hz, 
1H, (P)O-CH-CH=CH-CH2-O(P)), 5.05 – 4.99 (m, 1H, -CH2-(P)O-CH-CH=CH2), 4.92 
(ddq, J = 14.8, 4.0, 2.6 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.45 (ddd, J = 22.7, 14.8, 6.6 Hz, 
1H, (P)O-CHaHb-CH=CH-), 2.40 (ddd, J = 14.6, 12.0, 6.0 Hz, 1H, (P)O-CH-CHaHb-CH-
O(P)), 1.84 (dq, J = 14.6, 1.8 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 0.87 – 0.17 (m, 3H, -
BH3); 
13C NMR (126 MHz, CDCl3) δ 135.0 (d, JCP = 7.3 Hz, CH), 130.8 (CH), 128.8 (CH), 
117.8 (CH2), 77.4 (d, JCP = 8.9 Hz, CH), 70.7 (d, JCP = 6.9 Hz, CH), 63.4 (d, JCP = 8.1 
Hz, CH2), 35.6 (d, JCP = 5.8 Hz, CH2); 
31P NMR (162 MHz, CDCl3) δ 112.9 (short, d (br), J = 147.8 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.7 (dq, J = 98.8, 98.8 Hz); 
HRMS cald for oxidized parent molecule C8H11O4PNa (M+Na)+ 225.0293; found 
225.0295 (TOF MS ES+). 
 
(4S,6S,Z)-octa-2,7-diene-1,4,6-triol (C8H14O3, 3.10.1) 
 
To a stirring solution of (SP,S,S)-bicyclic phosphite-borane 3.9.4 (40 mg, 0.20 mmol) in 
toluene (2 mL) under argon was added Red-Al [0.3 mL, 65% wt.% in toluene], dropwise, 






at room temperature overnight (complete by TLC). The reaction was quenched with 
saturated sodium potassium tartrate (aq, 1 mL), and the reaction stirred at room 
temperature until clear, separable layers formed (~30 minutes). The biphasic solution was 
separated, and the aqueous layer was neutralized with 1 M HCl (aq) [monitored with pH 
paper] and then extracted with EtOAc [4 x 2 mL] and n-butanol [3 x 2 mL]. The organic 
layers were combined, dried over sodium sulfate, filtered, and concentrated under 
reduced pressure. The crude mix was purified via flash chromatography (silica, 50%–
100% EtOAc in hexanes) to afford triol 3.10.1 (24.3 mg, 0.15 mmol, 77% yield) as a 
colorless oil. All data was in agreement with previous reports.5 
1H NMR (500 MHz, CDCl3) δ 5.94 (ddd, J = 17.2, 10.4, 5.5 Hz, 1H), 5.75 (dddd, J = 
11.3, 6.8, 5.8, 1.2 Hz, 1H), 5.66 (dddd, J = 11.3, 7.5, 1.3, 1.3 Hz, 1H), 5.32 (ddd, J = 
17.2, 1.5, 1.5 Hz, 1H), 5.18 (ddd, J = 10.5, 1.4, 1.4 Hz, 1H), 4.80 (td, J = 7.7, 3.1 Hz, 
1H), 4.56 – 4.45 (m, 1H), 4.30 (dd, J = 13.3, 6.9 Hz, 1H), 4.20 (dd, J = 13.2, 5.8 Hz, 1H), 
3.06 (s, 1H), 2.53 (d, J = 4.3 Hz, 1H), 2.19 (s, 1H), 1.89 (ddd, J = 14.5, 8.5, 3.6 Hz, 1H), 
1.72 (ddd, J = 14.5, 7.6, 3.4 Hz, 1H); 
13C NMR (126 MHz, CDCl3) δ 140.2, 134.8, 130.0, 114.8, 70.6, 65.7, 58.7, 42.4; 
HRMS cald for C8H14O3Na (M+Na)+ 181.0841; found 181.0847 (TOF MS ES+). 
  
                                                







To a solution of (SP,S,S)-bicyclic phosphite-borane 3.9.4 (40 mg, 0.20 mmol) in 
methylene chloride (4 mL) was added o-nitrobenzenesulfonylhydrazide (0.43 g, 2.0 
mmol) and triethylamine (0.9 mL) at room temperature under argon. The flask was 
protected from light (covered with aluminum foil) and allowed to stir at room 
temperature for 12 hours, at which point additional o-nitrobenzenesulfonylhydrazide6 
(0.22 g, 1.0 mmol) and triethylamine (0.45 mL) were added to the mixture. The reaction 
continued to stir at room temperature for 10 hours, at which point the solution was diluted 
with EtOAc (10 mL) and washed with saturated sodium bicarbonate (2 x 2 mL). The 
aqueous layers were combined and extracted with EtOAc (3 x 10 mL), and the organic 
layers were combined, washed with brine, dried over anhydrous sodium sulfate, filtered, 
and concentrated under reduced pressure. The crude mix was purified via flash 
chromatography to provide 3.10.2 (29 mg, 0.14 mmol, 72% yield) as an off-white solid. 
FTIR (neat): 2970, 2933, 2881, 2403, 1462, 1396, 1360, 1259, 1097, 1059, 1024, 991, 
957, 941, 908, 870, 833, 779, 660 cm-1; 
Optical Rotation: [α]D = +150. (c = 1.21, CHCl3); 
                                                









1H NMR (500 MHz, CDCl3) δ 6.05 (dddd, J = 11.7, 6.7, 3.2, 2.0 Hz, 1H, -CH=CH-), 
5.63 (ddd, J = 11.6, 4.0, 2.7 Hz, 1H, -CH=CH-), 5.16 (dtt, J = 16.0, 4.0, 1.9 Hz, 1H, -
CH2-(P)O-CH-CH2CH3), 4.93 – 4.87 (m, 1H, (P)O-CHaHb-CH=CH-), 4.52 – 4.35 (m, 
2H, (P)O-CHaHb-CH=CH-, -CH2-(P)O-CH-CH=CH-), 2.30 (ddd, J = 14.6, 11.9, 6.1 Hz, 
1H, O(P)-CH-CHaHb-CH-O(P)), 1.81 – 1.69 (m, 2H, O(P)-CH-CHaHb-CH-O(P), -
CHaHbCH3), 1.66 – 1.56 (m, 1H, -CHaHbCH3), 0.98 (t, J = 7.5 Hz, 3H, -CH2-CH3), 0.82 – 
0.16 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 131.1 (CH), 128.5 (CH), 77.6 (d, JCP = 8.8 Hz, CH), 72.2 
(d, JCP = 7.2 Hz, CH), 63.3 (d, JCP = 8.1 Hz, CH2), 35.2 (d, JCP = 5.9 Hz, CH2), 28.8 (d, 
JCP = 6.5 Hz, CH2), 9.0 (CH3); 
31P NMR (162 MHz, CDCl3) δ 112.5 (short, d (br), J = 124.6 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.7 (dq, J = 98.7, 98.7 Hz); 
HRMS cald for oxidized parent molecule C8H13O4PNa (M+Na)+ 227.0449; found 227.0439 




(1S,6S,8S)-8-vinyl-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-ene 1-oxide (C8H11O4P, 
3.10.3) 
 
To (SP,S,S)-bicyclic phosphite-borane 3.9.4 (30.0 mg, 0.150 mmol) in a pressure tube 
under argon was added dry, degassed toluene (1.9 mL) and 1,4-diazabicyclo[2.2.2]octane 
[DABCO] (16.8 mg, 0.150 mmol). The tube was capped and heated to 60 oC and stirred 
for 2 hours (phosphite formation was complete by TLC, Rf = 0.84 in 1:1 
hexanes:EtOAc). The reaction was cooled to room temperature, where tBuOOH (21 mL, 
70% wt.% in H2O) was added in one portion via automatic micropipette and the reaction 
stirred at room temperature open to air for 1 hour (complete by TLC, Note: If the 
oxidation of phosphite to phosphate is incomplete—as sometimes happens, particularly 
with other substrates, an additional 0.1-0.2 equivalents of tBuOOH can be added without 
substantial oxidation of the olefins within the substrate. Significant excess of peroxide, 
however, does lead to product decomposition). The reaction was subsequently quenched 
with solid sodium sulfite, allowed to stir at room temperature to ensure consumption of 
excess peroxide, filtered over celite, and concentrated under reduced pressure. The crude 
mix was purified via flash chromatography to provide the corresponding bicyclic 
phosphate 3.10.3 (30.3 mg, 0.150 mmol, quantitative yield) as a white solid. All data was 









1H NMR (500 MHz, CDCl3) δ 6.06 (dddd, J = 12.0, 6.8, 3.2, 2.1 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.87 (dddd, J = 17.1, 10.6, 5.4, 2.0 Hz, 1H, -CH=CH2), 5.63 (ddd, J 
= 11.8, 4.0, 2.5 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.43 (ddd, J = 17.2, 1.2, 1.2 Hz, 
1H, -CH=CHaHb), 5.27 (ddd, J = 10.6, 1.1, 1.1 Hz, 1H, -CH=CHaHb), 5.21 (dtd, J = 24.5, 
4.2, 2.1 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.07 – 4.97 (m, 2H, -CH2-(P)O-CH-
CH=CH2, (P)O-CHaHb-CH=CH-), 4.39 (ddd, J = 27.7, 14.7, 6.7 Hz, 1H, (P)O-CHaHb-
CH=CH-), 2.28 – 2.20 (m, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.81 (dtd, J = 14.7, 2.3, 1.4 
Hz, 1H, (P)O-CH-CHaHb-CH-O(P)); 
13C NMR (126 MHz, CDCl3) δ 134.7 (d, JCP = 10.4 Hz, CH), 129.6 (CH), 128.1 (CH), 
117.4 (CH2), 76.96 (d, JCP = 4.99 Hz, CH), 76.2 (d, JCP = 6.2 Hz, CH), 63.0 (d, JCP = 6.4 
Hz, CH2), 34.9 (d, JCP = 5.8 Hz, CH2); 
31P NMR (162 MHz, CDCl3) δ -4.21; 





To (SP,S,S)-bicyclic phosphite-borane 3.9.4 (30.0 mg, 0.150 mmol) in a pressure tube 
under argon was added dry, degassed toluene (2.5 mL), 1,4-diazabicyclo[2.2.2]octane 









was capped and heated to 60 oC and stirred for 10 hours (complete by TLC). The reaction 
was concentrated, and the crude mixture immediately purified via flash chromatography 
(silica, 0%–50% EtOAc in hexanes) to afford bicyclic thiophosphate 3.10.4 (32.0 mg, 
0.147 mmol, 98% yield) as an off-white solid. 
FTIR (neat): 2993, 2964, 2933, 1427. 1394, 1258, 1236, 1084, 1051, 1026, 941, 910, 
872, 841, 827, 750, 739, 677, 584 cm-1; 
Optical Rotation: [α]D = +165 (c = 0.15, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.07 (dddd, J = 11.7, 6.6, 3.1, 2.0 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.90 (dddd, J = 17.5, 10.6, 5.8, 1.3 Hz, 1H, -CH=CH2), 5.62 (ddd, J 
= 11.7, 4.1, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.42 (dt, J = 17.2, 1.2 Hz, 1H, -
CH=CHaHb), 5.29 (dt, J = 10.6, 1.1 Hz, 1H, -CH=CHaHb), 5.21 (dtt, J = 23.8, 4.3, 2.0 Hz, 
1H, (P)O-CH-CH=CH-CH2-O(P)), 5.14 – 5.06 (m, 1H, -CH2-(P)O-CH-CH=CH2), 5.02 
(ddq, J = 14.8, 7.3, 2.7 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.41 (ddd, J = 28.3, 14.8, 6.6 Hz, 
1H, (P)O-CHaHb-CH=CH-), 2.38 – 2.30 (m, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.82 (dddd, 
J = 14.7, 3.2, 2.1, 1.3 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)); 
13C NMR (126 MHz, CDCl3) δ 134.9 (d, JCP = 10.0 Hz, CH), 129.9 (CH), 128.3 (CH), 
118.0 (CH2), 78.1 (d, JCP = 9.1 Hz, CH), 75.7 (d, JCP = 8.1 Hz, CH), 62.9 (d, JCP = 7.4 
Hz, CH2), 34.7 (d, JCP = 6.4 Hz, CH2); 
31P NMR (162 MHz, CDCl3) δ 64.8 (ddd, J = 28.2, 24.5, 7.4 Hz); 





borane (C10H18BO3P, 3.11.1) 
 
To a solution of (RP,R,R)-bicyclic phosphite-borane 3.9.5 (30.0 mg, 0.150 mmol) in a 
pressure tube under argon was added dry, degassed methylene chloride (1.9 mL), cis-3-
hexene (20 mL, 0.165 mmol), then Hoveyda-Grubbs second generation catalyst (4.7 mg, 
0.0075 mmol, 5 mol %). The pressure tube was capped, and the reaction was heated to 40 
oC. The reaction stirred at 40 oC for 2 hours (complete by TLC) and then concentrated 
under reduced pressure. The crude mixture was purified via flash chromatography (silica, 
0%–50% EtOAc in hexanes) to provide title 3.11.1 (29.7 mg, 0.130 mmol, 87% yield) as 
an off-white solid. 
FTIR (neat): 2964, 2930, 2881, 2403, 2357, 1460, 1397, 1259, 1117, 1091, 1072, 1045, 
1028, 995, 943, 916, 867, 831, 789, 667, 619, 582 cm-1; 
Optical Rotation: [α]D = –155 (c = 0.65, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.07 (dddd, J = 11.7, 6.6, 3.1, 1.9 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.88 (dtd, J = 15.5, 6.3, 1.1 Hz, 1H, -CH=CH-CH2CH3), 5.65 (ddd, 
J = 11.6, 4.0, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.50 (ddt, J = 15.4, 7.0, 1.7 Hz, 
1H, -CH=CH-CH2CH3), 5.17 (dtt, J = 15.9, 3.9, 1.9 Hz, 1H, (P)O-CH-CH=CH-CH2-
O(P)), 5.01 – 4.94 (m, 1H, -CH2-(P)O-CH-CH=CH-CH2-CH3), 4.95 – 4.88 (m, 1H, (P)O-









(ddd, J = 14.7, 11.9, 6.1 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 2.12 – 2.05 (m, 2H, -
CH=CH-CH2-CH3), 1.80 (dq, J = 14.6, 1.8 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.01 (t, J 
= 7.5 Hz, 3H, -CH=CH-CH2-CH3), 0.90 – 0.10 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 137.4 (CH), 130.9 (CH), 128.7 (CH), 126.1 (d, JCP = 7.3 
Hz, CH), 77.45 (d, JCP = 8.9 Hz, CH), 71.3 (d, JCP = 6.8 Hz, CH), 63.3 (d, JCP = 7.9 Hz, 
CH2), 36.1 (d, JCP = 5.7 Hz, CH2), 25.1 (CH2), 12.9 (CH3); 
31P NMR (162 MHz, CDCl3) δ 112.7 (short, d (br), J = 156.3 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.7 (dq, J = 95.9, 93.5 Hz); 
HRMS cald for oxidized parent molecule C20H30O8P2Na (2M+Na)+ 483.1314; found 
483.1321 (TOF MS ES+). 
 
(E)-3-((1R,6R,8R)-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-8-yl)allyl acetate 1-
borane (C11H18BO5P, 3.11.2) 
 
To a solution of (RP,R,R)-bicyclic phosphite-borane 3.9.5 (30.0 mg, 0.150 mmol) in a 
pressure tube under argon was added dry, methylene chloride (1.9 mL, degassed via 3 
freeze-degas-thaw cycles), cis-1,4-diacetoxy-2-butene (33.6 mg, 0.195 mmol), then 
Hoveyda-Grubbs second generation catalyst (4.7 mg, 0.0075 mmol, 5 mol %). The 
pressure tube was capped, and the reaction was heated to 40 oC. The reaction stirred at 40 










0.0075 mmol, 5 mol %) was added. The reaction continued to stir for 5 hours (stalled 
progression by TLC). The reaction was concentrated under reduced pressure, and the 
crude mixture was purified via flash chromatography (silica, 0%–50% EtOAc in hexanes) 
to provide title 3.11.2 (25.2 mg, 0.0926 mmol, 62% yield, 84% based on recovered 
starting material) as a pale yellow oil, along with unreacted 3.9.5 (7.9 mg, 0.0395 mmol). 
FTIR (neat): 2930, 2885, 2849, 2403, 1738, 1456, 1427, 1364, 1232, 1115, 1092, 1047, 
1026, 995, 945, 916, 876, 833, 785, 733, 665, 617 cm-1; 
Optical Rotation: [α]D = –124 (c = 1.07, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.08 (dddd, J = 11.7, 6.6, 3.1, 1.9 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.95 (dtd, J = 15.6, 5.6, 1.3 Hz, 1H, -CH=CH-CH2OAc), 5.78 (ddt, 
J = 15.5, 5.8, 1.5 Hz, 1H, -CH=CH-CH2OAc), 5.65 (ddd, J = 11.6, 4.0, 2.6 Hz, 1H, (P)O-
CH-CH=CH-CH2-O(P)), 5.19 (dtt, J = 16.0, 3.9, 1.9 Hz, 1H, (P)O-CH-CH=CH-CH2-
O(P)), 5.09 – 5.02 (m, 1H, -CH2-(P)O-CH-CH=CH-CH2OAc), 4.92 (ddq, J = 14.8, 3.9, 
2.6 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.59 (dt, J = 5.6, 1.2 Hz, 2H, -CH=CH-CH2-OAc), 
4.44 (ddd, J = 22.9, 14.8, 6.6 Hz, 1H, (P)O-CHaHb-CH=CH-), 2.48 – 2.34 (m, 1H, (P)O-
CH-CHaHb-CH-O(P)), 2.09 (s, 3H, -CH=CH-CH2-OC(O)(CH3)), 1.84 (dq, J = 14.6, 1.8 
Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 0.95 – 0.13 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 170.5 (C=O), 130.6 (CH), 130.2 (d, JCP = 7.2 Hz, CH), 
128.9 (CH), 127.7 (CH), 77.3 (d, JCP = 9.0 Hz, CH), 69.72 (d, JCP = 7.0 Hz, CH), 63.41 
(CH2), 63.35 (CH2), 35.7 (d, JCP = 5.8 Hz, CH2), 20.84 (CH3); 
31P NMR (162 MHz, CDCl3) δ 113.1 (short, d (br), J = 151.1 Hz); 
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11B NMR (160 MHz, CDCl3) δ -42.7 (dq, J = 98.5, 98.5 Hz); 
HRMS cald for oxidized parent molecule C11H15O6PNa (M+Na)+ 297.0504; found 
297.0501 (TOF MS ES+). 
 
(Z)-but-2-ene-1,4-diyl tetraethyl bis(phosphate) (C12H26O8P2, 3.11.7-SI) 
 
To a solution of (Z)-but-2-ene-1,4-diol (0.50 g, 5.68 mmol) in methylene chloride (57 
mL) was added triethylamine (2.4 mL, 17.0 mmol) and 4-dimethylaminopyridine 
(DMAP) (0.0693 g, 0.568 mmol) under argon. The reaction was cooled to 0 oC and 
diethylchlorophosphate (1.9 mL, 13.1 mmol) was added dropwise. The reaction was 
allowed to warm to room temperature in the ice bath and stirred at room temperature for 1 
hour (complete by TLC). The heterogeneous mixture was concentrated under reduced 
pressure and immediately purified via flash chromatography (silica, 0%–50% acetone in 
EtOAc) to provide 3.11.7-SI (1.47 g, 4.08 mmol, 72% yield) as a colorless liquid. 
FTIR (neat): 2984, 2934, 2910, 1479, 1394, 1265, 1167, 1030, 982, 870, 818, 802, 754, 
525 cm-1; 
1H NMR (500 MHz, CDCl3) δ 5.80 (t, J = 4.2 Hz, 2H), 4.62 (dd, J = 8.8, 4.3 Hz, 4H), 
4.10 (p, J = 7.3 Hz, 8H), 1.33 (t, J = 7.1 Hz, 12H); 
13C NMR (126 MHz, CDCl3) δ 128.4 (d, JCP = 6.8 Hz, CH), 63.8 (d, JCP = 5.9 Hz, CH2), 





31P NMR (162 MHz, CDCl3) δ -0.84 (hept, J = 8.5 Hz); 
HRMS cald for C12H26O8P2Na (M+Na)+ 383.1001; found 383.0996 (TOF MS ES+). 
 
(E)-3-((1S,6R,8R)-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-8-yl-1-borane)allyl 
diethyl phosphate (C13H25BO7P2, 3.11.3) 
 
To a solution of (RP,R,R)-bicyclic phosphite-borane 3.9.5 (50.0 mg, 0.250 mmol) under 
argon was added dry, methylene chloride (1.9 mL, degassed via 3 freeze-degas-thaw 
cycles), (Z)-but-2-ene-1,4-diyl tetraethyl bis(phosphate) (3.11.7-SI, 0.180 g, 0.500 
mmol), then Hoveyda-Grubbs second generation catalyst (4.7 mg, 0.0075 mmol, 3 mol 
%). The reaction mixture was heated to reflux and stirred at reflux for 2 hours, where 
additional Hoveyda-Grubbs second-generation catalyst (4.7 mg, 0.0075 mmol, 3 mol %) 
was added. The reaction continued to stir for 4 hours (stalled progression by TLC). The 
reaction was concentrated under reduced pressure, and the crude mixture was purified via 
flash chromatography (silica, 0%–100% EtOAc in hexanes) to provide title 3.11.3 (81.7 
mg, 0.223 mmol, 89% yield) as a colorless, viscous oil in a 7:1 mixture of E- and Z-
isomers. The mixture was further purified to exclusively provide the major E-isomer for 
full characterization and further use in the following cuprate addition reactions (vide 
infra). 










FTIR (neat): 2984, 2908, 2405, 1458, 1396, 1261, 1165, 1113, 1094, 1026, 995, 945, 
914, 833, 798, 784, 733, 663, 621, 536 cm-1; 
Optical Rotation: [α]D = –92.3 (c = 1.27, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.08 (dddd, J = 11.7, 6.7, 3.2, 1.9 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.97 (dt, J = 15.5, 5.3 Hz, 1H, -CH=CH-CH2OP(O)(OEt)2), 5.83 
(ddt, J = 15.4, 5.5, 1.6 Hz, 1H, -CH=CH-CH2OP(O)(OEt)2), 5.65 (ddd, J = 11.7, 4.0, 2.6 
Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.23 – 5.15 (m, 1H, (P)O-CH-CH=CH-CH2-
O(P)), 5.10 – 5.01 (m, 1H, -CH2-(P)O-CH-CH=CH-CH2OP(O)(OEt)2), 4.91 (dp, J = 
14.8, 2.8 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.55 (ddt, J = 7.9, 5.3, 1.3 Hz, 2H, -CH=CH-
CH2-OP(O)(OEt)2), 4.44 (ddd, J = 22.9, 14.8, 6.7 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.17 – 
4.07 (m, 4H, -OP(O)(OCH2CH3)2), 2.38 (ddd, J = 14.7, 12.0, 6.0 Hz, 1H, (P)O-CH-
CHaHb-CH-O(P)), 1.84 (dq, J = 14.6, 1.7 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.34 (tt, J 
= 7.1, 1.3 Hz, 6H, -OP(O)(OCH2CH3)2), 0.89 – 0.17 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 130.6 (CH), 129.9 (d, JCP = 7.2 Hz, CH), 128.9 (CH), 
127.9 (d, JCP = 7.2 Hz, CH), 77.3 (d, JCP = 8.9 Hz, CH), 69.6 (d, JCP = 6.9 Hz, CH), 66.2 
(d, JCP = 5.2 Hz, CH2), 63.9 (d, JCP = 5.9 Hz, 2 x CH2), 63.4 (d, JCP = 8.0 Hz, CH2), 35.7 
(d, JCP = 5.8 Hz, CH2), 16.1 (d, JCP = 6.8 Hz, 2 x CH3); 
31P NMR (162 MHz, CDCl3) δ 113.04 (short, d (br), J = 154.9 Hz), -1.02 (p, J = 8.4 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.8 (dq, J = 98.9, 98.9 Hz); 





methylbut-3-en-2-ol (C11H20BO4P, 3.11.4) 
 
To a solution of (RP,R,R)-bicyclic phosphite-borane 3.9.5 (30.0 mg, 0.150 mmol) in a 
pressure tube under argon was added dry, methylene chloride (1.9 mL, degassed via 3 
freeze-degas-thaw cycles), 2-methyl-3-buten-2-ol (47 mL, 0.450 mmol), then Hoveyda-
Grubbs second generation catalyst (2.8 mg, 0.0045 mmol, 3 mol %). The pressure tube 
was capped, and the reaction was heated to 40 oC. The reaction stirred at 40 oC for 3 
hours, where additional Hoveyda-Grubbs second-generation catalyst (2.8 mg, 0.0045 
mmol, 3 mol %) was added. The reaction continued to stir for 5 hours (stalled 
progression by TLC). The reaction was concentrated under reduced pressure, and the 
crude mixture was purified via flash chromatography (silica, 0%–100% EtOAc in 
hexanes) to provide title 3.11.4 (19.8 mg, 0.0767 mmol, 51% yield, 77% based on 
recovered starting material) as a colorless, viscous oil, along with unreacted 3.9.5 (10.1 
mg, 0.0505 mmol). 
FTIR (neat): 3381 (br), 2972, 2927, 2885, 2404, 1458, 1396, 1364, 1258, 1231, 1113, 
1092, 1076, 1049, 1026, 995, 947, 914, 874, 835, 813, 733, 623, 588 cm-1; 
Optical Rotation: [α]D = –127 (c = 0.43, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.08 (dddd, J = 11.7, 6.6, 3.2, 1.9 Hz, 1H, (P)O-CH-










= 15.5, 6.2 Hz, 1H, -CH=CH-C(CH3)2-OH), 5.65 (ddd, J = 11.6, 4.0, 2.6 Hz, 1H, (P)O-
CH-CH=CH-CH2-O(P)), 5.19 (dtt, J = 16.0, 3.9, 2.0 Hz, 1H, (P)O-CH-CH=CH-CH2-
O(P)), 5.08 – 5.00 (m, 1H, CH2-(P)O-CH-CH=C(CH3)2-OH), 4.92 (ddq, J = 14.8, 3.9, 2.6 
Hz, 1H, (P)O-CHaHb-CH=CH-), 4.44 (ddd, J = 22.8, 14.8, 6.7 Hz, 1H, (P)O-CHaHb-
CH=CH-), 2.41 (ddd, J = 14.7, 12.0, 6.0 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.83 (dq, J 
= 14.6, 1.7 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.59 (s (br), 1H, -OH), 1.33 (d, J = 6.2 
Hz, 6H, -CH=CH-C(CH3)2-OH), 0.91 – 0.15 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 141.7 (CH), 130.8 (CH), 128.8 (CH), 123.8 (d, JCP = 7.3 
Hz, CH), 77.4 (d, JCP = 8.8 Hz, CH), 70.5 (-C(CH3)-OH), 70.4 (d, J = 6.9 Hz, CH), 63.4 
(d, JCP = 8.0 Hz, CH2), 36.0 (d, JCP = 5.8 Hz, CH2), 29.6 (2 x CH3); 
31P NMR (162 MHz, CDCl3) δ 112.8 (short, d (br), J = 138.8 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.7 (dq, J = 98.5, 97.8 Hz); 
HRMS cald for phosphite fragment of parent molecule C11H17O4PNa (M+Na)+ 267.0762; 
found 267.0773 (TOF MS ES+). 
 
(E)-ethyl 3-((1S,6R,8R)-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-8-yl-1-
borane)acrylate (C11H18BO5P, 3.11.5) 
 
To a clean, dry round bottom flask equipped with a reflux condenser and magnetic stirbar 











dichloroethane (dry, degassed via 3 freeze-degas-thaw cycles, 6 mL), tetrafluoro-1,4-
benzoquinone (5.4 mg, 0.0300 mmol), ethyl acrylate (freshly distilled over CaH2 to 
remove hydroquinone stabilizer, 64 mL, 0.600 mmol), then Hoveyda-Grubbs second-
generation catalyst (5.6 mg, 0.009 mmol, 3 mol %). The reaction was heated to reflux and 
stirred at reflux for 2 hours, at which point additional HG-II (5.6 mg, 0.009 mmol, 3 mol 
%) and ethyl acrylate (64 mL, 0.600 mmol), and the reaction continued to stir for 5 hours 
(stalled progression by TLC). The reaction was concentrated under reduced pressure and 
purified via flash chromatography (silica, 50%–70% EtOAc in Hexanes) to provide 
3.11.5 (38.2 mg, 0.140 mmol, 47% yield) as a pale yellow liquid. 
FTIR (neat): 2980, 2930, 2405, 1718, 1666, 1444, 1396, 1367, 1306, 1279, 1258, 1232, 
1180, 1119, 1094, 1051, 1030, 955, 914, 887, 929, 787, 775, 754, 663, 611 cm-1; 
Optical Rotation: [α]D = –85.6 (c = 0.85, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.82 (ddd, J = 15.5, 4.2, 0.7 Hz, 1H, -CH=CH-
CO2CH2CH3), 6.20 (dd, J = 15.6, 1.9 Hz, 1H, -CH=CH-CO2CH2CH3), 6.11 (dddd, J = 
11.7, 6.7, 3.1, 1.9 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.67 (ddd, J = 11.6, 4.0, 2.5 Hz, 
1H, (P)O-CH-CH=CH-CH2-O(P)), 5.21 (dddq, J = 19.1, 12.0, 4.4, 2.0 Hz, 2H, (P)O-CH-
CH=CH-CH2-O(P), CH2-(P)O-CH-CH=CO2CH2CH3), 4.92 (ddq, J = 14.8, 4.0, 2.6 Hz, 
1H, (P)O-CHaHb-CH=CH-), 4.46 (ddd, J = 23.0, 14.8, 6.6 Hz, 1H, (P)O-CHaHb-CH=CH-
), 4.21 (q, J = 7.1 Hz, 2H, -CO2CH2CH3), 2.37 (ddd, J = 14.7, 12.1, 6.0 Hz, 1H, (P)O-
CH-CHaHb-CH-O(P)), 1.92 (dq, J = 14.6, 1.7 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.29 
(t, J = 7.1 Hz, 3H, -CO2CH2CH3), 0.92 – 0.19 (m, 3H, -BH3); 
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13C NMR (126 MHz, CDCl3) δ 165.7 (C=O), 142.7 (d, JCP = 7.1 Hz, CH), 130.4 (CH), 
129.3 (CH), 122.7 (CH), 77.4 (d, JCP = 8.0 Hz, CH), 68.5 (d, JCP = 7.1 Hz, CH), 63.5 (d, 
JCP = 8.0 Hz, CH2), 60.8 (CH2), 35.2 (d, JCP = 5.9 Hz, CH2), 14.2 (CH3); 
31P NMR (162 MHz, CDCl3) δ 113.5 (short, d (br), J = 147.4 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.8 (dq, J = 97.7, 97.2 Hz); 
HRMS cald for oxidized parent molecule C11H15O6PNa (M+Na)+ 297.0504; found 
297.0503 (TOF MS ES+). 
 
(R,E)-4-((1S,6R,8R)-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-8-yl-1-borane)-1-
(trityloxy)but-3-en-2-ol (C29H32BO5P, 3.11.6) 
 
To a solution of (RP,R,R)-bicyclic phosphite-borane 3.9.5 (30.0 mg, 0.150 mmol) in a 
pressure tube under argon was added dry methylene chloride (1.9 mL, degassed via 3 
freeze-degas-thaw cycles), (R)-1-(trityloxy)but-3-en-2-ol7  (149 mg, 0.450 mmol), p-
benzoquinone (1.6 mg, 0.015 mmol), then Hoveyda-Grubbs second generation catalyst 
(2.8 mg, 0.0045 mmol, 3 mol %). The pressure tube was capped, and the reaction was 
heated to 40 oC. The reaction stirred at 40 oC for 2 hours, where additional Hoveyda-
Grubbs second-generation catalyst (2.8 mg, 0.0045 mmol, 3 mol %) was added. The 
reaction continued to stir for 2 hours (complete by TLC). The reaction was concentrated 
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under reduced pressure, and the crude mixture was purified via flash chromatography 
(silica, 0%–70% EtOAc in hexanes) to provide title 3.11.6 (71.3 mg, 0.142 mmol, 95% 
yield) as a sticky, white foam. Note: 3.11.6 was isolated as a sticky, white foam that 
stored fairly well—when completely dry—at lower temperatures under inert atmosphere. 
However, extended store times (>5 months) led to decomposition even at lower 
temperature. Storage on the bench-top at ambient temperature led to decomposition 
within a few weeks and more quickly if the compound was not properly dried. 
FTIR (neat): 3568, 3466 (br), 3057, 3018, 2926, 2873, 2405, 1489, 1448, 1396, 1259, 
1219, 1117, 1092, 1076, 1047, 1028, 995, 947, 916, 879, 831, 752, 708, 633, 613, 592 
cm-1; 
Optical Rotation: [α]D = –61.2 (c = 1.47, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.47 – 7.43 (m, 6H, Aromatic C-H x 6), 7.37 – 7.32 (m, 
6H, Aromatic C-H x 6), 7.31 – 7.25 (m, 3H, Aromatic C-H x 3), 6.07 (dddd, J = 11.7, 
6.7, 3.2, 1.9 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.84 – 5.78 (m, 2H, -CH=CH-
CH(OH)-CH2OTr), 5.63 (ddd, J = 11.6, 4.0, 2.5 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 
5.17 (dtt, J = 16.0, 4.0, 1.9 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.01 (dq, J = 11.9, 2.4 
Hz, 1H, -CH2-(P)O-CH-CH=CH-CH(OH)-CH2OTr), 4.96 – 4.88 (m, 1H, (P)O-CHaHb-
CH=CH-), 4.43 (ddd, J = 23.0, 14.8, 6.7 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.34 (dq, J = 
6.7, 3.2 Hz, 1H, -CH=CH-CH(OH)-CH2OTr), 3.27 (dd, J = 9.5, 3.6 Hz, 1H, -CH=CH-
CH(OH)-CHaHbOTr), 3.11 (dd, J = 9.5, 7.8 Hz, 1H, -CH=CH-CH(OH)-CHaHbOTr), 2.55 
– 2.52 (m, 1H, -CH=CH-CH(OH)-CH2OTr), 2.37 (ddd, J = 14.7, 11.9, 6.0 Hz, 1H, (P)O-
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CH-CHaHb-CH-O(P)), 1.82 (dq, J = 14.6, 1.8 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 0.90 – 
0.13 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 143.5 (aromatic C x 3), 132.3 (CH), 130.7 (CH), 128.8 
(aromatic CH x 6), 128.6 (aromatic C-H x 6), 128.5 (d, JCP = 7.8 Hz, CH), 127.9 (CH), 
127.2 (aromatic CH x 3), 86.9 (CH), 77.4 (d, JCP = 8.8 Hz, CH), 70.6 (CH), 70.1 (d, JCP = 
6.9 Hz, CH), 67.2 (CH2), 63.3 (d, JCP = 7.9 Hz, CH2), 35.83 (d, JCP = 5.7 Hz, CH2); 
31P NMR (162 MHz, CDCl3) δ 112.9 (short, d (br), J = 144.1 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.7 (qd, J = 99.5, 90.8 Hz); 





In a glovebox, under argon, CuCN (7.0 mg, 0.074 mmol) and LiCl (6.0 mg, 0.15 mmol) 
were added to a pear-shaped flask equipped with a magnetic stirbar. The flask was 
capped with a rubber septum, removed from the glovebox, and equipped with an argon 
inlet. THF (0.25 mL) was added the flask, and the mix stirred at room temperature to 
dissolve all solids (~25 min). The flask was cooled to an external temperature of -30oC, 








slowly. The mix continued to stir at -30oC for 1 hour to generate the active 
(dimethyl)cyanocuprate. The flask was then cooled to -40oC, where 3.11.3 (18 mg, 0.049 
mmol) in THF (0.5 mL) was added, drop-wise, slowly. The reaction stirred while 
warming from -40oC to -20oC over 2 hours (complete by TLC). The reaction was 
quenched at -20oC with saturated ammonium chloride (1 mL) and stirred while warming 
to +10oC over 1 hour (salt and pepper solids formed and the aqueous layer turned blue). 
The biphasic solution was filtered over celite and separated. The aqueous layer was 
extracted with EtOAc (3 x 2 mL), and the organic layers were combined, dried over 
sodium sulfate, filtered over celite, and concentrated under reduced pressure. The crude 
mixture was purified via flash chromatography (silica, 0%–40% EtOAc in hexanes) to 
provide 3.12.1 (5.6 mg, 0.025 mmol, 50% yield) as an off-white solid and 2:1 mixture of 
diastereomers. Note: 13C NMR signal designations A and B relate to signals from the 
major (A) and/or minor (B) diastereomers. 
Yield: 50% (dr ~ 2:1, crude 1H) 
FTIR (neat): 2972, 2930, 2883, 2403, 1454, 1258, 1099, 1047, 1024, 993, 953, 912, 873, 
833, 791, 710, 654, 608, 584 cm-1; 
Optical Rotation: [α]D = –120 (c = 0.26, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.05 (ddtd, J = 12.1, 6.8, 3.5, 1.9 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.79 (ddd, J = 17.2, 10.4, 7.7 Hz, 1H, -CH(CH3)-CH=CH2), 5.65 – 
5.58 (m, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.21 – 5.06 (m, 3H, -CH(CH3)-CH=CH2, 
(P)O-CH-CH=CH-CH2-O(P)), 4.91 (ddq, J = 14.8, 3.9, 2.6 Hz, 1H, (P)O-CHaHb-
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CH=CH-), 4.51 – 4.37 (m, 2H, (P)O-CHaHb-CH=CH-, (P)O-CH-CH(CH3)-CH=CH2), 
2.47 – 2.32 (m, 2H, (P)O-CH-CH(CH3)-CH=CH2, (P)O-CH-CHaHb-CH-O(P)), 1.82 (dq, 
J = 14.7, 1.7 Hz, 0.5 H, Minor - (P)O-CH-CHaHb-CH-O(P)), 1.65 (dq, J = 14.6, 1.8 Hz, 
1H, Major - (P)O-CH-CHaHb-CH-O(P)), 1.12 (dd, J = 6.8, 1.5 Hz, 3H, (P)O-CH-
CH(CH3)-CH=CH2), 0.86 – 0.18 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 138.1 (CHB), 137.7 (CHA), 131.1 (2 x CHA,B), 128.7 
(CHA), 128.6 (CHB), 116.9 (CHB), 116.8 (CHA), 77.7 (d, JCP = 8.7 Hz, CHB), 77.5 (d, JCP 
= 8.7 Hz, CHA), 73.6 (d, JCP = 7.5 Hz, CHB), 73.49 (d, JCP = 7.6 Hz, CHA), 63.3 (d, JCP = 
8.1 Hz, 2 x CHA,B), 43.1 (d, JCP = 6.2 Hz, CHB), 42.2 (d, JCP = 6.0 Hz, CHA), 33.5 (d, JCP 
= 5.7 Hz, CHB), 32.6 (d, JCP = 5.8 Hz, CHA), 15.5 (CH3B), 15.2 (CH3A); 
31P NMR (162 MHz, CDCl3) δ 113.2 (short, broad, s); 
11B NMR (160 MHz, CDCl3) δ -42.78 (dq, J = 96.7, 95.4 Hz); 
HRMS cald for oxidized parent molecule C10H15O4PNa (M+Na)+ 253.0606; found 






borane (C11H20BO3P, 3.12.2) 
 
In a glovebox, under argon, CuCN (15.4 mg, 0.172 mmol) and LiCl (14.6 mg, 0.344 
mmol) were added to a pear-shaped flask equipped with a magnetic stirbar. The flask was 
capped with a rubber septum, removed from the glovebox, and equipped with an argon 
inlet. THF (0.2 mL) was added the flask, and the mix stirred at room temperature to 
dissolve all solids (~25 min). The flask was cooled to an external temperature of -30oC, 
and Et2Zn (0.18 mL, 1.0 M in hexanes) was added to the reaction mixture, drop-wise, 
slowly. The mix continued to stir at -30oC for 35 minutes to generate the active 
(diethyl)cyanocuprate. To the stirring cuprate solution was added 3.11.3 (18 mg, 0.049 
mmol) in THF (0.5 mL), drop-wise, slowly. The reaction stirred at -30oC for 2 hours 
(complete by TLC). The reaction was quenched at -30oC with saturated ammonium 
chloride (1 mL) and stirred while warming to 0oC over 1 hour (salt and pepper solids 
formed and the aqueous layer turned blue). The biphasic solution was filtered over celite 
and separated. The aqueous layer was extracted with EtOAc (3 x 2 mL), and the organic 
layers were combined, dried over sodium sulfate, filtered over celite, and concentrated 
under reduced pressure. The crude mixture was purified via flash chromatography (silica, 








yellow oil and 2:1 mixture of diastereomers (Note: A small amount of major 
diastereomer (dr ~ 10:1) for full characterization.) 
Yield: 55% (dr ~ 2:1, crude 1H, 13C) 
FTIR (neat): 2962, 2928, 2876, 2403, 1454, 1396, 1259, 1103, 1074, 1053, 1028, 995, 
955, 914, 876, 829, 797, 714, 652, 611, 584 cm-1; 
Optical Rotation: [α]D = –99.0 (c = 0.1, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.05 (dddd, J = 11.7, 6.7, 3.2, 2.0 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.68 (ddd, J = 17.2, 10.3, 9.2 Hz, 1H, -CH(CH2CH3)-CH=CH2), 
5.61 (ddd, J = 11.5, 4.0, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.20 (dd, J = 10.4, 
1.9 Hz, 1H, -CH(CH2CH3)-CH=CHaHb), 5.19 – 5.12 (m, 1H, (P)O-CH-CH=CH-CH2-
O(P)), 5.08 (ddd, J = 17.2, 1.9, 0.8 Hz, 1H, -CH(CH2CH3)-CH=CHaHb), 4.91 (dddt, J = 
14.7, 4.0, 3.2, 2.5 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.58 (dtd, J = 12.1, 3.2, 2.0 Hz, 1H, 
(P)OCH-CH(CH2CH3)-CH=CH2), 4.47 – 4.37 (m, 1H, (P)O-CHaHb-CH=CH-), 2.45 
(ddd, J = 14.7, 12.1, 6.1 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 2.01 (tt, J = 9.0, 3.9 Hz, 
1H, -CH(CH2CH3)-CH=CH2), 1.63 – 1.57 (m, 2H, (P)O-CH-CHaHb-CH-O(P), -
CH(CHaHbCH3)-CH=CH2), 1.53 – 1.41 (m, 1H, -CH(CHaHbCH3)-CH=CH2), 0.89 (t, J = 
7.4 Hz, 3H, -CH(CH2CH3)-CH=CH2), 0.83 – 0.14 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 136.3 (CH), 131.1 (CH), 128.6 (CH), 118.5 (CH2), 77.5 
(d, JCP = 8.7 Hz, CH), 72.5 (d, JCP = 7.6 Hz, CH), 63.3 (d, JCP = 8.1 Hz, CH2), 50.5 (d, 
JCP = 5.8 Hz, CH), 33.3 (d, JCP = 5.9 Hz, CH2), 23.2 (CH2), 11.6 (CH3); 
31P NMR (162 MHz, CDCl3) δ 113.7 (short, broad, s); 
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11B NMR (160 MHz, CDCl3) δ -42.80 (dq, J = 105.4, 101.9 Hz); 
HRMS cald for oxidized parent molecule C11H17O4PNa (M+Na)+ 267.0762; found 
267.0764 (TOF MS ES+). 
 
 (R,E)-4-((1S,6R,8R)-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-8-yl-1-borane)-1-
((tert-butyldiphenylsilyl)oxy)but-3-en-2-ol (C26H36BO5PSi, 3.13.1) 
 
To a stirring solution of (RP,R,R)-bicyclic phosphite-borane 3.9.5 (150 mg, 0.750 mmol) 
under argon was added dry methylene chloride (9.4 mL, degassed via 3 freeze-degas-
thaw cycles), (R)-1-((tert-butyldiphenylsilyl)oxy)but-3-en-2-ol8 (735 mg, 2.25 mmol), p-
benzoquinone (8.1 mg, 0.075 mmol), then Hoveyda-Grubbs second generation catalyst 
(14.1 mg, 0.0225 mmol, 3 mol %), and the reaction was heated to reflux. The reaction 
stirred at reflux for 3 hours, where additional Hoveyda-Grubbs second-generation 
catalyst (14.1 mg, 0.0225 mmol, 3 mol %) was added. The reaction continued to stir for 3 
hours (complete by TLC). The reaction was concentrated under reduced pressure, and the 
crude mixture was purified via flash chromatography (silica, 0%–70% EtOAc in hexanes) 
to provide title 3.13.1 (0.302 g, 0.607 mmol, 81% yield) as a white foam. 
                                                










FTIR (neat): 3558, 3433 (br), 3070, 2957, 2930, 2885, 2405, 1462, 1427, 1394, 1362, 
1259, 1221, 1113, 1047, 1028, 995, 947, 916, 880, 824, 785, 743, 704, 613, 503, 490  
cm-1; 
Optical Rotation: [α]D = –51.1 (c = 1.57, CHCl3); 
1H NMR (500 MHz, CDCl3) 7.69 – 7.63 (m, 4H, aromatic C-H x 4), 7.48 – 7.39 (m, 6H, 
aromatic C-H x 6), 6.07 (dddd, J = 11.7, 6.7, 3.2, 1.9 Hz, 1H, (P)O-CH-CH=CH-CH2-
O(P)), 5.86 – 5.75 (m, 2H, -CH=CH-CH(OH)-CH2OTBDPS), 5.63 (ddd, J = 11.6, 4.0, 
2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.16 (dtt, J = 15.9, 4.0, 2.0 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.05 – 4.97 (m, 1H, -CH2-(P)O-CH-CH=CH-CH(OH)-
CH2OTBDPS), 4.91 (ddq, J = 14.8, 3.8, 2.6 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.43 (ddd, J 
= 22.8, 14.8, 6.7 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.29 (dddd, J = 6.5, 3.7, 2.4, 1.2 Hz, 
1H, -CH=CH-CH(OH)-CH2OTBDPS), 3.73 (dd, J = 10.2, 3.7 Hz, 1H, -CH=CH-
CH(OH)-CHaHbOTBDPS), 3.53 (dd, J = 10.2, 7.4 Hz, 1H, -CH=CH-CH(OH)-
CHaHbOTBDPS), 2.59 (s, 1H, -CH=CH-CH(OH)-CH2OTBDPS), 2.35 (ddd, J = 14.7, 
12.0, 6.0 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.80 (dq, J = 14.7, 1.7 Hz, 1H, (P)O-CH-
CHaHb-CH-O(P)), 1.08 (s, 9H, -OSi(Ph)2-C(CH3)3), 0.52 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 135.5 (Aromatic CH x 2), 135.4 (Aromatic CH x 2) 
132.8 (Aromatic C), 132.7 (Aromatic C), 132.0 (CH), 130.7 (CH), 129.93 (Aromatic 
CH), 129.91 (Aromatic CH), 128.8 (CH), 128.6 (d, JCP = 7.2 Hz, CH), 127.8 (Aromatic 
CH x 4), 77.4 (d, JCP = 8.8 Hz, CH), 71.6 (CH), 70.0 (d, JCP = 6.9 Hz, CH), 67.3 (CH2), 
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63.3 (d, JCP = 7.9 Hz, CH2), 35.8 (d, JCP = 5.8 Hz, CH2), 26.8 (Si-C(CH3)3), 19.2 (Si-
C(CH3)3); 
31P NMR (162 MHz, CDCl3) δ 112.9 (short, d (br), J = 147.4 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.8 (dq, J = 99.8, 97.0 Hz); 
HRMS cald for oxidized parent molecule C26H33O6PSiNa (M+Na)+ 523.1682; found 
532.1686 (TOF MS ES+). 
 
(R,E)-4-((1R,6S,8S)-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-8-yl-1-borane)-1-
((tert-butyldiphenylsilyl)oxy)but-3-en-2-ol (C26H36BO5PSi, 3.13.2) 
 
To a stirring solution of (SP,S,S)-bicyclic phosphite-borane 3.9.5 (150 mg, 0.750 mmol) 
under argon was added dry methylene chloride (9.4 mL, degassed via 3 freeze-degas-
thaw cycles), (R)-1-((tert-butyldiphenylsilyl)oxy)but-3-en-2-ol8 (735 mg, 2.25 mmol), p-
benzoquinone (8.1 mg, 0.075 mmol), then Hoveyda-Grubbs second generation catalyst 
(14.1 mg, 0.0225 mmol, 3 mol %), and the reaction was heated to reflux. The reaction 
stirred at reflux for 3 hours, where additional Hoveyda-Grubbs second-generation 
catalyst (14.1 mg, 0.0225 mmol, 3 mol %) was added. The reaction continued to stir for 3 










crude mixture was purified via flash chromatography (silica, 0%–70% EtOAc in hexanes) 
to provide title 3.13.2 (0.268 g, 0.538 mmol, 72% yield) as a white foam. 
FTIR (neat): 3566, 3421 (br), 3070, 3013, 2940, 2858, 2405, 1460, 1427, 1394, 1362, 
1259, 1113, 1047, 1028, 995, 947, 916, 878, 824, 787, 743, 704, 613, 503 cm-1; 
Optical Rotation: [α]D = +65.2 (c = 1.42, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.68 – 7.64 (m, 4H, aromatic C-H x 4), 7.49 – 7.38 (m, 
6H, aromatic C-H x 6), 6.07 (dddd, J = 11.7, 6.7, 3.2, 2.0 Hz, 1H, (P)O-CH-CH=CH-
CH2-O(P)), 5.89 – 5.74 (m, 2H, -CH=CH-CH(OH)-CH2OTBDPS), 5.63 (ddd, J = 11.6, 
4.1, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.16 (dtt, J = 13.8, 4.0, 2.0 Hz, 1H, (P)O-
CH-CH=CH-CH2-O(P)), 5.01 (dqd, J = 10.3, 3.2, 2.2, 1.7 Hz, 1H, -CH2-(P)O-CH-
CH=CH-CH(OH)-CH2OTBDPS), 4.96 – 4.87 (m, 1H, (P)O-CHaHb-CH=CH-), 4.43 (ddd, 
J = 22.8, 14.8, 6.6 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.28 (dtd, J = 7.2, 3.8, 1.2 Hz, 1H, -
CH=CH-CH(OH)-CH2OTBDPS), 3.72 (dd, J = 10.2, 3.8 Hz, 1H, -CH=CH-CH(OH)-
CHaHbOTBDPS), 3.54 (dd, J = 10.2, 7.3 Hz, 1H, -CH=CH-CH(OH)-CHaHbOTBDPS), 
2.58 (s, 1H, -CH=CH-CH(OH)-CH2OTBDPS), 2.34 (ddd, J = 14.6, 12.0, 6.1 Hz, 1H, 
(P)O-CH-CHaHb-CH-O(P)), 1.79 (dq, J = 14.6, 1.8 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 
1.08 (s, 9H, -OSi(Ph)2-C(CH3)3), 0.86 – 0.18 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 135.52 (Aromatic CH x 2), 135.46 (Aromatic CH x 2), 
132.9 (Aromatic C), 132.7 (Aromatic C), 131.9 (CH), 130.7 (CH), 129.9 (Aromatic CH x 
2), 128.8 (CH), 128.4 (d, JCP = 7.2 Hz, CH), 127.8 (Aromatic CH x 4), 77.4 (d, JCP = 8.9 
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Hz, CH), 71.5 (CH), 69.9 (d, JCP = 6.9 Hz, CH), 67.3 (CH2), 63.3 (d, JCP = 8.0 Hz, CH2), 
35.8 (d, JCP = 5.8 Hz, CH2), 26.8 (Si-C(CH3)3), 19.2 (Si-C(CH3)3); 
31P NMR (162 MHz, CDCl3) δ 113.0 (short, d (br), J = 147.8 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.8 (dq, J = 99.1, 96.7 Hz); 
HRMS cald for oxidized parent molecule C26H33O6PSiNa (M+Na)+ 523.1682; found 
532.1675 (TOF MS ES+). 
 
(R,E)-4-((1S,6R,8R)-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-8-yl-1-borane)-1-
((tert-butyldiphenylsilyl)oxy)but-3-en-2-yl diethyl phosphate (C30H45BO8P2Si, 3.13.3) 
 
To a solution of 3.13.1 (17 mg, 0.034 mmol) in methylene chloride (dry, degassed, 0.4 
mL) was added N,N-diisopropyl(ethyl)amine (12 mL, 0.068 mmol) under argon, and the 
reaction flask was cooled to an external temperature of -30oC where 
diethylchlorophosphite (6 mL, 0.038 mmol) was added. The reaction was allowed to 
warm to 0 oC over 30 minutes (complete conversion by TLC), where tBuOOH (7.4 mL, 
5-6 M in decanes) was added. The reaction was allowed to warm to RT and continued to 
stir at room temperature for 2 hours (complete by TLC). Excess peroxide was quenched 
with solid sodium sulfite, and the heterogeneous mix stirred for 20 minutes to ensure a 










pressure, and purified via flash chromatography (silica, 0%–80% EtOAc in hexanes) to 
provide 3.13.3 (19.0 mg, 0.030 mmol, 88% yield) as a pale yellow, viscous oil. 
FTIR (neat): 2957, 2930, 2895, 2405, 1462, 1427, 1261, 1113, 1028, 995, 951, 916, 879, 
824, 789, 743, 704, 613, 505 cm-1; 
Optical Rotation: [α]D = –55.5 (c = 0.29, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.66 (dq, J = 6.5, 1.7 Hz, 4H, aromatic C-H x 4), 7.50 – 
7.36 (m, 6H, aromatic C-H x 6), 6.09 (dddd, J = 11.7, 6.7, 3.1, 1.9 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.91 (ddd, J = 15.5, 6.0, 1.0 Hz, 1H, -CH=CH-CH(O(PO(OEt)2))-
CH2OTBDPS), 5.85 (dd, J = 15.6, 5.0 Hz, 1H, -CH=CH-CH(O(PO(OEt)2))-
CH2OTBDPS), 5.63 (ddd, J = 11.5, 4.0, 2.5 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.16 
(dtt, J = 16.0, 3.9, 1.9 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.03 (dp, J = 11.3, 2.2 Hz, 
1H, -CH2-(P)O-CH-CH=CH-CH(O(PO(OEt)2))-CH2OTBDPS), 4.96 – 4.84 (m, 2H, 
(P)O-CHaHb-CH=CH-, -CH=CH-CH(O(PO(OEt)2))-CH2OTBDPS), 4.45 (ddd, J = 22.8, 
14.8, 6.6 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.15 – 4.02 (m, 4H, -P(O)(OCH2CH3)2), 3.81 
(dd, J = 10.8, 5.7 Hz, 1H, -CHaHbOTBDPS), 3.72 (ddd, J = 10.7, 5.2, 1.4 Hz, 1H, -
CHaHbOTBDPS), 2.32 (ddd, J = 14.7, 12.0, 6.0 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.79 
(dq, J = 14.6, 1.7 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.29 (dtd, J = 9.1, 7.1, 1.1 Hz, 6H, 
-P(O)(OCH2CH3)2), 1.06 (s, 9H, -OSi(Ph)2-C(CH3)3), 0.53 (d, J = 122.6 Hz, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 135.6 (Aromatic CH x 2), 135.5 (Aromatic CH x 2), 
133.0 (Aromatic C), 132.9 (Aromatic C), 130.72 (d, JCP = 7.2 Hz, CH), 130.65 (CH), 
129.84 (Aromatic CH), 129.81 (Aromatic CH), 129.3 (d, JCP = 3.4 Hz, CH), 128.9 (CH), 
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127.76 (Aromatic CH x 2), 127.75 (Aromatic CH x 2), 77.9 (d, JCP = 5.7 Hz, CH), 77.4 
(d, JCP = 9.6 Hz, CH), 69.5 (d, JCP = 7.0 Hz, CH), 65.9 (d, JCP = 7.2 Hz, CH2), 63.84 (d, 
JCP = 5.5 Hz, P(O)(OCH2CH3)), 63.77 (d, JCP = 5.5 Hz, P(O)(OCH2CH3)), 63.4 (d, JCP = 
8.0 Hz, CH2), 35.6 (d, JCP = 5.8 Hz, CH2), 26.7 (Si-C(CH3)3), 19.2 (Si-C(CH3)3), 16.1 (d, 
JCP = 2.3 Hz, P(O)(OCH2CH3)), 16.1 (d, JCP = 2.5 Hz, P(O)(OCH2CH3)); 
31P NMR (162 MHz, CDCl3) δ 113.2 (short, d (br), J = 172.9 Hz), -1.81 (q, J = 7.8 Hz); 
11B NMR (160 MHz, CDCl3) δ -42.8 (dq, J = 91.6, 90.1 Hz); 
HRMS cald for phosphite fragment of parent molecule C30H42O8P2SiNa (M+Na)+ 
643.2022; found 643.2016 (TOF MS ES+). 
 
(R,E)-4-((1R,6S,8S)-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-8-yl-1-borane)-1-
((tert-butyldiphenylsilyl)oxy)but-3-en-2-yl diethyl phosphate (C30H45BO8P2Si, 3.13.4) 
 
To a solution of 3.13.2 (77 mg, 0.155 mmol) in methylene chloride (dry, degassed, 1.5 
mL) was added N,N-diisopropyl(ethyl)amine (65 mL, 0.372 mmol) under argon, and the 
reaction flask was cooled to an external temperature of -30oC where 
diethylchlorophosphite (27 mL, 0.186 mmol) was added. The reaction was allowed to 
warm to 0 oC over 30 minutes (complete conversion by TLC), where tBuOOH (37 mL, 5-










stir at room temperature for 2 hours (complete by TLC). Excess peroxide was quenched 
with solid sodium sulfite, and the heterogeneous mix stirred for 30 minutes to ensure a 
complete quench. The reaction was filtered over cotton, concentrated under reduced 
pressure, and purified via flash chromatography (silica, 0%–80% EtOAc in hexanes) to 
provide 3.13.4 (80.7 mg, 0.127 mmol, 82% yield) as a pale yellow, viscous oil. 
FTIR (neat): 2980, 2957, 2930, 2405, 1472, 1427, 1393, 1362, 1263, 1113, 1028, 995, 
952, 916, 879, 822, 788, 741, 704, 613, 505 cm-1; 
Optical Rotation: [α]D = +48.7 (c = 0.59, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.66 (dt, J = 8.1, 1.7 Hz, 4H, aromatic C-H x 4), 7.49 – 
7.36 (m, 6H, aromatic C-H x 6), 6.08 (dddd, J = 9.6, 6.6, 3.1, 2.0 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.91 (dd, J = 15.7, 5.9 Hz, 1H, -CH=CH-CH(O(PO(OEt)2))-
CH2OTBDPS), 5.85 (dd, J = 15.6, 4.8 Hz, 1H, -CH=CH-CH(O(PO(OEt)2))-
CH2OTBDPS), 5.63 (ddd, J = 11.6, 4.0, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.17 
(dtd, J = 17.3, 4.0, 1.9 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.02 (ddd, J = 14.2, 4.8, 
2.2 Hz, 1H, -CH2-(P)O-CH-CH=CH-CH(O(PO(OEt)2))-CH2OTBDPS), 4.96 – 4.85 (m, 
2H, -(P)O-CHaHb-CH=CH-, -CH=CH-CH(O(PO(OEt)2))-CH2OTBDPS), 4.45 (ddd, J = 
22.8, 14.8, 6.7 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.17 – 4.00 (m, 4H, -P(O)(OCH2CH3)2), 
3.82 (dd, J = 10.7, 5.8 Hz, 1H, -CHaHbOTBDPS), 3.70 (ddd, J = 10.7, 5.2, 1.4 Hz, 1H, -
CHaHbOTBDPS), 2.33 (ddd, J = 14.6, 12.0, 6.0 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.79 
(dq, J = 14.6, 1.8 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.30 (dtd, J = 15.5, 7.1, 1.0 Hz, 
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6H, -P(O)(OCH2CH3)2), 1.06 (s, 9H, -OSi(Ph)2-C(CH3)3), 0.54 (d, J = 133.8 Hz, 3H, -
BH3); 
13C NMR (126 MHz, CDCl3) δ 135.57 (Aromatic CH x 2), 135.53 (Aromatic CH x 2), 
132.97 (Aromatic C), 132.93 (Aromatic C), 130.7 (CH), 130.5 (d, JCP = 7.2 Hz, CH), 
129.83 (Aromatic CH), 129.81 (Aromatic CH), 129.2 (d, JCP = 3.5 Hz, CH), 128.9 (CH), 
127.75 (Aromatic CH x 2), 127.74 (Aromatic CH x 2), 77.7 (d, JCP = 5.5 Hz, CH), 77.3 
(d, JCP = 9.3 Hz, CH), 69.5 (d, JCP = 7.0 Hz, CH), 65.9 (d, JCP = 7.1 Hz, CH2), 63.83 (d, 
JCP = 5.5 Hz, P(O)(OCH2CH3)), 63.79 (d, JCP = 5.6 Hz, P(O)(OCH2CH3)), 63.4 (d, JCP = 
8.0 Hz, CH2), 35.7 (d, JCP = 5.8 Hz, CH2), 26.7 (Si-C(CH3)3), 19.2 (Si-C(CH3)3), 16.13 
(d, JCP = 7.4 Hz, P(O)(OCH2CH3)), 16.07 (d, JCP = 7.5 Hz, P(O)(OCH2CH3)); 
31P NMR (162 MHz, CDCl3) δ 113.1 (short, d (br), J = 125.9 Hz), -1.77 (q, J = 7.8 Hz); 
11B NMR (160 MHz, CDCl3) δ  -42.8 (dq, J = 94.0, 92.4 Hz); 
HRMS cald for C30H45BO8P2SiNa (M+Na)+ 657.2350; found 643.2344 (TOF MS ES+). 
 
(1R,6S,8S)-8-((R,E)-5-((tert-butyldiphenylsilyl)oxy)pent-3-en-2-yl)-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-ene 1-borane (C27H38BO4PSi, 3.14.1) 
 
In a glovebox, under argon, CuCN (12.0 mg, 0.137 mmol) and LiCl (12.0 mg, 0.274 










capped with a rubber septum, removed from the glovebox, and equipped with an argon 
inlet. THF (0.27 mL) was added the flask, and the mix stirred at room temperature to 
dissolve all solids (~25 min). The flask was cooled to an external temperature of -30oC, 
and Me2Zn (0.14 mL, 1.0 M in hexanes) was added to the reaction mixture, drop-wise, 
slowly. The mix continued to stir at -30oC for 1 hour to generate the active 
(dimethyl)cyanocuprate. The flask was then cooled to -40oC, where 3.13.2 (29.0 mg, 
0.046 mmol) in THF (0.46 mL) was added, drop-wise, slowly. The reaction stirred while 
warming from -40oC to -10oC over 1 hour (complete by TLC). The reaction was 
quenched at -10oC with saturated ammonium chloride (1 mL) and stirred while warming 
to +10oC over 1 hour (salt and pepper solids formed and the aqueous layer turned blue). 
The biphasic solution was filtered over celite and separated. The aqueous layer was 
extracted with EtOAc (3 x 2 mL), and the organic layers were combined, dried over 
sodium sulfate, filtered over celite, and concentrated under reduced pressure. The crude 
mixture was purified via flash chromatography (silica, 0%–40% EtOAc in hexanes) to 
provide 3.14.1 (18.3 mg, 0.0369 mmol, 81% yield) as a colorless, viscous oil. 
FTIR (neat): 3070, 2961, 2930, 2857, 2405, 1472, 1460, 1427, 1381, 1360, 1259, 1111, 
1047, 1024, 995, 986, 957, 912, 874, 824, 785, 704, 663, 611, 505 cm-1; 
Optical Rotation: [α]D = +60.4 (c = 0.75, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.69 (dq, J = 6.6, 1.7 Hz, 4H, Aromatic C-H x 4), 7.49 – 
7.35 (m, 6H, Aromatic C-H x 6), 6.04 (dddd, J = 11.7, 6.7, 3.2, 1.9 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.65 – 5.60 (m, 2H, -CH(CH3)-CH=CH-CH2-OTBDPS), 5.58 (ddd, 
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J = 11.6, 4.0, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.13 (dtt, J = 15.9, 3.9, 1.9 Hz, 
1H, (P)O-CH-CH=CH-CH2-O(P)), 4.91 (ddq, J = 14.7, 3.9, 2.6 Hz, 1H, (P)O-CHaHb-
CH=CH-), 4.50 – 4.35 (m, 2H, -(P)O-CHaHb-CH=CH-, -CH2-(P)OCH-CH(CH3)-
CH=CH-CH2-OTBDPS), 4.25 – 4.17 (m, 2H, -CH=CH-CH2-OTBDPS), 2.45 – 2.36 (m, 
1H, -CH(CH3)-CH=CH-CH2-OTBDPS), 2.27 (ddd, J = 14.7, 12.1, 6.1 Hz, 1H, (P)O-CH-
CHaHb-CH-O(P)), 1.55 (dq, J = 14.6, 1.8 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.09 (d, J 
= 7.1 Hz, 3H, -CH(CH3)-CH=CH-CH2-OTBDPS), 1.07 (s, 9H, -OSi(Ph)2-C(CH3)3), 0.89 
– 0.14 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 135.53 (2 x aromatic CH), 135.52 (2 x aromatic CH), 
133.71 (aromatic C), 133.67 (aromatic C), 131.2 (CH), 131.1 (CH), 129.64 (2 x aromatic 
CH), 129.59 (CH), 128.6 (CH), 127.64 (2 x aromatic CH), 127.63 (2 x CH), 77.5 (d, JCP 
= 8.7 Hz, CH), 73.6 (d, JCP = 7.6 Hz, CH), 64.2 (CH2), 63.3 (d, JCP = 8.0 Hz, CH2), 40.8 
(d, JCP = 6.0 Hz, CH), 32.5 (d, JCP = 5.8 Hz, CH2), 26.8 (Si-C(CH3)3), 19.2 (Si-C(CH3)3), 
15.4 (CH3); 
31P NMR (162 MHz, CDCl3) δ 113.4 (short, broad, s); 
11B NMR (160 MHz, CDCl3) δ -42.4 (dq, J = 97.3, 95.6 Hz); 
HRMS cald for oxidized parent molecule C27H35O5PSiNa (M+Na)+ 521.1889; found 





phosphabicyclo[4.3.1]dec-4-ene 1-borane (C27H38BO4PSi, 3.14.2) 
 
In a glovebox, under argon, CuCN (85.0 mg, 0.946 mmol) and LiCl (80.0 mg, 1.89 
mmol) were added to a pear-shaped flask equipped with a magnetic stirbar. The flask was 
capped with a rubber septum, removed from the glovebox, and equipped with an argon 
inlet. THF (1.9 mL) was added the flask, and the mix stirred at room temperature to 
dissolve all solids (~25 min). The flask was cooled to an external temperature of -30oC, 
and Me2Zn (0.95 mL, 1.0 M in hexanes) was added to the reaction mixture, drop-wise, 
slowly. The mix continued to stir at -30oC for 1 hour to generate the active 
(dimethyl)cyanocuprate. The flask was then cooled to -40oC, where 3.13.1 (150 mg, 
0.236 mmol) in THF (2.4 mL) was added, drop-wise, slowly. The reaction stirred while 
warming from -40oC to 0oC over 1 hour (complete by TLC). The reaction was quenched 
at 0oC with saturated ammonium chloride (2 mL) and stirred while warming to +10oC 
over 1 hour (salt and pepper solids formed and the aqueous layer turned blue). The 
biphasic solution was filtered over celite and separated. The aqueous layer was extracted 
with EtOAc (3 x 2 mL), and the organic layers were combined, dried over sodium sulfate, 









purified via flash chromatography (silica, 0%–40% EtOAc in hexanes) to provide 3.14.2 
(64.3 mg, 0.140 mmol, 59% yield) as a colorless, viscous oil. 
FTIR (neat): 3070, 2961, 2930, 2885, 2405, 1470, 1462, 1427, 1261, 1111, 1095, 1074, 
1024, 9995, 957, 912, 872, 825, 739, 704, 611, 505 cm-1; 
Optical Rotation: [α]D = –69.2 (c = 0.24, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.67 (dq, J = 6.8, 1.4 Hz, 4H, aromatic C-H x 4), 7.49 – 
7.32 (m, 6H, aromatic C-H x 6), 6.04 (dddd, J = 11.7, 6.7, 3.2, 2.0 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.64 (dtd, J = 15.4, 4.9, 0.9 Hz, 1H, -CH(CH3)-CH=CH-CH2-
OTBDPS), 5.55 (ddd, J = 11.6, 4.0, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.48 (ddt, 
J = 15.4, 8.3, 1.6 Hz, 1H, -CH(CH3)-CH=CH-CH2-OTBDPS), 5.11 (dtt, J = 15.7, 3.9, 1.9 
Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 4.90 (ddq, J = 14.7, 3.9, 2.7 Hz, 1H, (P)O-CHaHb-
CH=CH-), 4.42 (ddd, J = 22.7, 14.8, 6.7 Hz, 1H, -(P)O-CHaHb-CH=CH-), 4.31 – 4.21 
(m, 1H, -CH2-(P)OCH-CH(CH3)-CH=CH-CH2-OTBDPS), 4.21 – 4.15 (m, 2H, -CH=CH-
CH2-OTBDPS), 2.40 (ddd, J = 14.6, 14.6, 7.1 Hz, 1H, -CH(CH3)-CH=CH-CH2-
OTBDPS), 2.17 (ddd, J = 14.7, 12.0, 6.1 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.72 (dq, J 
= 14.6, 1.8 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.08 (d, J = 6.7 Hz, 3H, -CH(CH3)-
CH=CH-CH2-OTBDPS), 1.06 (s, 9H, -OSi(Ph)2-C(CH3)3), 0.91 – 0.16 (m, 3H, -BH3); 
13C NMR (126 MHz, CDCl3) δ 135.5 (Aromatic CH x 4), 133.7 (Aromatic C), 133.6 
(Aromatic C), 131.3 (CH), 131.0 (CH), 130.0 (CH), 129.69 (Aromatic CH), 129.67 
(Aromatic CH), 128.6 (CH), 127.6 (Aromatic CH x 4), 77.7 (d, JCP = 8.8 Hz, CH), 73.8 
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(d, JCP = 7.6 Hz, CH), 64.2 (CH2), 63.3 (d, JCP = 8.1 Hz, CH2), 41.7 (d, JCP = 6.3 Hz, 
CH), 33.6 (d, JCP = 5.9 Hz, CH2), 26.8 (Si-C(CH3)3), 19.2 (Si-C(CH3)3), 15.9 (CH3); 
31P NMR (162 MHz, CDCl3) δ 113.2 (short, broad, s); 
11B NMR (160 MHz, CDCl3) δ -42.8 (dq, J = 97.6, 84.4 Hz); 
HRMS cald for oxidized parent molecule C27H35O5PSiNa (M+Na)+ 521.1889; found 
521.1874 (TOF MS ES+). 
 
(1S,6R,8R)-8-((R,E)-5-((tert-butyldiphenylsilyl)oxy)pent-3-en-2-yl)-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-ene 1-oxide (C27H35O5PSi, 3.14.3) 
 
To 3.14.2 (64.0 mg, 0.129 mmol) in a round bottom flask equipped with a reflux 
condenser and magnetic stirbar, under argon, was added dry, degassed toluene (1.6 mL) 
and 1,4-diazabicyclo[2.2.2]octane [DABCO] (15.0 mg, 0.129 mmol). The reaction was 
heated to 60 oC and stirred for 2 hours (phosphite formation was complete by TLC). The 
reaction was cooled to room temperature, where tBuOOH (26 mL, 5-6 M in decanes) was 
added in one portion via automatic micropipette and the reaction stirred at room 
temperature open to air for 1 hour (complete by TLC, The reaction was subsequently 
quenched with solid sodium sulfite, allowed to stir at room temperature to ensure 









pressure. The crude mix was purified via flash chromatography (silica, 0%–100% EtOAc 
in hexanes) to provide the corresponding bicyclic phosphate 3.14.3 (63.5 mg, 0.127 
mmol, 99% yield) as a colorless, viscous oil. 
FTIR (neat): 3070, 2961, 2930, 2856, 1462, 1427, 1302, 1261, 1111, 1078, 976, 922, 
879, 824, 743, 704, 609, 505 cm-1; 
Optical Rotation: [α]D = –45.8 (c = 0.53, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.73 – 7.63 (m, 4H, Aromatic C-H x 4), 7.52 – 7.35 (m, 
6H, Aromatic C-H x 6), 6.02 (dddd, J = 12.0, 6.8, 3.1, 2.1 Hz, 1H, (P)O-CH-CH=CH-
CH2-O(P)), 5.65 (dtd, J = 15.4, 4.9, 0.9 Hz, 1H, -CH(CH3)-CH=CH-CH2-OTBDPS), 5.57 
– 5.44 (m, 2H, -CH(CH3)-CH=CH-CH2-OTBDPS, (P)O-CH-CH=CH-CH2-O(P)), 5.15 
(dddd, J = 24.6, 6.3, 4.3, 2.0 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.00 (ddq, J = 14.9, 
5.6, 2.7 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.42 – 4.33 (m, 1H, (P)O-CHaHb-CH=CH-), 
4.32 – 4.27 (m, 1H, -CH2-(P)OCH-CH(CH3)-CH=CH-CH2-OTBDPS), 4.19 (ddd, J = 5.3, 
3.8, 1.6 Hz, 2H, -CH=CH-CH2-OTBDPS), 2.44 (h, J = 7.2 Hz, 1H, -CH(CH3)-CH=CH-
CH2-OTBDPS), 2.13 – 1.99 (m, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.75 – 1.66 (m, 1H, 
(P)O-CH-CHaHb-CH-O(P)), 1.10 (d, J = 6.7 Hz, 3H, -CH(CH3)-CH=CH-CH2-OTBDPS), 
1.06 (s, 9H, -OSi(Ph)2-C(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 135.49 (2 x aromatic CH), 135.49 (2 x aromatic CH), 
133.66 (aromatic C), 133.59 (aromatic C), 131.2 (CH), 130.2 (CH), 129.9 (CH), 129.69 
(CH), 129.67 (CH), 127.9 (CH), 127.63 (4 x aromatic CH), 79.8 (d, JCP = 7.3 Hz, CH), 
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77.2 (d, JCP = 7.2 Hz, CH), 64.2 (CH2), 63.0 (d, JCP = 6.4 Hz, CH2), 41.9 (d, JCP = 9.3 Hz, 
CH), 32.8 (d, JCP = 5.6 Hz, CH2), 26.8 (Si-C(CH3)3), 19.2 (Si-C(CH3)3), 15.9 (CH3); 
31P NMR (162 MHz, CDCl3) δ -3.66 (td, J = 26.8, 25.1, 5.5 Hz); 
HRMS cald for C27H35O5PSiNa (M+Na)+ 521.1889; found 521.1888 (TOF MS ES+). 
 
(1R,6S,8S)-8-((R,E)-5-((tert-butyldiphenylsilyl)oxy)pent-3-en-2-yl)-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-ene 1-oxide (C27H35O5PSi, 3.14.6-SI) 
 
To 3.14.1 (54.0 mg, 0.109 mmol) in a round bottom flask equipped with a reflux 
condenser and magnetic stirbar, under argon, was added dry, degassed toluene (1.4 mL) 
and 1,4-diazabicyclo[2.2.2]octane [DABCO] (13.0 mg, 0.109 mmol). The reaction was 
heated to 60 oC and stirred for 2 hours (phosphite formation was complete by TLC). The 
reaction was cooled to room temperature, where tBuOOH (22 mL, 5-6M in decanes) was 
added in one portion via automatic micropipette and the reaction stirred at room 
temperature open to air for 1 hour (complete by TLC, The reaction was subsequently 
quenched with solid sodium sulfite, allowed to stir at room temperature to ensure 
consumption of excess peroxide, filtered over celite, and concentrated under reduced 
pressure. The crude mix was purified via flash chromatography (silica, 0%–100% EtOAc 
in hexanes) to provide the corresponding bicyclic phosphate 3.14.6-SI (53.3 mg, 0.106 










FTIR (neat): 3069, 3045, 2961, 2930, 2856, 2889, 1470, 1427, 1302, 1259, 1102, 1070, 
986, 974, 918, 879, 824, 771, 742, 704, 609, 505 cm-1; 
Optical Rotation: [α]D = +36.3 (c = 0.14, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.73 – 7.63 (m, 4H, Aromatic C-H x 4), 7.47 – 7.36 (m, 
6H, Aromatic C-H x 6), 6.03 (dddd, J = 11.9, 6.7, 3.2, 2.1 Hz, 1H, (P)O-CH-CH=CH-
CH2-O(P)), 5.62 (dd, J = 4.7, 2.9 Hz, 2H, -CH(CH3)-CH=CH-CH2-OTBDPS), 5.55 (ddd, 
J = 11.8, 3.9, 2.5 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.16 (dddd, J = 24.4, 6.2, 4.0, 
1.8 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.00 (ddq, J = 14.8, 5.6, 2.7 Hz, 1H, (P)O-
CHaHb-CH=CH-), 4.48 (ddt, J = 12.1, 3.8, 1.7 Hz, 1H, -CH2-(P)OCH-CH(CH3)-CH=CH-
CH2-OTBDPS), 4.37 (ddd, J = 27.7, 14.7, 6.7 Hz, 1H, (P)O-CHaHb-CH=CH-), 4.23 – 
4.16 (m, 2H, -CH=CH-CH2-OTBDPS), 2.43 (dtd, J = 6.9, 4.5, 2.4 Hz, 1H, -CH(CH3)-
CH=CH-CH2-OTBDPS), 2.15 (ddd, J = 14.6, 12.0, 6.3 Hz, 1H, (P)O-CH-CHaHb-CH-
O(P)), 1.57 – 1.49 (m, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.10 (d, J = 6.9 Hz, 3H, -
CH(CH3)-CH=CH-CH2-OTBDPS), 1.06 (s, 9H, -OSi(Ph)2-C(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 135.5 (aromatic CH x 4), 133.70 (aromatic C), 133.66 
(aromatic C), 131.4 (CH), 129.9 (CH), 129.8 (CH), 129.7 (aromatic CH x 2), 127.9 (CH), 
127.64 (aromatic CH x 2), 127.63 (aromatic CH x 2), 79.4 (d, JCP = 7.0 Hz, CH), 77.1 
(CH), 64.3 (CH2), 63.0 (d, JCP = 6.4 Hz, CH2), 40.9 (d, JCP = 8.8 Hz, CH), 31.7 (d, JCP = 
5.7 Hz, CH2), 26.8 (Si-C(CH3)3), 19.2 (Si-C(CH3)3), 15.5 (CH3); 
31P NMR (162 MHz, CDCl3) δ -3.50 (t, J = 26.1 Hz); 




2-methoxy-1,3,2-dioxaphosphinane 2-oxide (C29H41O5PSi, 3.14.7-SI) 
 
In a glovebox, under argon, CuCN (28.0 mg, 0.311 mmol) and LiCl (26.0 mg, 0.622 
mmol) were added to a pear-shaped flask equipped with a magnetic stirbar. The flask was 
capped with a rubber septum, removed from the glovebox, and equipped with an argon 
inlet. THF (0.62 mL) was added the flask, and the mix stirred at room temperature to 
dissolve all solids (~25 min). The flask was cooled to an external temperature of -30oC, 
and Me2Zn (0.31 mL, 1.0 M in hexanes) was added to the reaction mixture, drop-wise, 
slowly. The mix continued to stir at -30oC for 1 hour to generate the active 
(dimethyl)cyanocuprate. The flask was then cooled to -40oC, where 3.14.3 (31 mg, 0.062 
mmol) in THF (0.31 mL) was added, drop-wise, slowly. The reaction was removed from 
the cooling bath and allowed to warm to room temperature, where it stirred for 2 hours 
(complete by TLC). The reaction was quenched with saturated NH4Cl (aq, 1 mL), diluted 
with EtOAc (3 mL), and vigorously stirred, open to air, for 1 hour. The reaction mixture 
was filtered over celite, dried over sodium sulfate, filtered over celite, and concentrated 
under reduced pressure. The crude material was taken up in MeOH (0.6 mL), and TMS-
diazomethane (124 mL, 2.0 M in diethyl ether) was added dropwise, slowly, at room 
temperature. (Note: when added too quickly, the TMS-diazomethane will cause the 









cooled to 0oC to control the fluctuation of temperature and decrease the sensitivity of the 
reaction to the rate of addition of TMS-diazomethane.) The reaction stirred for 12 H, 
where another 4 equivalents of TMS-diazomethane (124 mL, 2.0 M in diethyl ether) was 
added, and the reaction stirred for 1 hour at room temperature (complete by TLC). Excess 
TMS-diazomethane was quenched with 3 drops of glacial acetic acid, and the reaction 
was diluted with EtOAc (3 mL) and stirred at room temperature for 10 minutes (Note: 
complete quench is accompanied by a color change—from deep yellow to colorless). The 
mix was then dried over Na2SO4, filtered over celite (pipette filter), and concentrated 
under reduced pressure. The crude mix was separated by flash chromatography (silica, 0-
100% EtOAc in hexanes) and title compound 3.14.7-SI (18.0 mg, 0.0341 mmol, 55% 
yield) was isolated as a colorless oil and an inseparable mixture of diastereomers at the 
chiral phosphorus (dr ~ 1:1). 
FTIR (neat): 2961, 2932, 1462, 1427, 1379, 1288, 1111, 1030, 972, 924, 856, 822, 741, 
702, 611, 504 cm-1; 
Optical Rotation: [α]D = –4.2 (c = 0.85, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.66 (dq, J = 8.2, 1.7 Hz, 8H), 7.46 – 7.36 (m, 12H), 5.85 
– 5.73 (m, 2H), 5.63 (ddtd, J = 15.4, 13.7, 4.7, 0.8 Hz, 2H), 5.51 (ddt, J = 15.3, 8.5, 1.7 
Hz, 1H), 5.43 (ddt, J = 15.3, 8.7, 1.7 Hz, 1H), 5.13 – 5.05 (m, 4H), 4.41 (tdd, J = 8.0, 6.2, 
4.5 Hz, 1H), 4.28 (ddt, J = 10.0, 5.1, 3.1 Hz, 1H), 4.24 – 4.08 (m, 6H), 3.81 (d, J = 4.7 
Hz, 3H), 3.79 (d, J = 4.8 Hz, 3H), 2.65 (tt, J = 12.8, 4.6 Hz, 1H), 2.58 (ddt, J = 15.2, 8.6, 
6.8 Hz, 1H), 2.54 – 2.45 (m, 1H), 2.43 – 2.34 (m, 1H), 2.04 – 1.95 (m, 2H), 1.91 (dddd, J 
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= 14.8, 6.4, 4.5, 1.7 Hz, 1H), 1.87 – 1.80 (m, 1H), 1.15 (dd, J = 6.6, 5.5 Hz, 6H), 1.09 – 
1.01 (m, 24H); 
13C NMR (126 MHz, CDCl3) δ 138.3, 137.8, 135.5 (2 x 4 aromatic CH), 133.54 (2 x 
aromatic C), 133.52, 133.51, 131.22, 131.21, 130.5, 130.2, 129.72 (2 x aromatic CH), 
129.69 (2 x aromatic CH), 127.7 (2 x 4 aromatic CH), 116.7, 116.4, 81.9 (d, JCP = 7.0 
Hz), 80.3 (d, JCP = 6.8 Hz), 80.0 (d, JCP = 6.3 Hz), 78.9 (d, JCP = 6.8 Hz), 63.95, 63.92, 
54.36 (dd, JCP = 6.0, 2.2 Hz), 54.04 (d, JCP = 5.8 Hz), 42.5 (d, JCP = 7.8 Hz), 41.8 (d, JCP 
= 5.5 Hz), 41.5 (d, JCP = 6.3 Hz), 40.5 (d, JCP = 2.8 Hz), 30.2 (d, JCP = 6.3 Hz), 30.0 (d, 
JCP = 6.1 Hz), 26.8 (2 x Si-C(CH3)3), 19.2 (2 x Si-C(CH3)3), 17.2, 16.7, 15.9, 15.5; 
31P NMR (162 MHz, CDCl3) δ -4.48 (q, J = 9.6 Hz), -4.67 – -5.10 (m); 
31P NMR-{1H} (162 MHz, CDCl3) δ -4.48, -4.89; 





2-methoxy-1,3,2-dioxaphosphinane 2-oxide (C29H41O5PSi, 3.14.8-SI) 
 
In a glovebox, under argon, CuCN (40.0 mg, 0.441 mmol) and LiCl (37.0 mg, 0.882 
mmol) were added to a pear-shaped flask equipped with a magnetic stirbar. The flask was 
capped with a rubber septum, removed from the glovebox, and equipped with an argon 
inlet. THF (0.88 mL) was added the flask, and the mix stirred at room temperature to 
dissolve all solids (~25 min). The flask was cooled to an external temperature of -30oC, 
and Me2Zn (0.44 mL, 1.0 M in hexanes) was added to the reaction mixture, drop-wise, 
slowly. The mix continued to stir at -30oC for 1 hour to generate the active 
(dimethyl)cyanocuprate. The flask was then cooled to -40oC, where 3.14.6-SI (44 mg, 
0.0882 mmol) in THF (0.88 mL) was added, drop-wise, slowly. The reaction was 
removed from the cooling bath and allowed to warm to room temperature, where it 
stirred for 2 hours (complete by TLC). The reaction was quenched with saturated NH4Cl 
(aq, 1 mL), diluted with EtOAc (1 mL), and stirred open to air for 1 hour. The reaction 
mixture was filtered over celite, dried over sodium sulfate, filtered over celite, and 
concentrated under reduced pressure. The crude material was taken up in MeOH (0.9 
mL), and TMS-diazomethane (180 mL, 2.0 M in diethyl ether) was added dropwise, 
slowly, at room temperature. (Note: when added too quickly, the TMS-diazomethane will 









can be cooled to 0oC to control the fluctuation of temperature and decrease the sensitivity 
of the reaction to the rate of addition of TMS-diazomethane.) The reaction stirred for 12 
hours, where another 4 equivalents of TMS-diazomethane (180 mL, 2.0 M in diethyl 
ether) was added, and the reaction stirred for 1 hour at room temperature (complete by 
TLC). Excess TMS-diazomethane was quenched with 3 drops of glacial acetic acid, and 
the reaction was diluted with EtOAc (2 mL) and stirred at room temperature for 10 
minutes (Note: complete quench is accompanied by a color change—from deep yellow to 
colorless). The mix was then dried over Na2SO4, filtered over celite (pipette filter), and 
concentrated under reduced pressure. The crude mix was separated by flash 
chromatography (silica, 0-100% EtOAc in hexanes) and title compound 3.14.8-SI (26.0 
mg, 0.0492 mmol, 56% yield) was isolated as a colorless oil and an inseparable mixture 
of diastereomers at the chiral phosphorus (dr ~ 1:1). 
FTIR (neat): 2961, 2930, 1454, 1427, 1288, 1186, 1113, 1086, 1024, 972, 924, 852, 824, 
743, 704, 613, 505 cm-1; 
Optical Rotation: [α]D = +25.7 (c = 0.74, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.71 – 7.65 (m, 8H), 7.47 – 7.36 (m, 12H), 5.82 (dddd, J 
= 17.0, 10.5, 9.1, 7.7 Hz, 2H), 5.73 – 5.59 (m, 4H), 5.16 – 5.07 (m, 4H), 4.36 (ttd, J = 
9.9, 6.4, 5.3 Hz, 2H), 4.30 – 4.23 (m, 2H), 4.20 (dt, J = 3.2, 1.4 Hz, 4H), 3.78 (d, J = 11.2 
Hz, 3H), 3.76 (d, J = 11.3 Hz, 3H), 2.59 – 2.52 (m, 2H), 2.50 – 2.43 (m, 2H), 2.02 – 1.83 
(m, 4H), 1.12 – 1.00 (m, 30H); 
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13C NMR (126 MHz, CDCl3) δ 138.5, 137.9 (2 x 4 aromatic CH), 135.5, 133.66, 133.61 
(3 x aromatic C), 131.2, 130.8, 130.3, 129.8, 129.6 (4 x aromatic CH), 127.6 (2 x 4 
aromatic CH), 116.7, 116.3, 80.55 (d, JCP = 6.5 Hz), 80.47 (d, JCP = 6.5 Hz), 79.3 (d, JCP 
= 4.8 Hz), 79.2 (d, JCP = 4.6 Hz), 64.3, 64.2, 54.27 (d, JCP = 2.8 Hz), 54.23 (d, JCP = 2.7 
Hz), 42.5 (d, JCP = 7.8 Hz), 41.5 (d, JCP = 5.3 Hz), 41.2 (d, JCP = 8.2 Hz), 40.3 (d, JCP = 
5.4 Hz), 30.0 (d, JCP = 5.7 Hz), 29.9 (d, JCP = 5.4 Hz), 26.81 (Si-C(CH3)3), 26.78 (Si-
C(CH3)3), 19.2 (2 x Si-C(CH3)3), 16.4, 16.0, 15.7, 15.5; 
31P NMR (162 MHz, CDCl3) δ  -3.28 – -4.00 (m); 
31P NMR-{1H} (162 MHz, CDCl3) δ -3.50, -3.67; 
HRMS cald for C29H41O5PSiNa (M+Na)+ 551.2359; found 551.2364  (TOF MS ES+). 
 
(3S,4R,6R,7R,E)-10-((tert-butyldiphenylsilyl)oxy)-3,7-dimethyldeca-1,8-diene-4,6-
diol (C28H40O3Si, 3.14.4) 
 
To a stirring solution of 3.14.7-SI (24 mg, 0.045 mmol) in THF (0.5 mL) under argon 
was added LiAlH4 (4.7 mg, 0.12 mmol) in one portion at 0 oC. The reaction stirred at 0 
oC for 1 hour (complete by TLC), at which point the reaction was diluted with EtOAc (~1 
mL) and quenched by the sequential additions of H2O and 10% NaOH (wt.%, aq) [4.7 
mL H2O, 4.7 mL NaOH solution, 14.1 mL H2O]. The mixture was allowed to warm to 






The reaction was filtered over celite (wash with EtOAc, dichloromethane, and MeOH) 
and concentrated under reduced pressure. Purification via flash chromatography provided 
the corresponding diol (3.14.4, 17.0 mg, 0.038 mmol, 83% yield) as a colorless oil. 
FTIR (neat): 3398 (br), 3070, 2959, 2930, 2893, 1462, 1427, 1377, 1111, 999, 972, 914, 
822, 702, 611, 505 cm-1; 
Optical Rotation: [α]D = +10.9 (c = 0.17, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.71 – 7.66 (m, 4H, aromatic C-H x 4), 7.47 – 7.36 (m, 
6H, aromatic C-H x 6), 5.73 (ddd, J = 17.9, 9.8, 8.4 Hz, 1H, -CH(OH)-CH(CH3)-
CH=CH2), 5.63 – 5.58 (m, 2H, -CH(OH)-CH(CH3)-CH=CH-CH2-OTBDPS), 5.18 – 5.12 
(m, 2H, -CH(OH)-CH(CH3)-CH=CH2), 4.19 (d, J = 3.7 Hz, 2H, -CH=CH-CH2-
OTBDPS), 3.71 (dtd, J = 20.8, 7.2, 3.4 Hz, 2H, -CH(OH)-CH2-CH(OH)-), 2.43 (d, J = 
5.1 Hz, 1H, O-H), 2.31 (q, J = 6.7 Hz, 1H, -CH(CH3)-CH=CH-CH2-OTBDPS), 2.24 (dt, 
J = 8.2, 6.8 Hz, 1H, -CH(OH)-CH(CH3)-CH=CH2), 2.11 (d, J = 3.3 Hz, 1H, O-H), 1.62 
(ddd, J = 7.5, 5.7, 3.3 Hz, 2H, -CH(OH)-CH2-CH(OH)-), 1.09 – 1.03 (M, 12H, -
OSi(Ph)2-C(CH3)3, -CH(OH)-CH(CH3)-CH=CH-CH2-), 1.00 (d, J = 6.8 Hz, 3H, -
CH(OH)-CH(CH3)-CH=CH2); 
13C NMR (126 MHz, CDCl3) δ 140.5 (CH), 135.6 (4 x aromatic CH), 133.78 (aromatic 
C), 133.76 (aromatic C), 132.7 (CH), 129.9 (CH), 129.6 (2 x aromatic CH), 127.6 (4 x 
aromatic CH), 116.9 (CH2), 72.2 (CH), 72.1 (CH), 64.4 (CH2), 44.5 (CH), 42.5 (CH), 
36.6 (CH2), 26.8 (Si-C(CH3)3), 19.2 (Si-C(CH3)3), 16.3 (CH3), 15.9 (CH3); 




diol (C28H40O3Si, 3.14.5) 
 
To a stirring solution of 3.14.8-SI (30 mg, 0.057 mmol) in THF (1 mL) under argon was 
added LiAlH4 (4.3 mg, 0.11 mmol) in one portion at 0 oC. The reaction stirred at 0 oC for 
1 hour (complete by TLC), at which point the reaction was diluted with EtOAc (~1 mL) 
and quenched by the sequential additions of H2O and 10% NaOH (wt.%, aq) [4.3 mL 
H2O, 4.3 mL NaOH solution, 12.9 mL H2O]. The mixture was allowed to warm to room 
temperature and stir at room temperature for 2 hours (white precipitate formed). The 
reaction was filtered over celite (wash with EtOAc, dichloromethane, and MeOH) and 
concentrated under reduced pressure. Purification via flash chromatography provided the 
corresponding diol (3.14.5, 22 mg, 0.049 mmol, 86% yield) as a colorless oil. 
FTIR (neat): 3412 (br), 2959, 2930, 1462, 1427, 1379, 1111, 997, 974, 914, 739, 702, 
613, 503 cm-1; 
Optical Rotation: [α]D = +11.4 (c = 0.22, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.71 – 7.65 (m, 4H, aromatic C-H x 4), 7.47 – 7.36 (m, 
6H, aromatic C-H x 6), 5.83 – 5.73 (m, 1H, -CH(OH)-CH(CH3)-CH=CH2), 5.67 (dt, J = 
15.5, 4.6 Hz, 1H, -CH(OH)-CH(CH3)-CH=CH-CH2-OTBDPS), 5.59 (ddt, J = 15.4, 8.1, 
1.4 Hz, 1H, -CH(OH)-CH(CH3)-CH=CH-CH2-OTBDPS), 5.13 (dqd, J = 13.7, 1.9, 1.0 
Hz, 2H, -CH(OH)-CH(CH3)-CH=CH2), 4.21 (dd, J = 4.6, 1.4 Hz, 2H, -CH=CH-CH2-




OTBDPS), 3.80 – 3.59 (m, 2H, -CH(OH)-CH2-CH(OH)-), 2.41 (d, J = 3.3 Hz, 1H, O-H), 
2.26 (dddd, J = 14.0, 6.9, 3.0, 1.4 Hz, 2H, -CH(OH)-CH(CH3)-CH=CH2, -CH(OH)-
CH(CH3)-CH=CH-CH2-OTBDPS), 2.19 (d, J = 3.1 Hz, 1H, O-H), 1.63 (dt, J = 7.5, 3.5 
Hz, 2H, -CH(OH)-CH2-CH(OH)-), 1.07 (s, 9H, -OSi(Ph)2-C(CH3)3), 1.03 (d, J = 6.8 Hz, 
3H, -CH(OH)-CH(CH3)-), 1.00 (d, J = 6.8 Hz, 3H, -CH(OH)-CH(CH3)-); 
13C NMR (126 MHz, CDCl3) δ 140.7 (CH), 135.5 (4 x aromatic CH), 133.72 (aromatic 
C), 133.71 (aromatic C), 132.3 (CH), 131.2 (CH), 129.7 (2 x aromatic CH), 127.7 (4 x 
aromatic CH), 116.3 (CH2), 72.0 (CH), 71.8 (CH), 64.3 (CH2), 44.3 (CH), 42.9 (CH), 
36.4 (CH2), 26.9 (Si-C(CH3)3), 19.2 (Si-C(CH3)3), 16.4 (CH3), 16.1 (CH3); 
HRMS cald for C28H40O3SiK (M+K)+ 491.2384; found 491.2381 (TOF MS ES+). 
(1R,6S,8S)-8-((R,E)-4-((tert-butyldiphenylsilyl)oxy)-3-hydroxybut-1-en-1-yl)-2,9,10-
trioxa-1-phosphabicyclo[4.3.1]dec-4-ene 1-oxide (C26H33O6PSi, 3.8.5-SI) 
 
To a stirring solution of (SP,S,S)-bicyclic phosphate5 3.8.2 (95 mg, 0.47 mmol) under 
argon was added dry, degassed methylene chloride (4.7 mL), (R)-1-((tert-
butyldiphenylsilyl)oxy)but-3-en-2-ol8 (461 mg, 1.41 mmol), p-benzoquinone (5.1 mg, 
0.047 mmol), then Hoveyda-Grubbs second generation catalyst (8.8 mg, 0.0141 mmol, 3 
mol %), and the reaction was heated to reflux. The reaction stirred at reflux for 3 hours, 










mol %) was added. The reaction continued to stir for 18 hours (progression stalled by 
TLC). The reaction was concentrated under reduced pressure, and the crude mixture was 
purified via flash chromatography (silica, 0%–100% EtOAc in hexanes) to provide title 
3.8.5-SI (0.136 g, 0.272 mmol, 58% yield) as an off-white foam. 
FTIR (neat): 3398 (br), 3070, 2930, 2856, 1462, 1427, 1294, 1113, 1067, 1036, 997, 968, 
922, 883, 824, 775, 744, 704, 613 505, 490 cm-1; 
Optical Rotation: [α]D = +49.0 (c = 0.26, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.68 – 7.62 (m, 4H, aromatic C-H x 4), 7.48 – 7.37 (m, 
6H, aromatic C-H x 6), 6.05 (dddd, J = 11.9, 6.7, 3.1, 2.1 Hz, 1H, (P)O-CH-CH=CH-
CH2-O(P)), 5.88 – 5.76 (m, 2H, -CH=CH-CH(OH)-CH2OTBDPS), 5.60 (ddd, J = 11.9, 
4.0, 2.6 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.18 (dddt, J = 24.5, 6.1, 3.7, 1.9 Hz, 1H, 
(P)O-CH-CH=CH-CH2-O(P)), 5.07 – 4.96 (m, 2H, -CH2-(P)O-CH-CH=CH-CH(OH)-
CH2OTBDPS, (P)O-CHaHb-CH=CH-), 4.38 (ddd, J = 27.7, 14.9, 7.1 Hz, 1H, (P)O-
CHaHb-CH=CH-), 4.28 (dt, J = 7.1, 3.6 Hz, 1H, -CH=CH-CH(OH)-CH2OTBDPS), 3.71 
(dd, J = 10.3, 3.7 Hz, 1H, -CH=CH-CH(OH)-CHaHbOTBDPS), 3.53 (dd, J = 10.2, 7.3 
Hz, 1H, -CH=CH-CH(OH)-CHaHbOTBDPS), 2.69 (s, 1H, -CH=CH-CH(OH)-
CH2OTBDPS), 2.20 (ddd, J = 14.8, 12.0, 6.2 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.75 
(dq, J = 14.7, 2.0 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.08 (s, 9H, -OSi(Ph)2-C(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 135.52 (Aromatic CH x 2), 135.48 (Aromatic CH x 2), 
132.9 (Aromatic C), 132.8 (Aromatic C), 131.6 (CH), 129.9 (Aromatic CH x 2), 129.6 
(CH), 128.14 (CH), 128.06 (CH), 127.8 (Aromatic CH x 4), 76.9 (d, JCP = 6.6 Hz, CH), 
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75.5 (d, J = 5.7 Hz, CH), 71.5 (CH), 67.4 (CH2), 63.0 (d, JCP = 6.4 Hz, CH2), 35.1 (d, JCP 
= 5.5 Hz, CH2), 26.8 (Si-C(CH3)3), 19.2 (Si-C(CH3)3); 
31P NMR (162 MHz, CDCl3) δ 0.85 – -9.88 (m); 
HRMS cald for C26H33O6PSiNa (M+Na)+ 523.1682; found 523.1699 (TOF MS ES+). 
 
(R,E)-1-((tert-butyldiphenylsilyl)oxy)-4-((1R,6S,8S)-1-oxido-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-en-8-yl)but-3-en-2-yl diethyl phosphate (C30H42O9P2Si, 
3.8.1) 
 
To a solution of 3.8.5-SI (56 mg, 0.119 mmol) in methylene chloride (dry, degassed, 1.1 
mL) was added N,N-diisopropyl(ethyl)amine (39 mL, 0.224 mmol) under argon, and the 
reaction flask was cooled to an external temperature of -30oC where 
diethylchlorophosphite (18 mL, 0.123 mmol) was added. The reaction was allowed to 
warm to 0 oC over 30 minutes (complete conversion by TLC), where tBuOOH (25 mL, 5-
6 M in decanes) was added. The reaction was allowed to warm to RT and continued to 
stir at room temperature for 2 hours (complete by TLC). Excess peroxide was quenched 
with solid sodium sulfite, and the heterogeneous mix stirred for 30 minutes to ensure a 
complete quench. The reaction was filtered over cotton, concentrated under reduced 










wash with 10% MeOH in EtOAc) to provide 3.8.1 (41.7 mg, 0.0655 mmol, 59% yield) as 
a colorless, viscous oil. 
FTIR (neat): 3070, 3046, 2980, 2930, 2858, 1472, 1427, 1393, 1302, 1263, 1113, 1069, 
1033, 997, 974, 924, 883, 822, 797, 743, 706, 613, 505 cm-1; 
Optical Rotation: [α]D = +25.4 (c = 0.67, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.66 (dq, J = 6.5, 1.7 Hz, 4H, aromatic C-H x 4), 7.47 – 
7.35 (m, 6H, aromatic C-H x 6), 6.07 (dddd, J = 11.8, 6.7, 3.1, 2.0 Hz, 1H, (P)O-CH-
CH=CH-CH2-O(P)), 5.96 – 5.83 (m, 2H, -CH=CH-CH(O(PO(OEt)2))-CH2OTBDPS), 
5.60 (ddd, J = 11.9, 4.1, 2.5 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.19 (ddq, J = 24.5, 
6.5, 2.1 Hz, 1H, (P)O-CH-CH=CH-CH2-O(P)), 5.04 (dddt, J = 15.0, 12.1, 5.6, 2.3 Hz, 
2H, -CH2-(P)O-CH-CH=CH-CH(O(P(O)(OEt)2))-CH2OTBDPS, -(P)O-CHaHb-CH=CH-
), 4.93 – 4.85 (m, 1H, -CH=CH-CH(O(P(O)(OEt)2))-CH2OTBDPS), 4.40 (ddd, J = 27.8, 
14.8, 6.7 Hz, 1H, -(P)O-CHaHb-CH=CH-), 4.13 – 4.00 (m, 4H, -P(O)(OCH2CH3)2), 3.84 
– 3.76 (m, 1H, -CHaCHb-OTBDPS), 3.70 (ddd, J = 10.8, 5.2, 1.6 Hz, 1H, -CHaCHb-
OTBDPS), 2.18 (ddd, J = 14.8, 11.9, 6.2 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.76 (ddt, 
J = 14.7, 2.3, 1.2 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.29 (dtd, J = 15.3, 7.1, 1.1 Hz, 
6H, -P(O)(OCH2CH3)2), 1.05 (d, J = 1.7 Hz, 9H, -OSi(Ph)2-C(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 135.56 (aromatic CH x 2), 135.52 (aromatic CH x 2), 
132.97 (aromatic C), 132.91 (aromatic C), 130.3 (d, JCP = 10.4 Hz, CH), 129.84 
(aromatic CH), 129.81 (aromatic CH), 129.5 (CH), 129.0 (d, JCP = 3.6 Hz, CH), 128.2 
(CH), 127.75 (aromatic CH x 2), 127.74 (aromatic CH x 2), 77.8 (d, JCP = 5.6 Hz, CH), 
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76.90 (d, JCP = 6.7 Hz, CH), 75.1 (d, J = 5.9 Hz, CH), 65.9 (d, JCP = 6.8 Hz, CH2), 63.83 
(d, JCP = 3.0 Hz, CH2), 63.78 (d, JCP = 2.9 Hz, CH2), 63.01 (d, J = 6.4 Hz, CH2), 35.0 (d, 
JCP = 5.8 Hz, CH2), 26.7 (Si-C(CH3)3), 19.2 (Si-C(CH3)3), 16.1 (d, JCP = 7.0 Hz, CH3), 
16.04 (d, JCP = 7.6 Hz, CH3); 
31P NMR (162 MHz, CDCl3) δ -1.77 (q, J = 7.9 Hz), -4.48 (t, J = 25.7 Hz); 
HRMS cald for C30H42O9P2SiNa (M+Na)+ 659.1971; found 659.1974 (TOF MS ES+). 
 
(2R,3R,E)-1-((tert-butyldiphenylsilyl)oxy)-6-((4S)-2-methoxy-2-oxido-4,7-dihydro-
1,3,2-dioxaphosphepin-4-yl)-3-methylhex-4-en-2-yl diethyl phosphate (C32H48O9P2Si, 
3.8.4) 
 
In a glovebox, under argon, CuCN (9.0 mg, 0.094 mmol) and LiCl (8.0 mg, 0.19 mmol) 
were added to a pear-shaped flask equipped with a magnetic stirbar. The flask was 
capped with a rubber septum, removed from the glovebox, and equipped with an argon 
inlet. THF (0.19 mL) was added the flask, and the mix stirred at room temperature to 
dissolve all solids (~25 min). The flask was cooled to an external temperature of -30oC, 
and Me2Zn (0.09 mL, 1.0 M in hexanes) was added to the reaction mixture, drop-wise, 
slowly. The mix continued to stir at -30oC for 1 hour to generate the active 
(dimethyl)cyanocuprate. The flask was then cooled to -40oC, where 3.8.1 (20 mg, 0.031 










20oC while for 50 minutes (complete by TLC). The reaction was quenched with saturated 
NH4Cl (aq, 1 mL) and diluted with EtOAc (1 mL) at -20oC and vigorously stirred, open 
to air, while warming to +10oC over 1 H. The biphasic solution was separated, and the 
aqueous layer extracted with EtOAc [5 x 3 mL] doped with nBuOH [3-4 drops per mL 
EtOAc). The organic layers were combined, washed with saturated NH4Cl (2 mL), dried 
over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude 
material was taken up in MeOH (~0.4 mL), and TMS-diazomethane (0.05 mL, 2.0 M in 
diethyl ether) was added dropwise, slowly, at room temperature. (Note: when added too 
quickly, the TMS-diazomethane will cause the reaction to heat and effervesce. For large 
batches—or small, the reaction flask can be cooled to 0oC to control the fluctuation of 
temperature and decrease the sensitivity of the reaction to the rate of addition of TMS-
diazomethane.) The reaction stirred for 12 H, where another 1.5 equivalents of TMS-
diazomethane (25 mL) was added, and the reaction stirred for 1 hour at RT (complete by 
TLC). Excess TMS-diazomethane was quenched with 3 drops of glacial acetic acid, and 
the reaction was diluted with EtOAc (2 mL) and stirred at room temperature for 10 
minutes (Note: complete quench is accompanied by a color change—from deep yellow to 
colorless). The mix was then dried over Na2SO4, filtered over celite (pipette filter), and 
concentrated under reduced pressure. The crude mix was separated by flash 
chromatography (silica, 0-100% EtOAc in hexanes) and title compound 3.8.4 (10.6 mg, 
0.016 mmol, 52% yield) was isolated as a colorless oil and an inseparable mixture of 
diastereomers at the chiral phosphorus (dr ~ 1:1). 
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FTIR (neat): 2859, 2932, 2856, 1462, 1427, 1391, 1281, 1113, 1032, 824, 704, 613,  
505 cm-1; 
Optical Rotation: [α]D = + 15.2 (c = 0.27, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 7.66 (ddt, J = 7.8, 6.3, 1.5 Hz, 8H), 7.47 – 7.35 (m, 12H), 
5.68 – 5.56 (m, 4H), 5.54 – 5.38 (m, 4H), 5.14 – 5.05 (m, 1H), 4.98 – 4.85 (m, 2H), 4.72 
(ddq, J = 14.4, 8.5, 2.7 Hz, 1H), 4.57 – 4.39 (m, 2H), 4.34 (ddd, J = 10.0, 7.6, 4.8 Hz, 
2H), 4.13 – 3.95 (m, 8H), 3.84 (dd, J = 11.1, 3.1 Hz, 6H), 3.78 (dtd, J = 11.3, 6.4, 5.8, 3.1 
Hz, 2H), 3.71 – 3.61 (m, 2H), 2.76 (ddd, J = 12.0, 5.5, 3.0 Hz, 2H), 2.47 – 2.30 (m, 4H), 
1.29 (tt, J = 7.1, 1.4 Hz, 6H), 1.23 (tt, J = 7.0, 1.3 Hz, 6H), 1.11 – 1.02 (m, 24H); 
13C NMR (126 MHz, CDCl3) δ 135.6 (aromatic CH x 4), 135.51 (aromatic CH x 4), 
134.9 (CH), 134.8 (CH), 133.17 (aromatic C), 133.16 (aromatic C), 133.12 (aromatic C), 
133.08 (aromatic C), 130.9 (CH), 130.2 (CH), 129.79 (aromatic CH), 129.76 (aromatic 
CH), 129.74 (aromatic CH x 2), 127.71 (aromatic CH x 4), 127.69 (aromatic CH x 4), 
127.4 (CH), 126.3 (CH), 125.4 (CH), 125.1 (CH), 81.9 (d, JCP = 5.4 Hz, CH), 81.86 (d, 
JCP = 6.3 Hz, CH), 74.4 (d, JCP = 7.3 Hz, CH), 74.0 (d, JCP = 4.7 Hz, CH), 64.5 (d, JCP = 
4.9 Hz, CH2), 64.2 (d, JCP = 7.1 Hz, CH2), 63.63 (d, JCP = 6.1 Hz, CH2), 63.57 (d, JCP = 
5.8 Hz, CH2), 63.52 (CH2), 63.49 (CH2), 54.6 (d, JCP = 5.2 Hz, CH3), 54.5 (d, JCP = 5.2 
Hz, CH3), 39.0 (d, JCP = 9.9 Hz, CH2), 38.9 (d, JCP = 9.9 Hz, CH2), 38.33 (d, JCP = 4.2 
Hz, CH), 38.28 (d, JCP = 4.5 Hz, CH), 26.8 (-Si(Ph2)(C(CH3)3 x 2), 19.2 (-
Si(Ph2)(C(CH3)3 x 2), 16.8 (-CH3), 16.6 (-CH3), 16.13 (d, JCP = 6.9 Hz, -
OP(O)(OCH2CH3)2), 16.05 (d, JCP = 7.1 Hz, -OP(O)(OCH2CH3)2). 
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31P NMR (162 MHz, CDCl3) δ 3.16, -1.30 (d, J = 8.1 Hz); 
31P NMR-{1H} (162 MHz, CDCl3) δ 3.20, 3.11, -1.30; 




5.2.3 NMR Spectra 




































































































































































































 (E)-3-((1R,6R,8R)-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-8-yl)allyl acetate 1-



































































































































































































































































































































































































































































diol (C28H40O3Si, 3.14.5) 
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5.3.1 General Methods 
All reactions were carried out in oven- or flame-dried glassware under argon atmosphere 
using standard gas-tight syringes, cannulae, and septa.  Stirring was achieved with oven-
dried magnetic stir bars. Et2O, THF and CH2Cl2 were purified by passage through a 
purification system (Solv-Tek) employing activated Al2O3  (Grubbs, R. H.; Rosen, R. K.; 
Timmers, F. J. Organometallics 1996, 15, 1518–1520).  Et3N was purified by passage 
over basic alumina and stored over KOH.  Butyllithium was purchased from Aldrich and 
titrated prior to use.  All olefin metathesis catalysts were acquired from Materia and used 
without further purification.  Flash column chromatography was performed with Sorbent 
Technologies (30930M-25, Silica Gel 60A, 40-63 mm) and thin layer chromatography 
was performed on silica gel 60F254 plates (EM-5717, Merck).  Deuterated solvents were 
purchased from Cambridge Isotope laboratories. 1H, 13C, and corresponding 2D NMR 
spectra were recorded in CDCl3 (unless otherwise mentioned) on a Bruker DRX-500 
spectrometer operating at 500 MHz, and 125 MHz, respectively and calibrated to the 
solvent peak. 31P and 1H-decoupled 31P NMR spectra were recorded on a Bruker DRX-
400 spectrometer operating at 162 MHz. High-resolution mass spectrometry (HRMS) 
was recorded on a LCT Premier Spectrometer (Micromass UK Limited) operating on 
ESI-positive mode (MeOH). Observed rotations at 589 nm, were measured using 









To a solution of 2-methyl-3-buten-1-ol (1.35 g, 15.6 mmol) in THF (31 mL), under argon 
at -40 oC, was added n-butyllithium (6.3 mL, 2.5 M in hexanes), dropwise. The reaction 
mixture stirred at -30 oC for 15 minutes, at which point a solution of 
monochlorophosphate (S,S)-2.2A1 (3.59 g, 17.2 mmol) in THF (34 mL) was added 
dropwise, slowly. The reaction continued to stir at -40 oC for 30 minutes (complete by 
TLC), and the flask was removed from the cooling bath and quenched with saturated 
NH4Cl (aqueous, ~40 mL). The mixture was stirred, vigorously, as the flask warmed to 
room temperature, and then the biphasic solution was separated. The aqueous layer was 
extracted with EtOAc (3 x 50 mL), and the organic layers were combined, washed with 
brine, dried over Na2SO4, and concentrated under reduced pressure. The crude mixture 
was purified via flash column chromatography (silica, 0%–60% EtOAc in hexanes) to 
provide triene 4.6.2 (3.24 g, 12.5 mmol, 80% yield) as a colorless liquid and a 1:1 
mixture of inseparable diastereomers. 
                                                
[1]Whitehead, A.; McReynolds, M. D.; Moore, J. D.; Hanson, P. R. Multivalent 
Activation in Temporary Phosphate Tethers: A New Tether for Small Molecule 









FTIR (neat): 2966, 2934, 2895, 1423, 1283, 1119, 1013, 966, 928, 876, 756, 725 cm-1; 
Optical Rotation: [α]D = –61.7 (c = 0.54, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 6.07 – 5.99 (m, 2H), 5.94 – 5.86 (m, 2H), 5.75 (dddd, J = 
17.4, 10.5, 7.0, 3.5 Hz, 2H), 5.46 (dt, J = 17.1, 1.2 Hz, 2H), 5.37 (dt, J = 17.2, 1.1 Hz, 
2H), 5.31 (dt, J = 3.5, 1.2 Hz, 2H), 5.29 (dt, J = 3.5, 1.1 Hz, 2H), 5.14 – 5.08 (m, 2H), 
5.09 – 5.00 (m, 4H), 4.97 (dtdt, J = 8.5, 5.2, 3.4, 1.6 Hz, 2H), 4.03 – 3.91 (m, 4H), 2.63 – 
2.49 (m, 2H), 2.17 (dddd, J = 14.8, 8.3, 4.9, 1.5 Hz, 2H), 2.07 – 1.99 (m, 2H), 1.06 (dd, J 
= 6.8, 0.7 Hz, 6H); 
13C NMR (126 MHz, CDCl3) δ 139.49 (d, JCP = 5.6 Hz, CH x 2), 135.1 (CH x 2), 135.0 
(d, JCP = 4.0 Hz, CH x 2), 118.13 (CH2), 118.11 (CH2), 117.46 (CH2), 117.45 (CH2), 
115.53 (CH2), 115.47 (CH2), 77.9 (d, JCP = 6.8 Hz, CH x 2), 76.04 (d, JCP = 5.8 Hz, CH), 
76.01 (d, JCP = 6.0 Hz, CH), 71.6 (d, JCP = 6.3 Hz, CH2 x 2), 38.3 (d, JCP = 7.3 Hz, CH), 
38.2 (d, JCP = 6.9 Hz, CH), 35.21 (d, JCP = 7.6 Hz, CH2), 35.17 (d, JCP = 7.9 Hz, CH2), 
16.1 (CH3), 16.0 (CH3); 
31P NMR (162 MHz, CDCl3) δ –7.66 (dp, J = 13.3, 6.6 Hz); 





ene 1-oxide (C10H15O4P, 4.5D) 
 
To a round bottom flask, equipped with a stirbar, reflux condenser, and argon inlet, was 
added triene 4.6.2 (2.50 g, 9.68 mmol), CH2Cl2 (1383 mL), and Grubbs second-
generation catalyst [(ImesH2)(PCy3)(Cl)2Ru=CHPh,2 G-II, 123 mg, 1.5 mol %]. The 
reaction mixture was heated to reflux and stirred at reflux for 2 hours to ensure complete 
conversion of reactive starting material (~1:1 mix of starting material and product by 
TLC). The reaction mix was cooled to room temperature and concentrated under reduced 
pressure. Purification via flash column chromatography (silica, 0%–70% EtOAc in 
hexanes) provided bicyclic phosphate 4.5D (0.850 g, 3.69 mmol, 38% yield) as a white 
solid, along with unreacted starting material (0.800 g, 3.098 mmol). 
FTIR (neat): 2964, 2932, 2893, 1464, 1429, 1286, 1130, 1080, 1059, 1020, 966, 932, 
850, 837, 820, 735, 500 cm-1; 
Optical Rotation: [α]D = –138. (c = 0.57, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 5.83 (dddd, J = 17.1, 10.6, 5.4, 2.1 Hz, 1H, -CH=CH2), 
5.46 – 5.43 (m, 2H, (P)O-CH-CH=CH-CH(CH3)-), 5.40 (dt, J = 17.1, 1.2 Hz, 1H, -
CH=CHaHb), 5.29 – 5.21 (m, 2H, -CH=CHaHb, (P)O-CH-CH=CH-CH(CH3)-), 5.06 (ddt, 
                                                
[2] Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Synthesis and Activity of a New 
Generation of Ruthenium-Based Olefin Metathesis Catalysts Coordinated with 1,3-








J = 11.9, 5.4, 1.5 Hz, 1H, (P)O-CH(CH2)-CH=CH2), 4.30 (ddd, J = 10.8, 6.2, 2.1 Hz, 1H, 
-CH=CH-CH(CH3)-CHaHb-O(P)), 3.60 – 3.50 (m, 1H, (P)O-CH-CH=CH-CH(CH3)-), 
3.32 (ddd, J = 31.0, 12.6, 10.8 Hz, 1H, -CH=CH-CH(CH3)-CHaHb-O(P)), 2.18 (dddd, J = 
14.6, 11.9, 6.0, 0.8 Hz, 1H, (P)O-CH-CHaHb-CH-O(P)), 1.87 – 1.77 (m, 1H, (P)O-CH-
CHaHb-CH-O(P)), 0.99 (d, J = 6.6 Hz, 3H, (P)O-CH-CH=CH-CH(CH3)-); 
13C NMR (126 MHz, CDCl3) δ 135.0 (d, JCP = 10.0 Hz, CH), 134.0 (CH), 129.3 (CH), 
117.2 (CH2), 77.9 (d, JCP = 7.2 Hz, CH), 77.1 (d, JCP = 6.0 Hz, CH), 68.1 (d, JCP = 5.3 
Hz, CH2), 36.2 (d, JCP = 6.4 Hz, CH2), 31.1 (CH), 16.5 (CH3); 
31P NMR (162 MHz, CDCl3) δ –8.02 (dd, J = 30.7, 24.8 Hz); 
HRMS cald for C20H30O8P2Na (2M+Na)+ 483.1314; found 483.1333 (TOF MS ES+). 
 
(2S,5S,7S)-2-methyldodecane-1,5,7-triol (C13H28O3, 3.9.4) 
 
To a clean, dry round bottom flask equipped with a stirbar, reflux condenser, and argon 
inlet, was added 4.5D (60.0 mg, 0.261 mmol), 1,2-dichloroethane (1,2-DCE, 2.6 mL), 
cis-4-octene (73.1 mg, 0.652 mmol), and Hoveyda-Grubbs second-generation catalyst 
(HG-II, 9.7 mg, 6 mol %). The reaction was heated to 40 oC and stirred at 40 oC until 
4.5D was consumed (2 h, monitored by TLC). The reaction was cooled to room 
temperature and cannulated into a Parr hydrogenation reaction vessel. The vessel was 






under H2 pressure, for 16 h (complete by TLC), at which point the reaction was cooled to 
room temperature and solvent removed under reduced pressure. The crude oil was dried 
under high vacuum (~8 h) to ensure complete removal of 1,2-DCE. The crude mix was 
taken up in diethyl ether (Et2O, 4.3 mL) and cooled to 0 oC under argon. Solid lithium 
aluminum hydride (29.7 mg, 0.782 mmol) was added in one portion, and the reaction 
flask was removed from the cooling bath and allowed to warm to room temperature. The 
mixture stirred at room temperature for 1 hour (complete by TLC), and the reactiom was 
cooled to 0 oC and quenched by sequential addition of H2O and 10% NaOH (w/v, aq) [30 
µL H2O, 30 µL NaOH sln, 90 µL of H2O]. The reaction was allowed to warm to room 
temperature and stir at room temperature overnight (white solids formed). The crude 
mixture was filtered over celite (washed with CH2Cl2, EtOAc, and MeOH) and 
concentrated under reduced pressure. Purification via flash column chromatography 
(silica, 0%–100% EtOAc in hexanes) provided 4.5C (34.8 mg, 0.150 mmol, 57% yield 
over 3 reactions in one pot, 83% average per reaction) as a white solid. 
FTIR (neat): 3333 (br), 2930, 2872, 1462, 1454, 1121, 1034, 829  cm-1; 
Optical Rotation: [α]D = –2.5 (c = 0.28, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 4.01 – 3.85 (m, 2H), 3.59 – 3.40 (m, 2H), 3.08 (s, 1H), 
2.72 (s, 1H), 2.13 (s, 1H), 1.74 – 1.39 (m, 9H), 1.38 – 1.22 (m, 6H), 0.95 – 0.83 (m, 6H); 
13C NMR (126 MHz, CDCl3) δ 69.5 (CH), 69.2 (CH), 67.9 (CH2), 42.5 (CH2), 37.4 
(CH2), 35.3 (CH), 34.3 (CH2), 31.8 (CH2), 29.0 (CH2), 25.5 (CH2), 22.6 (CH2), 16.6 
(CH3), 14.0 (CH3); 
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To a round bottom flask, equipped with a stirbar, was added 4.5C (5.0 mg, 0.022 mmol), 
CH2Cl2 (0.4 mL), TEMPO (0.3 mg, 0.0022 mmol, 10 mol%), tetrabutylammonium 
chloride (TBACl, 0.6 mg, 0.0022 mmol, 10 mol%), and aqueous NaHCO3/K2CO3 buffer 
(0.4 mL, 0.5 M NaHCO3: 0.05 M K2CO3). To the stirring biphasic solution was added N-
chlorosuccinimide (14.4 mg, 0.1075 mmol, 5 equiv.) in one portion, and the reaction 
continued to vigorously stir at room temperature for 2 hours (complete by TLC). The 
biphasic solution was diluted with CH2Cl2 (0.5 mL) and water (0.5 mL), and the layers 
separated. The aqueous layer was extracted with CH2Cl2 (3 x 1.5 mL), and the organic 
layers were combined, dried over Na2SO4, filtered over celite, and concentrated under 
reduced pressure. Purification via flash column chromatography (silica, 0%-50% EtOAc 
in hexanes) provided 4.8.1 (4.7 mg, 0.021 mmol, 96% yield) as a colorless liquid. 
FTIR (neat): 3435 (br), 2953, 2930, 2858, 1738, 1726, 1462, 1454, 1379, 1227, 1200, 
1117, 1082, 1024, 935 cm-1; 






1H NMR (500 MHz, CDCl3) δ 4.64 (tt, J = 11.3, 3.0 Hz, 1H), 3.97 (t, J = 8.3 Hz, 1H), 
2.64 (ddq, J = 10.6, 8.2, 6.8 Hz, 1H), 2.12 (dddd, J = 13.6, 9.6, 8.1, 7.2 Hz, 1H), 1.92 
(dddd, J = 13.9, 9.4, 4.3, 3.4 Hz, 1H), 1.77 (ddd, J = 14.6, 9.8, 2.3 Hz, 1H), 1.67 (dddd, J 
= 14.0, 7.0, 4.1, 2.4 Hz, 2H), 1.61 – 1.54 (m, 2H), 1.49 – 1.39 (m, 3H), 1.30 (tdd, J = 
15.0, 13.8, 6.9, 4.5 Hz, 5H), 1.23 (d, J = 6.7 Hz, 3H), 0.93 – 0.86 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 176.5 (C=O), 74.8 (CH), 67.6 (CH), 42.8 (CH2), 38.1 
(CH2), 33.2 (CH), 31.8 (CH2), 27.2 (CH2), 25.7 (CH2), 25.2 (CH2), 22.6 (CH2), 16.1 
(CH3), 14.0 (CH3); 
HRMS cald for C13H24O3Na (M+Na)+ 251.1623; found 251.1612 (TOF MS ES+).  
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(2S,5S,7S)-2-methyldodecane-1,5,7-triol (C13H28O3, 3.9.4) 
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(3S,6S)-6-((S)-2-hydroxyheptyl)-3-methyltetrahydro-2H-pyran-2-one (C13H24O3, 
4.8.1) 
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